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MR-based protein imaging of the human brain bymeans of dualCEST
Chemical exchange saturation transfer (CEST) is an emerging magnetic resonance imaging
(MRI) technique enabling indirect detection of low-concentration cellular compounds in living
tissue by their magnetization transfer with water. In particular, protein-attributed CEST sig-
nals have been shown to provide valuable diagnostic information for various diseases. While
conventional CEST approaches suffer from confounding signals from metabolites and macro-
molecules, the novel dual-frequency irradiation CEST (dualCEST) technique enables increased
protein specificity by selectively detecting the intramolecular spin-diffusion. However, applica-
tion of this technique has so far been limited to spectroscopic investigations of model solutions
at ultrahigh magnetic field strengths.
In this thesis, dualCEST was translated to a clinical whole-body MR scanner, enabling protein
imaging of the human brain. To this end, several methodological developments were imple-
mented and optimized: (i) improved dual-frequency pulses for signal preparation, (ii) a fast and
robust volumetric image readout, (iii) a weighted acquisition scheme, and (iv) an adaptive de-
noising technique. The resulting improvements are not limited to dualCEST but are relevant
for the research field of CEST-MRI in general. Extensive measurements of biochemical model
solutions and volunteers demonstrated the protein specificity and reproducibility of dualCEST-
MRI. The clinical applicability was verified in pilot studies with tumor and Alzheimer’s patients.
MR-basierte Protein-Bildgebung desmenschlichen Gehirns mittels dualCEST
Chemical Exchange Saturation Transfer (CEST) ist eine neuartige Magnetresonanz-
Bildgebungstechnik, welche eine indirekte Detektion von niedrig konzentrierten organischen
Verbindungen in lebendem Gewebe anhand ihres Magnetisierungstransfers mit Wasser er-
möglicht. Insbesondere mit Proteinen in Verbindung gebrachte CEST-Signale konnten dabei
bereits wertvolle diagnostische Informationen für etliche Erkrankungen liefern. Während kon-
ventionelle CEST-Ansätze durch überlagernde Signale von Metaboliten und Makromolekülen
beeinträchtigt werden, erreicht die neue Dual-Frequency Irradiation CEST (dualCEST)-
Technik eine erhöhte Proteinspezifizität mittels selektiver Detektion von intramolekularen
Spindiffusionsprozessen. Eine Anwendung der neuen Technik war bisher jedoch nur für
spektroskopische Untersuchungen von Modellösungen bei ultrahohen Magnetfeldstärken
möglich.
In dieser Arbeit wurde die dualCEST-Technik nun erstmals auf einen klinischen Ganzkörper-
tomographen übertragen, so dass eine Proteinbildgebung des menschlichen Gehirns möglich ist.
Zu diesem Zwecke wurden methodische Weiterentwicklungen für alle relevanten Teilbereiche
der Technik implementiert und optimiert: (i) verbesserte Sättigungspulse für die Signalpräpa-
ration, (ii) eine schnelle und robuste 3D Bildauslese, (iii) eine gewichtete Bildaufnahme, sowie
(iv) einen Algorithmus zur Rauschunterdrückung. Die erzielten Fortschritte sind dabei nicht auf
dualCEST beschränkt, sondern relevant für das CEST-Forschungsfeld im Allgemeinen. Um-
fangreiche Untersuchungen an biochemischen Modelllösungen und Probanden stellten dabei
die Spezifität und Reproduzierbarkeit der dualCEST-Bildgebung unter Beweis. Die klinische
Anwendbarkeit und Leistungsfähigkeit wurde abschließend im Rahmen erster Pilotstudien von
Hirntumor- und Alzheimerpatienten erprobt.
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Medical imaging encompasses different imaging modalities and processes to examine the
human body in order to diagnose or monitor medical conditions. Each type of technol-
ogy contributes different information about the examined part of the body, related to possi-
ble disease, injury, or the effectiveness of medical treatment.1, 2 In general and on a rough
level they can be divided into primarily anatomical modalities such as computed tomog-
raphy (CT), ultrasonography (US) and magnetic resonance imaging (MRI), investigating
structural and morphological details of the patients body, and functional imaging modal-
ities such as positron emission tomography (PET) and single-photon emssion computed
tomography (SPECT), providing information about the physiological activity within a cer-
tain tissue or organ.
In this context, the distinguishing feature of MRI compared to many other imaging modal-
ities is its multiplicity. Besides the excellent soft-tissue contrast utilized for morphological
imaging, MRI provides a wide range of possibilities for functional imaging including the
visualization of blood flow and diffusion processes,3, 4 the mapping of activated brain areas5
and the spectroscopic investigation of the chemical composition of tissues.6 However, con-
ventional spectroscopic imaging techniques have so far been impeded from entering daily
clinical practice due to limitations in the sensitivity, spatial resolution, and scanning time.
Chemical exchange saturation transfer (CEST)-MRI has emerged as an alternative solu-
tion for the imaging of low-concentrated organic compounds in living tissue such as pro-
teins, peptides and various other metabolites, e.g. creatine and glutamate.7–9 In particular
CEST signals attributed to proteins have been shown to provide valuable diagnostic infor-
mation for a variety of diseases, in particular cancer and Alzheimer’s.10–15 However, in living
tissue, various CEST signals from different cellular compounds such as proteins,10, 11, 16, 17
metabolites,18–22 lipids12, 23 and semi-solid macromolecular structures24–26 are superimpos-
ing indistinguishably. Moreover, these signals depend on multiple physiological parameters,
in particular pH and temperature.10, 27, 28 Although by now several attempts have been made
to highlight the signal contribution of proteins by adjusting the CEST pulse scheme, i.e.,
the saturation amplitude or the pulse timing,29–31 to date an exclusive assignment of the
observed effects to solely proteins is practically impossible.
Recently, dual-frequency irradiation CEST (dualCEST)32 has been introduced as a novel
technique to overcome these selectivity limitations. This method enables the selective detec-
tion of endogenous proteins in living tissue without contributions of other saturation transfer
effects by utilizing the coupling between different CEST signals as a distinguishing feature.
In the preceding master thesis33 the approach was extensively investigated in spectrometer
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measurements of model solutions at ultra-high magnetic fields strengths, confirming the
exclusive dependency on the concentration, molecular size and folding state of the mobile
proteins. These results substantiate the potential of dualCEST as a promising tool for the
detection of aberrant proteomes in vivo, and thus novel diagnostic imaging modality.
The aim of this thesis was therefore the translation of the dualCEST technique to a clinical
whole-body scanner (i.e. with a static magnetic field strength B0 ≤ 3T) to enable protein
imaging of the human brain. To achieve this goal, several methodological improvements
were developed and applied: (i) Implementation of dual-frequency pulses allowed for an im-
proved signal preparation, which was additionally refined by (ii) a newly developed weighted
acquisition scheme allowing for an optimal use of the limited examination time. The opti-
mized signal preparation was subsequently combined with (iii) a fast and robust volumet-
ric image readout, which moreover facilitated the application of (iv) a newly developed de-
noising technique. Following the methodological developments, extensive measurements of
biochemical model solutions and volunteers confirmed the protein specificity of dualCEST-
MRI and demonstrated its reproducibility. Furthermore, applicability in a clinical setting
was demonstrated in pilot studies with brain tumor and Alzheimer’s patients.
The following explanations summarize the basic principles of MRI, CEST and dualCEST,
introducing the necessary concepts and methodologies for this study and thereby setting the
general conceptual framework.
1.1 MRI
Following the discovery of the proton spin in the Stern-Gerlach experiment in 1922,34 Isidor
I. Rabi and co-workers35 described and measured in 1938 for the first time nuclear magnetic
resonance. By using oscillating magnetic fields they were able to induce transitions between
the discrete energy levels in a beam of molecules traversing a static magnetic field. In 1946,
based on these observations, the research groups of Felix Bloch36 and Edward M. Purcell37
were – independently of each other – able to demonstrate nuclear magnetic resonance in
condensed matter. In the liquid phase, nuclear magnetic resonance (NMR) experiments are
well described by the empirical Bloch equations,36 which introduce two important kinetic
parameters: the longitudinal relaxation time T1 and the transversal relaxation time T2. The
discovery of the chemical environment dependent dispersion of the nuclear spin resonance
frequency38, 39 gave rise to the field of NMR spectroscopy. This important research tool, uti-
lized in physics and biochemistry, allows information about the electronic structure, binding
characteristics, functional groups, and chemical environment of molecules to be obtained by
analyzing their chemical shifts in the NMR spectrum.
In 1973 Paul C. Lauterbur40 and Sir Peter Mansfield41 demonstrated that by applying ad-
ditional magnetic field gradients the spatial distribution of nuclear spins can be encoded
within the magnetic resonance (MR) signal, hence facilitating imaging. In the following
years magnetic resonance imaging, utilizing the dominant NMR signal of free water pro-
tons, has proven to be one one of the most versatile imaging techniques in particular for
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diagnostic medicine and biomedical research. This success can be explained by the benefi-
cial combination of two factors: the very large abundance of water protons in living tissue
(e.g. 44 M in human brain grey matter) and the strong dispersion of T1 and T2 in different
tissues entailing a unique soft tissue contrast. The latter resulted in T1- and T2-weighted
MRI becoming the workhorse for visualizing the human anatomy and detecting pathologic
alterations.
In addition to these conventional relaxation-weighted imaging contrasts of free water pro-
tons – providing mainly information about structural and macroscopic tissue properties –
several other methods have been developed to provide insights on various scales and levels
of living tissue. Functional MRI (fMRI) for example uses differences in the magnetic prop-
erties of oxygen-rich and oxygen-depleted blood to measure neural activity in the brain.5
Another example is diffusion weighted MRI (DWI), which allows the diffusion processes
of water molecules to be mapped, revealing microscopic tissue properties such as the cellular
environment.3, 4 Moreover, NMR spectroscopy applied to living tissue (in vivo magnetic
resonance spectroscopy, MRS) allows to obtain a manifold of biochemical information such
as relative concentrations of organic compounds and metabolic turnover as well as physio-
logical parameters like intra- and extracellular pH.6, 42 However, as the abundance of the
compounds and nuclear spins of interest are so much smaller compared to water protons
(i.e. by a factor of 106), molecular and non-proton MRI in vivo are challenging in terms of
signal-to-noise ratio (SNR), spatial resolution and scanning time.
1.2 CEST
Another alternative technique allowing to assess the molecular and biochemical level in vivo
is CEST-MRI,7–9, 43 which combines the spectral selectivity of MRS with the high spatial
resolution and SNR of conventional MRI. To achieve this, the imaging contrast utilizes the
chemical exchange process between water protons and protons of nonequivalent chemical
environment such as labile protons in molecules. Application of a frequency selective radio
frequency (RF) irradiation on-resonant with the solute protons of interest, results in a satu-
ration of the respective spin states, and hence in a destruction of the net magnetization. The
perpetual chemical exchange transfers this saturation to the water magnetization resulting in
an attenuation of the water signal. In view of the low solute concentration (typically micro-
to millimolar) a single transfer of saturation would affect the much larger water proton pool
(on the order of 100 M) only insignificantly. However, as the water proton pool is so much
larger, each exchanging saturated solute proton is subsequently replaced by an unsaturated
water proton, which is in turn again saturated. For a sufficiently fast enough exchanging
solute (residence time in milliseconds range) and long enough saturation time tsat (in the
range of seconds) this results in an accumulation of the saturation over time and thereby
substantial (negative) signal enhancement on the order of the exchange rate (i.e. an ampli-
fication factor of 10 to 1000). Subsequent acquisition of the modified water proton signal
Msat yields therefore an indirect imaging of the low-concentration solutes (Figure 1A).
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Figure 1: The CEST experiment. (A) Selective RF saturation of the solute and subsequent
saturation transfer via the chemical exchange is followed by the acquisition of the
modified water signal. (B) Repetition for multiple frequency offsets yields the
Z-spectrum, which comprises in vivo contributions of various different cellular
compounds. (C) Appropriate evaluation (AREX) allows to some extent isolating
CEST signals from other confounding effects. Subfigure B is adapted from [32].
4
1.2 CEST
Repetition of the experiment for multiple frequency offsets (∆ω) relative to the water Lar-
mor frequency, and normalization with the equilibrium water magnetization M0 yields a





Z-spectra acquired in vivo comprise contributions of various different effects (Figure 1B),
which are briefly discussed in the following.
• The most prominent spectral feature is the symmetric collapse of the signal at 0 ppm
caused by saturating the water proton pool itself, which is referred to as direct water
saturation. The effect is well described by the Bloch equations and decreases rapidly
with the off-resonance.44, 45
• In the positive frequency range (∆ω > 0 ppm) selective resonances of chemical ex-
change effects can be observed, attributed to the labile protons of functional groups,
such as amide (-NH), amine (-NH2) and hydroxyl (-OH) groups. Although the
chemical shift and therefore the resonance frequency is depending on the specific
proton site in the molecule, an unambiguous assignment of CEST signals to specific
compounds in vivo is impossible. However, prior knowledge about the tissue compo-
sition, the expectable exchange rates, chemical shifts and relaxation times allows to a
certain degree to correlate the observed effects with the compounds in question.45
• The dipolar interactions between close nuclear spins – the so called nuclear Over-
hauser effect (NOE)46 – constitutes another magnetization transfer pathway besides
the physical transfer of protons through space. For proteins and other large bio-
molecules with a high proton density, this coupling results in the transfer of mag-
netization throughout the whole molecule, referred to as spin diffusion. Moreover,
this entails the magnetization transfer from non-exchanging covalent bound protons
to protons of a chemically exchanging group. A subsequent inter-molecular exchange
can relay the magnetization to the water pool. This sequence of processes is therefore
referred to as exchange-relayed nuclear Overhauser effect (rNOE) and is the dominant
dipolar-coupling-based exchange with water protons.23, 47 In the in vivo Z-spectrum
the rNOE of aliphatic and aromatic protons can be observed in the range from −2 to
−5 ppm and 1 to 4 ppm respectively.
• The semi-solid magnetization transfer (ssMT) is a non-selective effect, which can be
observed across a very large frequency range in the Z-spectrum. It summarizes several
different magnetization transfer pathways to the protons in free water molecules. The
ssMT is mainly attributed to motion restricted water protons bound to the macro-
molecular matrix, as well as protons bound directly to the surface of these macro-
molecules.25, 47 The macromolecular matrix is composed of large and semi-solid com-
ponents of the cell, e.g. cell membranes, surface proteins and the cytoskeleton. Of
note, the strongly broadened resonance corresponds to the short T2 times, i.e. in the




By now CEST imaging has been reported to be able to detect a variety of different diluted
solutes including proteins and peptides,10, 10, 11, 17 creatine,19, 48, 49 glutamate,18 lactate,50 glu-
cose,21, 22 myo-inositol,51 and exogenous contrast agents such as iopamidol.52, 53 In particu-
lar the CEST signals attributed to proteins have been shown to provide valuable diagnostic
information – namely the amide proton transfer (APT)10 signal originating from the amide
protons in peptide bonds in the backbone of mobile proteins, resonating at around 3.5 ppm,
and the rNOE12 signal of aliphatic protons, resonating at around -3.5 ppm. Potential appli-
cations range from tumor detection,54, 55 assessment of tumor malignancy,56, 57 and differ-
entiation of radiation necrosis and tumor progression58–60 to the detection of neurodegen-
erative diseases such as Alzheimer’s,14, 15 Parkinson’s,61 and multiple sclerosis.62 Although
these approaches are very promising, the underlying origin is not completely understood. Ex-
clusive assignment of the observed effects to proteins is prevented by the signal superposition
of various cellular compounds in living tissue, i.e. proteins, metabolites and small peptides,
lipids and semi-solid macromolecular structures (Figure 1B). These signals are moreover af-
fected by tissue relaxation properties (T1 and T2) and depend on the exchange rate, which
is in turn determined by physiological conditions, in particular pH and temperature.10, 27, 28
The improvement of specificity has therefore become one of the most important issues in
the research field of CEST-MRI.
A first step towards the selective measurement of quantitative CEST signals was induced
by deriving a full analytical model of the Z-spectrum. The magnetization dynamics of two
coupled spin pools during an RF irradiation are described by the Bloch-McConnell equa-
tions.63 In this context, the rotating frame of reference is defined by the off-resonance ∆ω
and amplitude B1 of the RF irradiation. Solving the Bloch-McConnell equations by an
eigenspace approach and considering only the significant remaining contribution, the small-
est eigenvalue λ1, allowed the reduction to an one-dimensional system, which can be solved
straightforward.45, 64, 65 Moreover, it was shown that λ1 can be approximated by the longi-
tudinal relaxation rate in the rotating frame R1ρ ≈ −λ1, which is the sum of the effective
relaxation rate due to the direct water saturation Re f f and the sum of all exchange-dependent
relaxation rates of solute pools i:64, 65
R1ρ(∆ω) = Re f f +∑
i
Rex,i (2)
with Re f f = R1 cos2 θ +R2 sin2 θ , the water relaxation rates R1 = 1/T1 and R2 = 1/T2, and
the tilt angle of the effective field θ = tan−1 (γ B1/∆ω). In other words, the chemical ex-
change or dipolar interactions can be understood as an additional spectral selective relaxation
pathway in the rotating frame. The Z-spectrum after an irradiation with duration tsat can
then be described by
Z(∆ω) = Zss+(Zinit −Zss)e−tsat ·R1ρ (3)







Based on this analytical model, the isolation of individual CEST effects becomes possible
by computing the apparent exchange-dependent relaxation rate (AREX):66











where Zre f is a reference spectrum containing all contributions but the solute of interest,
typically obtained by spectral fitting. Besides the term cos2 θ , AREX is a quantitative metric
allowing to obtain the relaxation rate of a single CEST effect (Figure 1C), corrected for other
influences of the direct water saturation, T1 relaxation and confounding signal contributions,
i.e. ssMT.
Although this sophisticated approach addresses some of the challenges and issues of CEST-
MRI, a selective detection of one specific CEST compound without signal contributions
from other compounds in vivo is still impossible. The AREX metric depends crucially on
obtaining an appropriate reference spectra; however, in living tissue it is typically only pos-
sible to take into account the prevalent contributions of the direct water saturation and the
ssMT, thus preventing a further isolation of signal contributions (Figure 1C). This is even
more critical for a possible application at clinical MR systems with lower magnetic field
strength, which do not allow to resolve distinct peaks anymore due to the decreased spectral
resolution. In addition, it would be desirable to obtain a protein signal without dependency
on physiological parameters, i.e. pH and temperature. This would allow to assign observed
changes in disease states to actual alterations of the proteome, i.e. changes in the concen-
tration, folding state or molecular size of proteins. Therefore there is still a need for novel
approaches and experiments to enable the selective detection of protein CEST signals.
1.3 DualCEST
Recently a new CEST-based technique was introduced for the detection of endogenous bulk
mobile proteins, allowing to overcome the aforementioned specificity limitations by intro-
ducing of a novel kind of selectivity: the detection of the coupling between different CEST
signals. The dualCEST approach was first mentioned by Steffen Goerke,67 subsequently
investigated in the preceding master thesis of the author33 and finally comprehensively pre-
sented in Goerke S, Breitling J, et al.32 The latter includes as well the first results of this
dissertation. The following explanations summarize the most important findings of these
previous works.
The dualCEST approach extends, to this end, the conventional CEST experiment by an
additional interleaved RF saturation pulse at a second frequency offset ∆ωc (Figure 2A). In
doing so, both frequency offsets are simultaneously saturated. Repetition of the sequence for
multiple such frequency offset pairs effectively results in the acquisition of a two-dimensional
Z-spectrum Z(∆ω,∆ωc) (Figure 2B), which features contributions of CEST effects resonat-
ing at either one of the two frequency offsets. For this, the measured effect will depend on
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Figure 2: The dualCEST experiment. (A) Extension of the conventional CEST sequence
by an additional interleaved saturation pulse with a second frequency allows to si-
multaneously saturate a pair of frequency offsets. (B) Repetition for multiple pairs
yields a two-dimensional Z-spectrum, visualized by three representative profiles,
i.e. Z-spectra. The coupling of CEST signals, e.g. the intra-molecular spin diffu-
sion in proteins, results in a reduction of the measured joint CEST effect as com-
pared to uncoupled resonances. (C) The impact of the coupling (T) can be isolated
by comparison with the (inverse) sum of the individual CEST effects. Specificity
to proteins is ultimately achieved by setting the frequency offsets to the positive
and negative frequency range. Subfigure C is adapted from [67].
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whether the CEST signals resonating at ∆ω and ∆ωc are coupled, i.e. connected by a mag-
netization transfer pathway, or not. For uncoupled CEST signals the individual effects just
add up linearly, for example in the case of lipids and metabolites. In contrast, a coupling of
CEST signals results effectively in a reduction of the measured joint CEST effect. For pro-
teins, such a coupling is given by the intra-molecular spin-diffusion underlying the rNOE.
As explained earlier, this process is responsible for the magnetization transfer from the non-
exchanging covalent bound protons to the chemically exchanging groups, e.g. the amide
protons responsible for the APT. In this way, the rNOE resonance at around −3.5 ppm
and the APT resonance at around 3.5 ppm are not independent effects but will exhibit a
coupled behavior for a simultaneous saturation of both frequencies. Such a coupling can be
described on the level of the exchange-dependent relaxation rates as a non-linearity of the
CEST effects in question:
Rex(∆ω,∆ωc)
{
= Rex(∆ω)+Rex(∆ωc) : uncoupled effects
̸= Rex(∆ω)+Rex(∆ωc) : coupled effects (6)
The observed mismatch, termed saturation crosstalk T =Rex(∆ω)+Rex(∆ωc)−Rex(∆ω,∆ωc),
can be used as a measure for the amount of magnetization transfer, i.e. the coupling strength
(Figure 2C). The saturation crosstalk can be quantified by subtracting two AREX spectra:
one with the second RF irradiation being far off-resonant or disabled, and the other one
with the additional RF irradiation saturating frequency offset ∆ωc: T =AREX(∆ω,∆ωoff)−
AREX(∆ω,∆ωc). Moreover, it was shown analytically that the saturation crosstalk can be

















where ∆ωoff is a frequency offset far off-resonant to any CEST signal, which is synony-
mous with disabling the saturation. This calculation avoids the necessity of obtaining an
appropriate reference spectrum and thereby estimating the direct water saturation and other
confounding effects by a fitting procedure. Thus, calculation of the saturation crosstalk be-
tween two particular frequency offsets is possible by only acquiring the four corresponding
Z-values, which facilitates in general a fast and direct measurement.
In living tissue a comparatively broad saturation crosstalk is observed, exceeding consider-
ably the frequency range of proteins. Hence, the acquired signal comprises, in addition to
the signal of proteins, a superimposing signal contribution of semi-solid macromolecular
structures. Retrieval of the superimposed protein signal is achieved by subtracting the con-
tribution of the ssMT. The selectivity of the dualCEST approach can be once more utilized
for this purpose: shifting one or both the frequency offsets off-resonant from the mobile
protein signals while remaining on-resonant to the signal of the ssMT allows to determine
and subtract the amplitude of the contribution:




where ∆ωssMT is the ssMT specific frequency offset. Of note, this correction method is in-
dependent of the actual ssMT lineshape, allowing the removal of both symmetric and asym-
metric ssMT contributions. Application of this correction requires in total nine Z-values for
the calculation of a protein specific signal without any confounding saturation transfer ef-
fects of metabolites, lipids and semi-solid macromolecular structures. Moreover, the signal
has been shown to be independent of water relaxation properties and, in the physiological
pH range between 7 and 7.4, of changes in the chemical exchange properties.
The resulting opportunity to selectively measure the intra-molecular spin diffusion in pro-
teins is of particular interest as it may provide additional information about the pathological
changes of the proteome. This is the case, as the intra-molecular spin diffusion processes
depend on the size and the conformation of the involved proteins. The slower tumbling
rate (i.e. molecular correlation times) of larger proteins results in a more pronounced spin
diffusion, whereas an unfolding of the protein results in an distance increase between the
involved nuclei and therefore in a signal decrease.68 Indeed, investigations of protein model
solutions revealed a distinct dualCEST signal increase as function of the molecular weight,
indicating the potential to detect a decomposition of proteins into smaller fragments, and
moreover a significant signal decrease was observed upon the unfolding of the proteins, in-
dicating the potential to detect aberrant structural and conformational changes of proteins.
The combination of all these properties render dualCEST a promising tool for the detection
of aberrant proteomes in vivo and thus a potential novel diagnostic imaging modality for
neurodegenerative diseases and cancer.
The aim of this thesis was therefore the translation of the dualCEST technique to a clinical
whole-body MR scanner to enable protein imaging of the human brain. The dualCEST ap-
proach was up to now restricted to investigations of protein model solutions at NMR spec-
trometers with ultra-high magnetic field strengths. The required further developments of
such a preclinical technique in order to enable patient examinations at a clinical whole-body
MR scanner entail overcoming a number of technical and experimental challenges. To men-
tion only a few: (i) the reciprocal interference of CEST preparation and imaging readout,
(ii) the considerably worse SNR and spectral resolution of a clinical whole-body MR scan-
ner, (iii) the occurrence of strong spatial B0 and B1 inhomogeneities, (iv) subject movement
and the resulting motion artifacts, (v) acquisition time constraints of in vivo examinations,
as well as (iv) safety and hardware restrictions limiting the saturation parameters.
The methodological further developments to overcome these challenges, the subsequent in-
vestigations concerning the specificity and reproducibility of the dualCEST contrast, as well
as the first in vivo examinations are the main outcomes of this work. The results of this
thesis were published in four scientific journal articles, which are enclosed in the following
chapter and complemented by a summary, putting them into an overall context. The thesis
is eventually completed by a comprehensive discussion of the results and limitations of this
study in chapter 3 and a conclusion in chapter 4.
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This thesis is written in cumulative format in accordance with the regulations regarding the
conferral of doctoral degrees of the Department of Physics and Astronomy of the Ruperto-
Carola University of Heidelberg. It comprises four articles published in internationally ac-
claimed peer-reviewed journals. Within this thesis the individual manuscripts will be ref-
ereed to by roman numerals. All articles were written during the PhD project and have
not been used in other dissertations. Note, the in vitro data of the first publication were
topic of the preceding master thesis and are therefore referred to as reference 32, whereas
the optimization at the clinical scanner and the in vivo experiments are ascribed solely to the
doctoral studies and therefore referred to as Publication I. I am first author of Publications
I, III and IV — principal author of III and IV, shared authorship for I and III — and co-
author of Publication II. The detailed author contributions to each publication are stated in
the respective sections. All articles are reproduced with kind permission of JOHN WILEY &
SONS.
In addition to the four publications, this cumulative thesis includes three appendices (A, B
and C) comprising the most recent methodological developments and applications. Appen-
dices A and B were originally submitted by the author as conference abstracts for the 28th
Annual Meeting of the International Society for Magnetic Resonance in Medicine, Paris, France
2020 and the Joint Annual Scientic Meeting ISMRM-ESMRMB, Paris, France 2018, respec-
tively, and have been reproduced with kind permission of the INTERNATIONAL SOCIETY FOR
MAGNETIC RESONANCE IN MEDICINE.69, 70
In the following the individual contributions and results are recapitulated and put into the
overall thematic context. The topics covered in this thesis are moreover graphically summa-
rized in figure 3.
Thematic overview over the individual publications
Publication I comprises the in vitro experiments presented in the preceding master thesis,33
as well as the first results of this PhD project — the successful translation of the dualCEST
technique from a 14.1 T narrow-bore NMR spectrometer to a 3 T clinical whole-body MR
scanner and a first proof-of-concept in vivo examination. The translation was based on a
comprehensive study and subsequent optimization of diverse technical parameters. As a
result of the investigation, lower static magnetic field strengths were found to be beneficial
for the dualCEST technique, further encouraging the translation of the approach to clinical
11
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Figure 3: Illustration of the thematic allocation of the four publications (I to IV) and three
appendices (A to C), which comprise this cumulative dissertation. Contributions
on the right address general problems of CEST-MRI, whereas the left side specif-
ically displays applications and developments for dualCEST. The subfigures are
adapted partly from the respective contributions.
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field strengths. Furthermore, the broader resonances associated with the lower field strength
combined with slightly adjusted saturation frequency offsets render the dualCEST approach
insensitive to the B0 inhomogeneities encountered at a clinical system. The RF saturation
pulses were optimized in amplitude, length and timing to maximize the signal while avoiding
excessive broadening of the spectral resonances. In the end, the dualCEST approach was
applied in a proof-of-concept examination of a patient with glioblastoma. In the necrotic
tumor region a significant alteration of the dualCEST contrast was observable, indicating
as expected a considerable degeneration of proteins.
Although the presented protocol enabled the first in vivo protein imaging by means of
dualCEST, this implementation had some major limitations. (i) The used imaging pro-
tocol only enables 2D acquisitions and thereby offers only a small volume coverage. First of
all, this reduces the practicality as a diagnostic tool as only a small section of the body can
be investigated. And secondly, it effectively prevents the crucial application of a motion cor-
rection as a displacement or tilting of the investigated body region out of the imaging slice
results in the irreversible loss of information. (ii) The inherently low SNR of the dualCEST
approach resulted in the necessity of acquiring multiple averages to achieve a sufficiently
good image quality. The resulting comparatively long measurement time prevented, at this
point in time, the application in clinical trials.
To overcome the first set of limitations, the aim was to combine the dualCEST approach
with a suitable fast and robust 3D image-readout – namely the snapshot-CEST sequence.71
This gradient echo-based acquisition scheme has been specifically developed for CEST imag-
ing and is tailored to its particular requirements. In the second publication, the snapshot-
CEST readout was utilized for a state-of-the-art conventional CEST acquisition proto-
col.The study included among other things a thorough investigation and optimization of
the imaging parameters, e.g. parallel acceleration factor and readout bandwidth, to max-
imize the SNR and volume coverage while at the same time avoiding contrast deviations.
With regard to the topic of this thesis, the obtained optimal imaging parameters are not
only valid for the presented conventional CEST approach, but – as they were determined
with the same setup and 3T whole-body MR-scanner as intended for dualCEST studies
– also for the application together with the dualCEST technique. In addition, the imag-
ing protocol presented in Publication II, with its optimized readout and fitting routines,
represents a state-of-the-art conventional protein CEST approach and is therefore in what
follows an ideal reference for the comparison with the dualCEST technique.
In addition to the obtained volume coverage and being more SNR-efficient, a 3D image
readout generates tens of thousands of CEST spectra in a single measurement, raising the
possibility for statistical denoising. The basis to this end is the identification of spectral re-
dundancies allowing to separate noise-like characteristics from meaningful spectral features.
In the third publication a novel denoising technique is presented that allows an effective
and robust denoising of CEST data. The approach combines a principal component analy-
sis (PCA)72 with an appropriate data-driven identification of the relevant information.73–75
PCA is a well-established technique for reducing the dimensionality of data sets, while pre-
serving most of the contained information. For this purpose the data is transformed into
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a new basis, which is obtained by identifying and exploiting linear correlations. The infor-
mation content of the data set, i.e. the variance, concentrates on only a few of these new
components with the others describing mainly noise.76 Therefore, reducing the dimension-
ality of the data set by retaining only the relevant components will remove noise. In the
presented approach, the PCA is applied in conjunction with data-driven methods to iden-
tify the relevant components. The latter is essential for the final outcome as retaining too
few components will result in the loss of actual information, whereas too many components
will diminish the denoising effect. In the publication, the proposed method was thoroughly
examined and validated on synthesized data, generated by adding artificial noise to fitted in
vivo Z-spectra. Furthermore, the approach was applied to data of seven healthy volunteers
acquired at clinical or ultra-high field whole-body scanners. For conventional CEST data
the denoising capability was quantified to be comparable or even superior to the averaging
of six measurements. The application of the proposed denoising algorithm is not restricted
to conventional CEST data sets but can be applied to any other CEST–related approach
providing a spectral dimension to exploit redundancies. For dualCEST-MRI this opens up
the possibility to overcome the inherently low SNR.
In the fourth and last publication all further developments were brought together to form a
dualCEST-MRI protocol enabling protein imaging in a clinically-relevant time frame. To
this end, the previous results – i.e. the initial investigations of Publication I, the fast and
robust volumetric image readout of Publication II and the adaptive denoising technique of
Publication III – were complemented by two additional methodological advances: (i) im-
proved dual-frequency pulses and (ii) a weighted acquisition scheme. The implementation
and optimization of cosine-modulated dual-frequency presaturation pulses77, 78 enabled a
simultaneous irradiation at both frequency offsets and thereby a significantly improved satu-
ration efficiency compared to the previous alternating RF irradiation scheme. Development
of a weighted acquisition scheme furthermore allowed for an optimal use of the limited ex-
amination time. This is based on the remaining necessity to acquire multiple averages of
each frequency offset pair to achieve a satisfying image quality for dualCEST-MRI. In the
calculation of the dualCEST contrast certain frequency offset pairs have ultimately a larger
impact on the quality image than others, and hence should be averaged more often. The
idea was therefore to determine the optimal measurement distribution for the acquisition
scheme, which minimizes the overall measurement error for an analytical model of the error
propagation. This approach thereby results in an improved image quality while maintaining
the same number of total repetitions. Overall, the application of optimized saturation, sam-
pling scheme, readout with motion correction and denoising algorithm resulted in an SNR
gain by a factor of eight compared to the initial imaging protocol presented in Publication
I.
To assess the potential applicability in a clinical setting, Publication IV comprised further-
more investigations concerning the protein specificity, repeatability, and sensitivity to patho-
logical alterations. Preserved specificity of the dualCEST technique despite the translation
to a clinical whole-body MR scanner was confirmed in extensive measurements of biochem-
ical model solutions. Furthermore, repeated volunteer examinations demonstrated a good-
to-excellent reproducibility79 of the imaging protocol and allowed to estimate the smallest
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resolvable contrast change. Finally, a first proof-of-principle examination with this protocol
showed alterations in the tumor region of a patient with glioblastoma, indicating a significant
pathological modification of mobile proteins. Altogether the proposed imaging protocol en-
ables prospectively the examination of larger patient cohorts, and thus assessment of the
potential diagnostic value of dualCEST-MRI.
With this well-established imaging protocol at hand the prospective aims are twofold: in-
vestigation of the diagnostic value for various pathologies and a further acceleration of the
technique to enable the incorporation into standard clinical protocols. The Appendices A,
B and C present the most recent advances for both objectives.
An acceleration of dualCEST-MRI, i.e. a reduction of the overall examination time, can
in principle be realized in two ways: increasing the SNR of each repetition to reduce the
necessary number of averages, or to shorten the time for one repetition. In Appendix A a
further developed denoising approach is presented allowing to effectively increase the SNR
by an additional 14% compared to the previous technique. To achieve this, the algorithm
combines the formation of subsets of similar spectra with a subsequent PCA. Exploiting
only the subtle remaining spectral differences of the reduced data set allows for a better
identification and isolation of the obscured spectral features.
The second possibility is exploited in Appendix B. DualCEST as most other quantitative
CEST techniques relies on the steady-state signal, which entails a long enough saturation
period in the order of 3−5 times T1.45 The proposed method allows to bypass this obstacle
by calculating the steady-state signal from an experiment using only a reduced saturation
period. To this end, the analytical description of the signal evolution (Equation 3) is numer-
ically solved for the steady-state magnetization. For dualCEST-MRI this would allow to
reduce the saturation period by up to 75%, at however the cost of slightly reduced SNR.
Finally, Appendix C comprises the first preliminary results of a forthcoming pilot study
concerning Alzheimer’s disease. The dualCEST examinations of two patients and two age-
matched healthy volunteers revealed considerable changes for one of the two patients and,
interestingly, no apparent abnormalities for the other. This difference in the contrast behavior
might actually be related to a genuine difference in the stage of the disease progression. In
this case, dualCEST-MRI could be used to avoid other invasive modalities to monitor the
disease progression. As a result, examinations could be performed on a more regular and
frequent basis, resulting in an improved level of patient care. However, the study size is yet
too small to draw any final conclusions and more participants will have to be included to




Dual-frequency irradiationCEST-MRI of endogenous
bulk mobile proteins
Authors: Steffen Goerke†, Johannes Breitling†, Moritz Zaiss, Johannes Windschuh,
Patrick Kunz, Patrick Schuenke, Daniel Paech, Dario L. Longo, Karel D. Klika, Mark
E. Ladd, and Peter Bachert
† both authors contributed equally to this work
Journal reference: NMR in Biomedicine. 2018;31:e3920.
DOI: 10.1002/nbm.3920
Author contributions: SG conceived together with MZ and JW the idea of the dualCEST ap-
proach. SG and JB designed together the study with consultation of PK for the in vitro
experiments. JB performed, with minor exceptions, all data acquisition, processing and analy-
sis. In addition JB conceived the correction approach necessary for the in vivo application. PS
integrated the dualCEST approach into the imaging sequence. DP was responsible for the re-
cruitment and medical supervision of the patient examination. DLL provided the investigated
protein-free brain lipids. KDK provided technical support for the NMR spectrometer. SG
drafted and revised the manuscript with support of JB and critical review by all co-authors.
Remark: The in vitro experiments of this publication were topic of the preceding master thesis. The




R E S E A R CH AR T I C L E
Dual‐frequency irradiation CEST‐MRI of endogenous bulk
mobile proteins
Steffen Goerke1 | Johannes Breitling1 | Moritz Zaiss1,2 | Johannes Windschuh1 |
Patrick Kunz3 | Patrick Schuenke1 | Daniel Paech4 | Dario L. Longo5 | Karel D. Klika6 |
Mark E. Ladd1,7,8 | Peter Bachert1,7
1Division of Medical Physics in Radiology,
German Cancer Research Center (DKFZ),
Heidelberg, Germany
2Department of High‐field Magnetic
Resonance, Max‐Planck‐Institute for
Biological Cybernetics, Tübingen, Germany
3Division of Functional Genome Analysis,
German Cancer Research Center (DKFZ),
Heidelberg, Germany
4Department of Radiology, German Cancer
Research Center (DKFZ), Heidelberg, Germany
5 Institute of Biostructure and Bioimaging
(IBB), National Research Council (CNR),
Torino, Italy
6Molecular Structure Analysis, German
Cancer Research Center (DKFZ), Heidelberg,
Germany
7Department of Physics and Astronomy,
University of Heidelberg, Heidelberg,
Germany
8Faculty of Medicine, University of
Heidelberg, Heidelberg, Germany
Correspondence
S. Goerke, Division of Medical Physics in
Radiology, German Cancer Research Center
(DKFZ), Im Neuenheimer Feld 280, 69120
Heidelberg, Baden‐Württemberg, Germany.
Email: s.goerke@dkfz.de
A novel MRI contrast is proposed which enables the selective detection of endoge-
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and the removal of semi‐solid macromolecular signal components by a correction pro-
cedure. For this purpose, the approach of chemical exchange saturation transfer
(CEST) was extended to a radiofrequency (RF) irradiation scheme at two different fre-
quency offsets (dualCEST). Using protein model solutions, it was demonstrated that
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sively sensitive to changes in concentration, molecular size and the folding state of
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selectivity limitations at relatively low magnetic field strengths, and thus enables
examinations on clinical MR scanners. The feasibility of dualCEST examinations in
humans was verified by a proof‐of‐principle examination of a brain tumor patient at
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this technique represents a further step towards the non‐invasive imaging of proteo-
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Chemical exchange saturation transfer (CEST) MRI has emerged as an important contrast mechanism for the detection of low concentration sol-
utes, such as proteins or small metabolites in living tissue.1-5 CEST exploits the spontaneous chemical exchange of protons in order to indirectly
detect the solutes via the abundant water proton signal. This is realized by a frequency‐selective pre‐saturation of chemically exchanging protons
in solutes and a subsequent fast MRI readout of the water signal. The indirect detection generates a signal amplification enabling, in principle,
high‐resolution imaging of solutes with a sensitivity comparable to normal water proton MRI.
However, in living tissue diverse CEST signals of different cellular compounds, such as proteins,6-9 small metabolites,10-15 lipids16,17 and semi‐
solid macromolecular structures,18-20 spectrally overlap in the Z‐spectrum (Figure 1B). Moreover, CEST signals depend on the rate of chemical
exchange, which in turn is determined by various physiological parameters, in particular pH and temperature.3,21-23 On the one hand, this
multi‐parametric dependence makes CEST a valuable imaging technique with the potential to depict a wide range of physiological processes,
but, on the other, the numerous parameters are also a strong drawback in terms of specificity. Although specific adjustments of the CEST pulse
scheme (e.g. tuning of the pre‐saturation amplitude B1 or the interpulse delay td) allow the design of exchange rate filters
24-26 that highlight the
signal component of one specific compound, to date a selective detection without contributions from other cellular compounds has not been
possible. The introduction of specificity has become one of the most important issues in the research field of CEST‐MRI.
Here, we present a novel CEST‐based technique – dual‐frequency irradiation CEST (dualCEST) – that allows the selective detection of
endogenous bulk mobile proteins in vivo. Specificity of the dualCEST signal is achieved by the introduction of a novel dimension of selectivity:
the detection of the coupling between different CEST signals (Figure 1B). As only mobile proteins possess individual resonances of significant
amplitude on both sides of the Z‐spectrum that are coupled via a magnetization transfer pathway, exceptional specificity can be achieved by
taking advantage of this trait. Signal contributions from the comparatively broad resonance of the semi‐solid magnetization transfer (ssMT)
can be removed by a correction procedure. Pre‐saturation at two different frequency offsets, Δω and ΔωC, was realized by an alternating
radiofrequency (RF) irradiation scheme (Figure 1A).
The terminology ‘bulk mobile proteins’ is a combination of the specificity of the dualCEST technique to the collective signal of all proteins and
the separation of MR signals by their mobility (for a detailed explanation, see the Discussion section). The bulk mobile protein signal comprises
mainly cytosolic proteins, many endoplasmic reticulum proteins and secreted proteins.8 Although the detection of specific protein species is
not feasible by this means, the bulk mobile protein signal is expected to be a valuable marker for diseases that are associated with profound
alterations of the proteome. Bulk mobile proteins are generally assumed to be the main source of the prominent amide proton resonance at
FIGURE 1 The dual‐frequency irradiation chemical exchange saturation transfer (dualCEST) approach. (A) Scheme of the pulse sequence. (B) Z‐
spectrum of ex vivo porcine brain tissue homogenate (B1 = 0.75 μT, B0 = 14.1 T). The subdivision of the Z‐spectrum into contributions of different
cellular compounds is an estimation. dualCEST detects the coupling of different CEST signals, allowing the selection of signals of bulkmobile proteins
(orange) from the background of other cellular compounds: metabolites (green), lipids (gray), semi‐solid macromolecular structures (purple) and
water (blue)
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Δω = +3.5 ppm or the relayed nuclear Overhauser effect (rNOE)‐CEST signal of aliphatic protons at around Δω = −3.5 ppm.6-8,16,17,27-32 These
two signals have already been shown to allow the diagnosis of several diverse diseases and to provide decisive information for ongoing therapy.
Especially with respect to cancer, CEST imaging at Δω = ±3.5 ppm has enabled the assessment of tumor malignancy,33 the differentiation between
radiation necrosis and tumor progression34,35 and the detection of disrupted blood–brain barriers without the application of contrast media.9
Although the value of the amide and aliphatic proton signal has been demonstrated in diverse studies, nevertheless, the underlying origin of
the contrast is not completely understood. The technique of dualCEST represents a unique opportunity to determine the actual contribution of
mobile proteins to CEST signal changes in pathological tissue, which may lead to new insights into diseases on a molecular level.
This study comprises the introduction of the dualCEST contrast mechanism, a comprehensive optimization of technical parameters, an
analytical model of the observed signal, an experimental verification of its specificity to mobile proteins in vitro and a proof‐of‐principle demon-
stration of its applicability in vivo. A detailed analysis of the diagnostic value of the method will be addressed in a future study. With respect to
examinations in humans, the exceptional specificity of the presented technique evades the ultra‐high static magnetic field strengths B0 ≥ 7 T that
are required for the adequate separation of individual resonances in conventional CEST‐MRI, thus allowing its straightforward application on
clinical MR scanners (B0 ≤ 3 T). Hence, dualCEST enables the selective detection of endogenous bulk mobile proteins at clinical magnetic field
strength, providing the potential to be a valuable diagnostic tool to detect aberrant proteomes in vivo.
2 | MATERIALS AND METHODS
2.1 | Model solutions
In total, 42 model solutions containing varying amounts of globular proteins, sodium dodecyl sulfate (SDS), creatine, carnosine, lipids and tissue
homogenates were prepared. A detailed list of all experimental parameters is presented in Supporting Information Table S1. Unless otherwise
specified, model solutions were buffered at pH 7 using phosphate‐buffered saline (PBS). Final pH values were checked by means of a calibrated
pH electrode, and deviations from pH 7 (e.g. in the case of high solute concentrations) were corrected using NaOH or HCl. All model solutions
were pipetted from highly concentrated stock solutions to ensure the precise adjustment of different concentrations. Samples containing
ex vivo tissue components were continuously chilled on ice before measurement. Protein‐free brain lipids were extracted from mouse brain tissue
with tetrahydrofuran, filtered and lyophilized for liposome preparation (size, 120 nm) throughout sonication. Tissue homogenates were obtained
from white matter porcine brain tissue and prepared as described in previous studies.9
2.2 | Subjects
One 57‐year‐old male patient with newly diagnosed and histopathologically proven glioblastoma (grade IV) was examined before therapy. This
study was approved by the local ethics committee of the Medical Faculty of the University of Heidelberg and is in accordance with the relevant
guidelines and regulations. Written informed consent was received from the patient prior to the examination.
2.3 | CEST spectroscopy
Model solutions were examined on 14.1‐T (600 MHz for 1H) Avance II and 9.4‐T (400 MHz for 1H) Avance III narrow‐bore spectrometers (Bruker
BioSpin, Karlsruhe‐Rheinstetten, Germany). A 5‐mm or 8‐mm probe was used for RF irradiation and signal acquisition. To avoid radiation damping,
the probes were operated detuned. The temperature of the samples was stabilized at 25 or 37°C using the internal heating and cooling device. For
conventional CEST measurements, pre‐saturation at Δω was achieved by Gaussian‐shaped RF pulses of mean amplitude B1 = flip angle/(γ·tp),
length tp and duty cycle DC = tp/(tp + td). In the case of dualCEST, an additional Gaussian‐shaped RF pulse (ΔωC) of the same amplitude and length
was centered in the middle of the interpulse delay td (Figure 1A). A detailed list of all experimental parameters is presented inTable S1. The overall
duration of the pre‐saturation period tsat complied with the criterion for steady‐state measurements, tsat > 3–4·T1obs, with the observed longitu-
dinal relaxation time of water T1obs.
20 Z‐values were calculated by integration of the water resonance in the range of ±0.45 ppm (Msat) and
normalized with the equilibrium magnetization (M0): Z = Msat/M0. To compensate for systematic signal fluctuations (i.e. caused by the signal
amplifier or receiver), M0 was acquired at different time points and interpolated to obtain an individual M0 for each pre‐saturation cycle. Conven-
tional Z‐spectra were sampled at 118 frequency offsets in unequal steps between ±150 ppm. Isolated CEST signals, compensated for direct water
saturation effects (spillover dilution), ssMT and water relaxation properties, were calculated at each frequency offset Δω using the apparent








. The observed longitudinal relaxation rate of water
R1obs ¼ 1T1obs was measured using a saturation‐recovery sequence. The reference spectrum Zref was estimated by a multi‐parametric fit:
Zref ¼ 1–∑iLi , where Li are Lorentzian‐shaped functions representing the direct water saturation and ssMT. To avoid contributions from CEST
signals, as well as to take into account the broadening of the direct water saturation as a result of a pulsed pre‐saturation, data points in the range
from ±10 to ±0.5 ppm and in between ±0.2 ppm were excluded from the fitting procedure. Conventional asymmetry analysis (based on non‐fitted
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data) was performed by: MTRasym(Δω) = Z(−Δω) – Z(Δω). Depending on the CEST signal strength of the respective evaluation method, measure-
ments were repeated several times (Table S1).
2.4 | DualCEST MRI
In vivo measurements were performed on a 3‐T (123.26 MHz for 1H) whole‐body MR‐PET tomograph (Biograph mMR; Siemens Healthcare
GmbH, Erlangen, Germany) using a custom‐developed CEST pulse sequence based on a two‐dimensional Half Fourier Acquisition Single Shot
Turbo Spin Echo (HASTE) readout and a 16‐channel Siemens mMR Head/Neck A Tim Coil. Msat images (matrix, 128 × 102; resolution,
1.88 × 1.88 × 5 mm3) were acquired after pre‐saturation with 84 pairs of Gaussian‐shaped RF pulses at Δω and ΔωC of B1 = 2 μT, tp = 20 ms
and DC = 28%, leading to tsat = 6 s. All images were corrected for motion artifacts by an intensity‐based image registration. Analogous to CEST
spectroscopy, several M0 images were acquired at different time points and interpolated to yield an individual M0 for each Z‐image. To increase
the signal‐to‐noise ratio (SNR), Z‐images were averaged over 18 acquisitions and smoothed by a Gaussian kernel (σ = 1 pixel). The final dualCEST
contrast (Equation 2) was corrected for B1 inhomogeneities by means of the one‐point ‘contrast‐correction’ method as described in a previous
study.37 B0 and B1 were determined by the simultaneous mapping of the water shift and B1 (WASABI)
38 approach using the same CEST pulse
sequence with adjusted pre‐saturation parameters. T1obs mapping was achieved by fitting T1obs‐weighted images of a saturation recovery
HASTE sequence. In total, the overall measurement time was approximately 22 min, comprising 18 min of dualCEST, 2 min of WASABI and
2 min of T1obs mapping.
To investigate the influence of B0, the same dualCEST pulse sequence was implemented on a 7‐T whole‐body MR tomograph (MAGNETOM
7 T; Siemens Healthcare GmbH), but based on a two‐dimensional gradient echo (GRE) readout.
3 | RESULTS
3.1 | The dualCEST approach
To demonstrate the concept of the dualCEST approach, a mobile protein solution containing bovine serum albumin (BSA) was investigated.
DualCEST detects the MR signal of water after alternating RF irradiation at two different frequency offsets, Δω and ΔωC (Figure 1A). This allows
the simultaneous sampling of the conventional Z‐spectrum as a function of Δω while constantly saturating CEST signals at ΔωC (Figure 2A). For a
FIGURE 2 Isolation of the saturation crosstalk. (A) Z‐spectra of a mobile protein solution containing BSA (B1 = 0.45 μT, B0 = 14.1 T) with and
without constant saturation at ΔωC. (B) Isolated CEST signals calculated by the AREX evaluation. The saturation crosstalk TΔωc(Δω) (red dots) is
defined by the difference between the two AREX spectra
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detailed analysis of the influence of the constant saturation, the CEST signals of proteins were separated from the direct water saturation
(Δω = 0 ppm) by the AREX evaluation36 (Figure 2B). Constant saturation at ΔωC = −3.0 ppm led to a significant reduction in protein CEST signals
on the opposite side of the water resonance (Δω > 0 ppm). Hence, protein CEST signals in the positive and negative frequency region are coupled
via a magnetization transfer pathway. The amount of magnetization transfer between two particular frequency offsets – in the following, termed
as saturation crosstalk TΔωc(Δω) – can be quantified by subtraction of the AREX spectra. Quantification by simple subtraction of the two spectra is
justified because of the linearity of CEST signals using the AREX evaluation. Remarkably, for mobile proteins, the saturation crosstalk is on the
order of 30–40% of the conventional AREX spectrum, demonstrating the potential for its application in vivo. The observed saturation crosstalk
is attributed to intramolecular spin diffusion39 between dipolar‐coupled protons. Spin diffusion is also known to mediate the intramolecular
magnetization transfer of rNOE‐CEST signals, which have been studied extensively in the past few years.16,17,26,40
Rearrangement of the mathematical expression for T allows the calculation of the saturation crosstalk without the need for prior AREX
evaluation (Supporting Information Figure S1):
















where ZΔωc(Δω) is the Z‐value after saturation at Δω and ΔωC, and the far off‐resonant frequency offset, off = 150 ppm, which is synonymous
with disabling of the saturation. This calculation has the advantage that TΔωc(Δω) can be determined without the need for the estimation of
the direct water saturation by a fitting procedure. Consequently, the saturation crosstalk between two particular frequency offsets is characterized
by only four Z‐values (Equation 1), allowing a fast and direct acquisition which is crucial for application in vivo.
In order to maximize the dualCEST signal, its dependence on several technical parameters was investigated. T monotonically increases as a
function of the saturation duration and reaches steady state at tsat ≈ 3·T1obs (Figure 3B). Furthermore, T is effectively independent of the DC
(Figure 3D), in compliance with the AREX evaluation. An unexpected observation is the increase inT for shorter pulse lengths tp (Figure 3F), which
thereby provides a simple means to amplify the dualCEST signal. A detailed explanation of this effect is provided in the Discussion section.
Remarkably, an increase inT can also be observed for decreasing magnetic field strengths (Figure 3J), thus enabling the application of the dualCEST
technique on clinical MR scanners. In addition, B1 can be increased to amplify the dualCEST signal (Figure 3H). The monotonic increase is again in
coherence with the AREX evaluation. For further investigations on the 14.1‐T MR spectrometer, tp = 7.8 ms and B1 = 1.5 μT were used, which are
optimal in terms of maximizing the signal strength while avoiding an excessive broadening of signals.
The advantage of the dualCEST approach in comparison to conventional CEST is that it provides a novel dimension of selectivity. As dualCEST
detects the coupling between two different CEST signals, selectivity to compounds that exhibit more than one resonance in the Z‐spectrum can be
achieved. Consequently, by setting the two frequency offsets to the positive and negative regions (Δω > 0 and ΔωC < 0 ppm), the dualCEST signal
is selective to mobile proteins because only mobile proteins offer individual resonances of significant amplitude on both sides of the Z‐spectrum
(Figure 1B). However, as the comparatively broad resonance of ssMT also ranges from positive to negative frequency offsets, a contribution to
the dualCEST signal from macromolecular structures can be expected. To retrieve the isolated signal of mobile proteins, a correction method
has to be applied.
3.2 | Correction for signals of semi‐solid macromolecular structures
To investigate the dualCEST signal of mobile proteins in the presence of semi‐solid macromolecular structures, an ex vivo tissue homogenate
derived from porcine brain was prepared. The corresponding dualCEST spectrum obtained with similar sequence parameters as in Figure 2
(ΔωC = −3.5 ppm) exhibits a comparatively broad saturation crosstalk with a spectral width larger than 10 ppm (Figure 4B, red line). Hence,
the acquired signal comprises, in addition to signals of mobile proteins, a component originating from semi‐solid macromolecular structures.
To extract the superimposed signal of mobile proteins Tprotein, the selectivity of the dualCEST approach was utilized (Figure 4A): By shifting
the constant saturation frequency off‐resonance from mobile protein signals while remaining on‐resonance for the ssMT (ΔωC = −10 ppm),
the spectral profile of the underlying ssMT component can be sampled in an isolated manner (Figure 4B, magenta line). The actual amplitude
of the isolated saturation crosstalk of semi‐solid macromolecular structures TssMT (Figure 4B, black line) is determined by scaling the spectral
profile by the factor T–3.5(+10)/T−10(+10) (Figure 4B, gray circles). This calculation is not an estimation but can be derived analytically (Supporting
Information Figure S2). It is important to note that the correction method is also independent of the ssMT line shape, allowing application even in
the case of an asymmetric ssMT. Overall, the isolated signal of mobile proteins in the presence of semi‐solid macromolecular structures can be
determined by:
Tprotein Δωð Þ ¼ T−3:5 Δωð Þ − T–3:5 þ10ð ÞT–10 þ10ð Þ · T−10 Δωð Þ|fflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl{zfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl}
TssMT
(2)
Equation 2 enables the application of the dualCEST approach to investigate alterations of bulk mobile proteins in living organisms. For the
calculation of Tprotein, altogether nine Z‐values are required, which leads to about a doubling in the acquisition time compared with the uncor-
rected signal (Equation 1). However, a fitting procedure is still not required, allowing the fast determination of Tprotein in vivo without the need
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to sample an entire spectrum at various Δω. The absence of signals Tprotein at frequency offsets larger than 10 ppm (Figure 4B, orange line)
indicates proper functioning of the proposed correction procedure. It is worth noting the presence of an asymmetric ssMT in this experiment
(Figure 4A, purple region) which does not distract from proper functioning of the correction method. However, to unambiguously verify the
assignment of the dualCEST signal to mobile proteins, different cellular compounds were added successively to a protein model solution.
FIGURE 3 Dependence of the dualCEST signal on technical parameters. T‐spectra of BSA (ΔωC = −3.5 ppm, B1 = 1.5 μT, B0 = 14.1 T) for different
saturation lengths tsat (A), duty cycles (DC) (C), pulse lengths tp (E), B1 (G) and B0 (I). (B, D, F, H, J) Percentage variation of T at Δω = +3.5 ppm. Signal
dependences allow the optimization of the pulse sequence in terms of SNR. Displayed errors are the standard deviation of repeated measurements
(Table S1)
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3.3 | Characterization of the dualCEST signal
As is commonly known, signals of different cellular compounds spectrally overlap in Z‐spectra in vivo (Figure 1B). To mimic this situation, mobile
protein solutions were prepared containing: (i) BSA, as well as varying amounts of (ii) metabolites (i.e. carnosine and creatine) and (iii) lipids purified
from mouse brain tissue (Figure 5). In addition to the CEST signals of BSA in the positive and negative frequency regions (Figure 5B, orange line),
individual resonances of carnosine, creatine and tissue‐lipids are resolved around Δω = +3.5, +2.0 and − 3.5 ppm, respectively (Figure 5B). In addi-
tion, a broad asymmetric ssMT of tissue‐lipids is also present (Figure 5A, blue lines), completing the imitated in vivo Z‐spectrum. The asymmetry of
the ssMT can be seen in the MTRasym spectra, which leads to negative values (Figure 5C). Remarkably, although Z‐spectra and MTRasym spectra
strongly depend on the added cellular compounds, the dualCEST signal remains constant (Figure 5D). This verifies the assignment of Tprotein to
originate exclusively from mobile proteins. Furthermore, Tprotein is compensated for changes in water signal relaxation (Figure 5E), enabling an
independent investigation of bulk mobile proteins in living organisms.
To identify the physiological parameters that affect the amplitude of the dualCEST signal, mobile protein solutions were investigated
under various conditions (i.e. concentration, molecular size, folding state and pH). As these model solutions did not contain any semi‐solid macro-
molecular structures, the dualCEST signal T was evaluated without the ssMT correction procedure being applied (Equation 1). As expected, T
increases as a function of mobile protein concentration (Figure 6A). The deviation from a linear increase at high concentrations, c > 10%(w/v), most
likely originates from crowding effects that influence the mobility of BSA molecules.41 In addition to its obvious dependence on concentration, a
considerable variation in T as a function of the molecular size, and also the protein folding state (i.e. conformation), is expected. This is the case, as
the dualCEST signal arises from intramolecular spin diffusion processes that are stronger with slower tumbling of the molecules (i.e. molecular cor-
relation time) and are weaker with increasing distances between the involved nuclei.39 Indeed, a distinct increase in T as a function of the molec-
ular weight (MW, i.e. molecular size) is observed (Figure 6B), demonstrating the potential of dualCEST to detect a decomposition of proteins into
smaller fragments. For different MWs the mass concentration (i.e. protein mass per unit volume) was kept constant to exclude concentration
effects. In addition, effects from different folding states of the proteins are negligible because all of the investigated proteins belong to the same
class of globular proteins, which are spherical in shape. Following previous studies,42-44 the equilibrium unfolding transition of BSA was examined
using the detergent SDS as a denaturant and monitored by fluorescence spectroscopy (Figure 6F). Indeed, a good correlation between T and the
protein folding state is observed. This illustrates the potential of dualCEST to image aberrant structural and conformational changes of proteins.
Finally, the pH dependence was investigated in order to demonstrate the robustness of the dualCEST signal against changes in the chemical
FIGURE 4 The semi‐solidmagnetization transfer (ssMT) correction procedure. (A) Z‐spectrumof ex vivo porcine brain tissue homogenate (B1 = 0.75
μT, B0 = 14.1 T). The subdivision of the Z‐spectrum into contributions from different cellular compounds is an estimation. By the choice of ΔωC,
selectivity of the dualCEST signal to different cellular compounds can be achieved. (B) Scaling of the spectral profile of signals originating from semi‐
solid macromolecular structuresT−10(Δω) (magenta line) allows the retrieval of the isolated signal of mobile proteinsTprotein (orange line)
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FIGURE 5 Assignment of the dualCEST signal to mobile proteins. Z‐ (A), AREX (B), MTRasym (C) and T‐spectra (D) of BSA for varying
concentrations of cellular compounds (ΔωC = −3.5 ppm, B1 = 1.5 μT, B0 = 14.1 T). In contrast to conventional CEST, the signal Tprotein can
unambiguously be assigned to mobile proteins. (E) With an increasing concentration of compounds, the observed longitudinal relaxation time
of water T1obs is reduced
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exchange properties (i.e. exchange rate). T remains constant in the physiological range between pH 7 and 7.4 (Figure 6H, gray‐shaded area), but
seems to be slightly affected by a decreasing pH. Consequently, for example, pH < 7 in the extracellular tumor environment can have an influence
on the dualCEST signal of secreted proteins. Deviations at acidic pH values might be a result of either the pH dependence of the chemical
exchange between exchangeable protons in BSA and water,3,44 or the overall BSA conformation which is also dependent on pH.41,45
Thus, in the physiological pH range, the dualCEST signal exclusively depends on the concentration, molecular size and folding state of the
mobile proteins. Contributions from other cellular compounds, water relaxation properties or changes in the chemical exchange properties can
be excluded. With this knowledge in hand, the dualCEST approach was utilized to investigate alterations of the mobile fraction of the proteome
in a glioblastoma brain tumor.
3.4 | Application of dualCEST in vivo
For examinations in humans, the dualCEST pulse sequence was implemented on a clinical 3‐T MR scanner. Transfer of the dualCEST approach to
lower B0, while maintaining its specificity to mobile proteins, is enabled by the newly introduced dimension of selectivity. As for the NMR spec-
trometer (Figure 3), pre‐saturation parameters were optimized for the MR scanner to maximize the signal strength T, while avoiding excessive
broadening of the signals. tp = 20 ms and B1 = 2 μT were found to be optimal at B0 = 3 T. In addition, the dualCEST signal is approximately linear
FIGURE 6 Dependence of the dualCEST signal on physiological parameters. T spectra of BSA (ΔωC = −3.5 ppm, B1 = 1.5 μT, B0 = 14.1 T) for
different concentrations (A), folding states (E) and pH (G). (C) T spectra of various globular proteins of different molecular weights (i.e.
molecular sizes). (B, D, F, H) Percentage variation of T at Δω = +3.5 ppm. (F) As a reference, the protein folding state was monitored by
fluorescence spectroscopy (FL). Signal dependencies demonstrate that variations inT can be attributed to changes in the concentration, molecular
size or folding state of mobile proteins. Displayed errors are the standard deviation of repeated measurements (Table S1)
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as a function of B1 for the aforementioned parameters (Supporting Information Figure S3), allowing for a simple correction of B1 inhomogeneities
in living tissue. However, a correction for B0 inhomogeneities is not necessary because of the comparatively broad plateau of the dualCEST res-
onance at 3 T around its maximum (Figure 3I, red line). To maximize the range of tolerable B0 inhomogeneities, the frequency offsets for mobile
protein signals in Equation 2 were adjusted from ±3.5 to ±5 ppm. Moreover, the frequency offsets for ssMT signals were adjusted from ±10 to
±30 ppm to allow an isolated sampling of the ssMT component without contributions from mobile protein signals also at 3 T (Figure 3). Finally,
the far off‐resonant frequency offset in Equation 1 was adjusted from 150 to 300 ppm.
Isolated endogenous bulk mobile protein MRI of a patient with glioblastoma shows a significantly reduced signal Tprotein in the necrotic tumor
region compared with normal‐appearing white matter (Figure 7H). Edges are clearly defined and show a good correlation with the inner part of the
ring enhancement in the contrast media‐enhanced image. The amplitude of Tprotein in necrotic tissue is comparable with the values in
cerebrospinal fluid (CSF), suggesting a considerable degeneration of the mobile fraction of the proteome in the tumor core. The specificity to
mobile proteins allows the assignment of the observed signal drop to a reduced concentration, a reduced average molecular size or a denatured
global folding state of bulk mobile proteins. Correct functioning of the dualCEST measurement is confirmed by signal values around zero in the
CSF, where a negligible concentration of proteins can be assumed. Anatomical structures between brain matter and peripheral CSF show a
good correlation with Tprotein. In a region of interest analysis, differences in Tprotein between gray and white matter are marginal, confirming the
absence of contributions from lipids to the dualCEST signal. The equivalent signal in these two tissues is in line with data from MR spectroscopy
when analyzing macromolecular resonances that are associated with bulk mobile proteins,46 as well as rNOE‐CEST signals evaluated by the var-
iable delay multi‐pulse (VDMP) method.47 Overall, the presented in vivo image data verify the feasibility of dualCEST examinations in humans,
enabling further investigations of the mobile fraction of the proteome in diverse pathologies.
4 | DISCUSSION
In this study, a novel MRI contrast is proposed, enabling the selective detection of endogenous bulk mobile proteins in living organisms. By contrast,
in conventional Z‐spectra in vivo, the CEST signals of mobile proteins spectrally overlap with signals originating from other cellular compounds
(Figure 1B). Several attempts have been made in the past to overcome this obstacle and to highlight the signal component of mobile proteins. Ideas
range from multi‐parametric fitting,17,32,48-50 to the incorporation of several types of exchange rate filters,24-26,47,51-53 to the suppression of
confounding signals by simultaneous pre‐saturation at various frequency offsets.30,54-56 Although these approaches work appropriately and allow
the isolation of the prominent amide proton resonance at Δω = +3.5 ppm or the rNOE‐CEST signal of aliphatic protons at around Δω = −3.5 ppm,
the assignment of these signals exclusively to mobile proteins remains questionable. With respect to the amide proton signal, a considerable part
originates from small peptides and various metabolites.57 In addition, the aliphatic rNOE‐CEST signal comprises contributions from other mobile
macromolecules, e.g. lipids or saccharides.16,17 In both cases, magnetization transfer rates to water are comparable with the rates occurring in mobile
FIGURE 7 In vivo dualCEST examination at B0 = 3 T. Multi‐modal MR images of a patient with glioblastoma. (A–C) Conventional MR contrasts: T2‐
weighted (T2w), T1‐weighted (T1w) and subtracted gadolinium contrast‐enhanced T1‐weighted (sub‐Gd‐T1w) MR images. (D) The selective dualCEST
signal of mobile proteinsTprotein showing substantial alterations of the mobile fraction of the proteome in the tumor region. (E–H) Fusion of
conventional MR contrasts and the dualCEST image
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proteins, thus preventing separation by exchange rate filtering. Here, we introduce a novel dimension of selectivity which is based on the cross mag-
netization transfer between two particular CEST signals – termed saturation crosstalk TΔωc(Δω). For this purpose, the conventional CEST technique
was extended to an RF irradiation scheme at two different frequency offsets. Incorporation of a saturation at an additional frequency offset was
introduced for the first time in 2010.54 In the following year, saturation with frequency‐alternating RF irradiation (SAFARI) was proposed to avoid
signal contributions from direct water saturation and ssMT.30 In our study, an identical pre‐saturation pulse scheme, but with different combinations
of the two frequency offsets, is used to selectively detect the coupling between different CEST signals. The detection of the coupling between the
CEST signal of amide and aliphatic protons provides a unique specificity to mobile proteins. In contrast, immobile proteins, such as cytoskeletal or
membrane proteins, do not contribute toTprotein, as immobile proteins show comparatively broad signals with linewidths of several 10 ppm,
57 which
are suppressed by the proposed ssMT correction method. As is commonly known, proton transversal relaxation times (T2) of immobile solid‐like
structures are very short (on the order of 10 μs) in comparison with the T2 values of mobile molecules (several 10 ms). As the linewidths of CEST
signals inversely depend on T2,
58 proteins can be roughly classified by their mobility into two types – mobile and immobile.8 The specificity of the
dualCEST signal to mobile proteins was verified experimentally by the successive addition of different cellular compounds to a protein model solu-
tion (Figure 5). Moreover, we demonstrated that the dualCEST signal is intrinsically corrected for changes in water relaxation (i.e. T1obs, Figure 5D), as
well as robust against changes in the chemical exchange properties in the physiologically relevant range (i.e. pH, Figure 6H). Parameters that affect
the amplitude of the dualCEST signal are the concentration, molecular size and folding state of mobile proteins (Figure 6), making dualCEST a
valuable diagnostic tool to detect aberrant proteomes in vivo.
The largest drawback of the method is the inherently smaller SNR in comparison with conventional CEST. The reason for this is the quite large
number of nine Z‐values required for the calculation of the isolated mobile protein signal Tprotein (Equation 2). However, the newly introduced
dimension of selectivity opens up new possibilities to overcome this limitation. As the specificity of the dualCEST signal to mobile proteins relies
on the coupling of two signals, rather than on the resolution of individual resonances, high spectral resolutions are not required. This allows the
application of high B1 values to increase the signal strength without a loss of specificity (Figure 3H). In contrast, the spectral selectivity clearly
deteriorates when acquiring conventional Z‐spectra using high B1 because of extensive peak broadening. Other possibilities to further amplify
the dual CEST signal were found to be the reduction in tp (Figure 3F) and B0 (Figure 3J). The signal amplification at shorter tp can be attributed
to the expansion of the spectral bandwidth of the pre‐saturation pulses and the concomitant incorporation of more protons from neighboring
chemical shifts into the measurement procedure. This is because, in proteins, the chemical shift of identical proton types (e.g. amides) is dispersed,
depending on their location inside the protein and the respective chemical environment.59 In a similar manner, the number of saturated protons,
and thus the signal strength, is also increased by reducing the spectral resolution (i.e. reducing B0). Consequently, the dualCEST signal profits from
lower magnetic field strengths, paving the way for dualCEST examinations on clinical MR scanners. In this study, in vivo measurements were per-
formed at a magnetic field strength of 3 T and optimized to maximize the signal amplitude, while avoiding an excessive broadening of the signals.
Linewidths broader than the distance between the two frequency offsets Δω and ΔωC might cause a direct saturation of CEST signals at one fre-
quency offset induced by pulses applied at the other. This might influence the signal preparation, leading to disturbed dualCEST signals. However,
the utilized distance of 10 ppm at 3 T between Δω and ΔωC should be sufficient to avoid such influences, assuming that the linewidths of the
individual CEST pools do not exceed 20 ppm. These features should have allowed the acquisition of dualCEST images with adequate SNR. How-
ever, there were technical limitations of the MR scanner used in this work which prevented a pre‐saturation with an ideal DC of 50% (please note:
these limitations were caused by the restricted amplifier performance and not the specific absorption rate, SAR). Instead, only a DC of approxi-
mately half the desired value could be realized, which is why several repetitions were required to acquire a reliable dualCEST image in vivo.
For repeated measurements, the dualCEST approach profits from a fast and direct acquisition. By ‘direct’, we mean that TΔωc(Δω) can be
calculated from unprocessed data without the application of any fitting procedure to approximate the direct water saturation or ssMT. This allows
a fast determination of the dualCEST signal without the need for the sampling of an entire spectrum, leading to a considerable saving in acquisition
time. Exclusion of the fitting procedure was enabled by an analytical description based on the AREX36 evaluation (Figure S1). In this theory,
TΔωc(Δω) is a correction term – considering the exchange of magnetization between two different CEST pools – which is added to the longitudinal
relaxation rate in the rotating frame R1ρ of a multi‐pool system.
58,60,61 The validity of the analytical model requires a saturation length in
compliance with the criterion for steady state (Figure 3B). In addition, the tilt angle θ of the effective field and the z‐axis must be small in
compliance with: cos2θ ¼ Δω
2
Δω2 þ γB1ð Þ2
≈1.21,36,58 This limits the evaluation of signals at small Δω when applying comparatively high B1. Violation
of this assumption leads to strong signal distortions, as observed at Δω < 2.75 ppm when acquiring signals at B0 = 3 T and B1 = 2 μT (Figure 3I,
red line). The saving in acquisition time allowed the repetition of the acquisitions to accumulate sufficient SNR for dualCEST examinations of a
brain tumor patient without impractical lengthening of the measurement time.
The dualCEST approach allows the identification of pathological modifications of the mobile fraction of the proteome in vivo. Significant
changes in the isolated mobile protein signal Tprotein were detected in the necrotic region of a human brain tumor (Figure 7). Necrotic tissue is
known to consist of decomposing or dead cells, verifying the ability of the dualCEST signal to detect aberrant proteomes in living organisms. In
the future, whole cohorts of patients will need to be examined to reliably determine the actual contribution of mobile proteins to CEST signal
changes in different pathologies, and to further investigate the diagnostic value of the presented method. As Tprotein is a quantitative value, a
comparison between different subjects is possible. Applications range from staging and follow‐up studies of cancer treatment to the diagnosis
of neurodegenerative diseases associated with the accumulation of pathogenic protein plaques, e.g. Alzheimer's disease. In addition, the dualCEST
GOERKE ET AL. 11 of 14
Publication I
29
approach should be particularly suitable for the selective detection of binding mechanisms of mobile proteins, as its specificity relies on the
coupling of different CEST signals. In this context, selective imaging of small exogenous CEST agents binding to mobile proteins is plausible
because of the immobilization of the small molecules and the resulting intermolecular magnetization transfer pathway.62
5 | CONCLUSIONS
A novel MRI technique – termed dualCEST – is proposed, allowing the selective detection of endogenous bulk mobile proteins in humans. In this
study, for the first time, the coupling of different CEST signals mediated by intramolecular spin diffusion is exploited to introduce an exceptional
specificity into the CEST experiment. The specificity of the dualCEST signal to bulk mobile proteins was verified experimentally by the investiga-
tion of different cellular compounds under different physiological conditions. A fast and direct acquisition of the dualCEST signal was enabled by
an analytical description of the dualCEST signal. With regard to applications in humans, the dualCEST signal was maximized by a comprehensive
study of diverse technical parameters. Remarkably, it was found that the dualCEST signal profits from lower magnetic field strengths, allowing a
straightforward implementation of dualCEST examinations on clinical MR scanners. The applicability of the dualCEST technique for examinations
in humans was verified in a proof‐of‐principle study of a brain tumor patient at 3 T.
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Purpose: Relaxation‐compensated CEST‐MRI (i.e., the inverse metrics magnetization 
transfer ratio and apparent exchange‐dependent relaxation) has already been shown to 
provide valuable information for brain tumor diagnosis at ultrahigh magnetic field 
strengths. This study aims at translating the established acquisition protocol at 7 T to a 
clinically relevant magnetic field strength of 3 T.
Methods: Protein model solutions were analyzed at multiple magnetic field strengths 
to assess the spectral widths of the amide proton transfer and relayed nuclear 
Overhauser effect (rNOE) signals at 3 T. This prior knowledge of the spectral range 
of CEST signals enabled a reliable and stable Lorentzian‐fitting also at 3 T where 
distinct peaks are no longer resolved in the Z‐spectrum. In comparison to the estab-
lished acquisition protocol at 7 T, also the image readout was extended to three 
dimensions.
Results: The observed spectral range of CEST signals at 3 T was approximately ±15 
ppm. Final relaxation‐compensated amide proton transfer and relayed nuclear 
Overhauser effect contrasts were in line with previous results at 7 T. Examination of 
a patient with glioblastoma demonstrated the applicability of this acquisition proto-
col in a clinical setting.
Conclusion: The presented acquisition protocol allows relaxation‐compensated 
CEST‐MRI at 3 T with a 3D coverage of the human brain. Translation to a clinically 
relevant magnetic field strength of 3 T opens the door to trials with a large number of 
participants, thus enabling a comprehensive assessment of the clinical relevance of 
relaxation compensation in CEST‐MRI.
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1 |  INTRODUCTION
Chemical exchange saturation transfer (CEST)1,2 is an emerg-
ing MRI technique for the detection of organic compounds 
present in low concentration in living tissue such as proteins 
and peptides3-5 or various metabolites (e.g., glucose,6-8 cre-
atine,9-12 glutamate13-15). The potential to obtain information 
at the molecular level with a spatial resolution comparable to 
conventional MRI makes CEST a promising imaging tech-
nique for the detection of a diversity of diseases and espe-
cially for cancer.
The most commonly used CEST technique for tumor 
imaging is amide proton transfer (APT) imaging,3,16,17 
which uses the asymmetry analysis (MTRasym) to correct 
for symmetric direct water saturation (DS) effects and to 
detect the CEST signal of amide protons located in the 
backbone of proteins and peptides. APT–CEST‐MRI at 3 
T has already been shown to provide information of high 
clinical relevance, like tumor grading,18,19 or differentiation 
of radiation necrosis and tumor progression.20,21 However, 
over the past few years, concerns about concomitant ef-
fects competing with the actual APT signal have arisen. 
Investigations at higher magnetic field strengths (B0) iden-
tified superimposing contributions originating from the 
relayed nuclear Overhauser effect22,23 (rNOE) as well as 
from semisolid magnetization transfer23,24 (ssMT). In addi-
tion, theoretical descriptions showed that CEST signals are 
intrinsically diluted by spillover effects leading to an inter-
fering dependence on the water relaxation properties (i.e., 
the longitudinal and transversal relaxation rate of water R1 
and R2).25-27
Relaxation‐compensated CEST‐MRI (i.e., the inverse 
metrics MTRRex25,26 and AREX27) (Equations 2 and 3) in com-
bination with a multipool Lorentzian‐fit analysis to separate 
the individual CEST signals (e.g., APT, rNOE) provides a 
means to evade such spillover effects.28,29 The unraveling of 
the different CEST signals and compensation for competing 
relaxation effects is particularly promising with regard to 
an increase in specificity for the identification of new bio-
markers. At 7 T, relaxation‐compensated CEST‐MRI of the 
APT and rNOE signals has already been shown to provide 
additional features that are not visible in uncorrected CEST 
images or conventional MRI.29,30 Moreover, relaxation‐
compensated CEST‐MRI at 7 T has recently been applied to 
various neuro‐oncological clinical questions, which demon-
strated the potential to differentiate histologic and genetic 
subtypes of glioma,31 as well as to allow early assessment32 
and prognostication33 of treatment response in patients with 
glioblastoma. Although similar clinical questions have also 
been reported to be accessible by uncorrected CEST‐MRI 
at 3 T,34-37 it appears that relaxation‐compensated CEST‐
MRI provides higher diagnostic accuracy. Nevertheless, 
the actual clinical relevance of relaxation compensation in 
CEST‐MRI remains to be investigated in detail. Thus, the 
aim of this study was to translate the established acquisi-
tion protocol for relaxation‐compensated CEST‐MRI at 7 
T29 to a clinically relevant magnetic field strength of 3 T. 
This would open the door to clinical trials with larger pa-
tient cohorts, thus enabling a comprehensive assessment of 
the clinical relevance of relaxation compensation in CEST‐
MRI. In addition, the translation to 3 T would also allow 
excluding magnetic field–dependent biases for comparison 
to APT‐weighted MRI.34
At 3 T, distinct peaks for the APT and rNOE signals 
are not resolved in the Z‐spectrum.37-39 Consequently, a 
strong variability of fit parameters is observed when ap-
plying a multipool Lorentzian‐fit procedure. In this study, 
reliable and stable fitting of the APT and rNOE signals 
at 3 T has been realized by adjusting the fit parameters 
(i.e., start values and borders) of the spectral widths of 
CEST signals to significantly larger values in comparison 
to previous reports.38-40 This is based on an investigation of 
protein model solutions at multiple magnetic field strengths 
(i.e., B0 = 3 T, 7 T, and 14.1 T) demonstrating a spectral 
range of CEST signals at 3 T of approximately ±15 ppm 
(Figure 1A).
In comparison to the established acquisition protocol 
for relaxation‐compensated CEST‐MRI at 7 T, the image 
readout was extended to three dimensions using the snap-
shot‐CEST approach,39,41 which allows adequate cover-
age of the tumor volume. The feasibility of applying this 
acquisition protocol in a clinical setting is demonstrated by 
examination of a patient with newly diagnosed glioblas-
toma. Similar CEST contrasts to those obtained at ultra-
high magnetic field strengths were observed.29 Overall, we 
were able to successfully translate relaxation‐compensated 
CEST‐MRI to a clinically relevant magnetic field strength 
of 3 T, thereby allowing a comprehensive assessment of 
relaxation compensation in CEST‐MRI.
2 |  METHODS
2.1 | CEST metrics
The Z‐spectrum is defined as the normalized water magneti-
zation (Msat) after presaturation at a frequency offset (Δω): 
K E Y W O R D S
APAT, cancer, CEST, MRI, proteins, rNOE
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, where M0 is the equilibrium water magneti-
zation. Application of a multipool Lorentzian‐fit procedure 
allows defining a labeled Z‐spectrum (Zlab) and a reference 
Z‐spectrum (Zref) for each individual pool.29 Zlab consists of 
all fitted pools, whereas the pool of interest is excluded for 
Zref. Consequently, calculation of a CEST effect of interest is, 
in principle, possible by calculating the Lorentzian difference 
(LD) 23:
However, subtraction of the Z‐values in Equation 1 does 
not account for spillover effects that dilute the actual CEST 
effect, depending on the vertical position of the Z‐values 
along the Z‐axis.25,26 Consequently, LD depends not only on 
the actual CEST effect, but also on the water relaxation prop-
erties (i.e., R1 and R2 of water) as well as on other magneti-
zation transfer signals that are present in the spectral region 
of interest (e.g., ssMT). In the steady state (i.e., saturation 
duration tsat >> T1), a compensation for such spillover effects 
can be achieved by using the inverse magnetization transfer 
ratio (MTRRex)25,26:
In addition, a compensation for the scaling of all CEST ef-
fects by the T1 relaxation of water is possible by the apparent 
exchange‐dependent relaxation (AREX)27:
2.2 | In vivo CEST‐MRI
2.2.1 | Subjects
One patient with newly diagnosed glioblastoma (WHO 
grade IV) was examined before therapy. In addition, one 
healthy volunteer was examined several times for optimi-
zation of the pulse‐sequence parameters. Examinations 
were approved by the local ethics committee of the Medical 
Faculty of the University of Heidelberg and are in accord-
ance with the relevant guidelines and regulations. Written 
informed consent was received from the subjects before the 
examination.
2.2.2 | MRI acquisition
In vivo CEST‐MRI was performed on a 3T whole‐body 
MR scanner (MAGNETOM Prisma; Siemens Healthineers, 
Erlangen, Germany) using a 3D spiral‐centric‐reordered gra-
dient‐echo acquisition (i.e., snapshot CEST39,41) and a 64‐
channel receive head/neck coil.
Image‐readout parameters were adapted from literature39 
and were found to be optimal for FOV = 220 × 179 × 48 
mm3, matrix = 128 × 104 × 16, resolution = 1.7 × 1.7 × 
3 mm3, GRAPPA acceleration factor = 2, TE = 2.75 ms, 
TR = 5.5 ms, bandwidth = 340 Hz/pixel, flip angle = 7°, 
and elongation factor = 0.5. The acquisition duration (tacq) 
for one 3D image was 3.6 seconds. For optimization of the 
image‐readout parameters, SNR maps were calculated by the 










F I G U R E  1  Z‐spectra and AREX spectra (B1 = 0.75 µT) of bovine serum albumin (BSA) (A) and cross‐linked BSA (B) at multiple B0. As 
B0 decreases, the spectral range of CEST signals and semisolid magnetization transfer (ssMT) broadens substantially (colored arrows). The direct 
water‐saturation (DS) fits for calculation of the AREX spectra are indicated with dashed lines
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Presaturation was achieved by a train of 148 Gaussian‐shaped 
RF pulses of mean amplitude B1 = flip angle/(γ·tp) = 0.6 µT 
or 0.9 µT, length tp = 20 ms, and duty cycle = 80%, resulting 
in an overall duration of tsat = 3.7 seconds. The Z‐spectra 
were sampled at 57 frequency offsets in unequal steps be-
tween ±250 ppm (the complete list of frequency offsets is 
provided in the Supporting Information). For normalization, 
M0 was acquired at the beginning and at the end of the CEST‐
image series and interpolated to obtain an individual M0 for 
each presaturation cycle. The acquisition duration for collect-
ing CEST data at two B1 values was 7:36 minutes each.
For correction purposes, a B0 map and a B1 map were 
acquired by the WASABI42 (simultaneous mapping of water 
shift and B1) approach and a T1 map by the saturation recov-
ery sequence. For both techniques, the same image‐readout 
parameters were used as for the acquisition of CEST data. 
The acquisition durations for WASABI data and T1 data were 
3:41 minutes and 1:58 minutes, respectively.
2.2.3 | Data processing
All images (i.e., CEST, WASABI, and T1 data) were co‐ 
registered using an intensity‐based rigid registration algo-
rithm in the Medical Imaging Interaction Toolkit.43 To correct 
for B0 inhomogeneities, Z‐spectra were shifted along 
the Δω dimension according to the acquired B0 map and 
denoised using principal component analysis as previously 
described.39
The resulting Z‐spectra were fitted pixel‐wise using a 
4‐pool Lorentzian‐fit model representing the APT, rNOE, 
ssMT, and DS. The Lorentzian function of the DS was 
adjusted by a constant plateau around 0 ppm to account for 
the broadening of the DS due to pulsed presaturation.39 A 
detailed description of the fit model and the optimized fit 
parameters (i.e., start values and borders) can be found in the 
Supporting Information.
The fitted Z‐spectra were used for calculation of the differ-
ent CEST contrasts defined in Equations 1‐3. For the APT and 
rNOE pools, the contrasts were calculated at +3.5 and −3.5 
ppm, respectively. Final CEST contrasts were corrected for B1 
inhomogeneities by means of the 2‐point “contrast‐correction” 
method as previously described44 (reconstructed B1 = 0.7 µT).
2.3 | In vitro CEST measurements
2.3.1 | Model systems
Two model solutions containing 15% weight‐per‐volume 
bovine serum albumin (BSA) were prepared. The solutions 
were buffered at pH 7 using phosphate‐buffered saline. Both 
model solutions were prepared from highly concentrated stock 
solutions to ensure precise attainment of the desired concen-
tration. In one sample, BSA was cross‐linked using 30 µL per 
milliliter of a 25% weight‐per‐weight aqueous glutaraldehyde 
solution. To ensure homogenous cross‐linking, stock solutions 
were continuously stirred and chilled on ice during mixing.
2.3.2 | MRI acquisition
In vitro CEST measurements were performed at three mag-
netic field strengths (i.e., B0 = 3 T, 7 T, and 14.1 T). For 
measurements at 3 T, the same setup as for in vivo measure-
ments was used. Measurements at 7 T were also performed 
on a whole‐body MR scanner (MAGNETOM 7 T; Siemens 
Healthineers) using a setup that was established in previ-
ous studies.29,44 Measurements at 14.1 T were performed 
on a narrow bore Avance II spectrometer (Bruker BioSpin, 
Karlsruhe‐Rheinstetten, Germany) using a setup also 
established in previous studies.5,45,46 The aforementioned 
references also provide details for the B0, B1, and T1‐map-
ping techniques used at each magnetic field strength.
The sample temperatures were stabilized at 25°C using a 
thermos flask containing 1.8 L water or the internal heating 
device for the whole‐body MR scanner and the MR spec-
trometer, respectively.
Presaturation was achieved by a train of 84 Gaussian‐
shaped RF pulses of mean amplitude B1 = 0.75 µT, tp = 100 ms, 
and duty cycle = 56%, resulting in tsat = 15 seconds. The 
Z‐spectra were sampled at 107 frequency offsets in unequal 
steps between ±250 ppm. Analogous to in vivo measure-
ments, M0 was acquired at several time points and interpo-
lated to obtain an individual M0 for each presaturation cycle.
2.3.3 | Data processing
The Z‐spectra were corrected for B0 inhomogeneities and fit-
ted pixel‐wise by a 1‐pool Lorentzian‐fit model representing 
the DS. To avoid contributions from CEST signals, as well as to 
take into account the broadening of the DS due to a pulsed pre-
saturation for the BSA sample, data points in the range of ±25 
ppm to ±0.6 ppm and between ±0.3 ppm were excluded from 
the fitting procedure. For cross‐linked BSA, data points in the 
range from ±220 ppm, ±150 ppm, or ±80 ppm to ±0.8 ppm 
at B0 = 14.1 T, 7 T and 3 T, respectively, and between ±0.3 
ppm were excluded. A detailed description of the fit model 
can be found in Ref 5.
The fitted and acquired Z‐spectra were used as Zref 
and Zlab, respectively, for calculation of the AREX spectra 
defined in Equation 3. Final AREX spectra were selected from 
regions with homogenous B1 and apparent values equal to the 
nominal B1.
3 |  RESULTS
To assess the spectral range of CEST signals at 3 T, a pro-
tein model solution was analyzed at multiple B0 over a broad 
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range of frequency offsets (Figure 1A). At 14.1 T, several 
individual CEST signals were observed, whereas at 3 T dis-
tinct peaks were not resolved in the Z‐spectrum. Separation 
of the CEST signals from the DS by the AREX evaluation 
revealed a substantial signal broadening with decreasing B0. 
The observed spectral range of CEST signals was approxi-
mately ±7 ppm, ±10 ppm, and ±15 ppm at B0 = 14.1 T, 7 
T and 3 T, respectively. The steady increase of the spectral 
range of CEST signals, as well as of the fitted DS (Figure 1A, 
dashed lines), verified the correct separation of CEST sig-
nals at 3 T. In addition, the observed continuous increase 
of the CEST signal amplitudes in the AREX spectra with 
decreasing B0 is in line with previous reports,5,30,47 which has 
been attributed to the saturation of an increasing number of 
spectrally neighboring proton species. To further validate the 
observed signal broadening with decreasing B0, in addition, a 
cross‐linked protein model solution was analyzed (Figure 1B). 
The resulting ssMT provides a means to investigate signals 
far off‐resonance from the DS, and thus independent of the 
applied fitting procedure. Likewise, a substantial broadening 
of the spectral range of the ssMT was found. The observed 
spectral range was approximately ±50 ppm, ±100 ppm, and 
±200 ppm at B0 = 14.1 T, 7 T and 3 T, respectively. In com-
parison to untreated BSA, the percentage broadening of the 
ssMT was in the approximate range, as was the case for the 
CEST signals (Figure 1A, B, colored arrows).
Before the acquisition of the in vivo CEST data, the band-
width and GRAPPA acceleration factor of the 3D‐image 
readout was optimized to maximize SNR, while minimiz-
ing tacq (Figure 2). The flip angle of the image readout was 
adjusted according to the Ernst angle,41 depending on the 
resulting TR at different bandwidths and GRAPPA acceler-
ation factors. For calculation of the SNR maps, presaturated 
images Msat(−3.5 ppm) were used to optimize the image‐
readout parameters for the acquisition of actual CEST data. 
The optimum was achieved for bandwidth = 340 Hz/px and 
a GRAPPA acceleration factor of 2, leading to a tacq of 3.6 
seconds. Note that the two outer slices on each side could not 
be evaluated meaningfully due to aliasing artifacts in the slice 
direction (data not shown), resulting in an effective number 
of 12 slices.
The optimized 3D‐image readout was used to investigate 
in detail the CEST signals observable at 3 T in the human 
brain. Acquisition of densely sampled Z‐spectra over a 
broad range of frequency offsets and at multiple B1 re-
vealed a spectral range for the ssMT of approximately ±200 
ppm (Figure 3A, B), in line with findings for the in vitro 
measurements at 3 T (Figure 1B). In addition, distinct 
F I G U R E  2  SNR maps (slice 8 of 16) 
for various bandwidths (BW) and GRAPPA 
acceleration factors at 3 T. Maximum SNR, 
while minimizing the tacq, was obtained for 
bandwidth of 340 Hz/px and a GRAPPA 
acceleration factor of 2, yielding tacq = 
3.6 seconds. Regions of interest in white 
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peaks for the APT and rNOE signals were also not resolved 
in living tissue (Figure 3C, D). Even though slight dips 
were observable for B1 less than 0.7 µT at around +3.5 ppm 
and −3.5 ppm, these do not constitute the complete CEST 
signals, as was demonstrated in vitro (Figure 1A). The Z‐
values close to 1 at far off‐resonance frequency offsets 
(Figure 3A, B, Δω = ±250 ppm) verify compliance with 
the steady‐state criterion (Equation 2).
The prior knowledge about the actual spectral range of 
CEST signals at 3 T (i.e., approximately ±15 ppm) was used 
to specify the fit parameters (i.e., start values and borders, 
Supporting Information Tables S1 and S2) of the 4‐pool 
Lorentzian fit in vivo (Figure 4). In addition, the spectral 
positions of the Lorentzian functions were fixed to +3.5 ppm, 
−3.5 ppm, and −2.5 ppm for the APT, rNOE and ssMT, re-
spectively. The resulting spectral range of the fitted APT and 
rNOE signals was in line with the range obtained in the mea-
surement of the protein model solution (Figures 1A and 4A, 
orange arrows). Reliability and stability of the fit was ver-
ified by the evenly distributed values in the histograms of 
the resulting fit parameters without being restricted by the fit 
borders (Figure 4B). Furthermore, in compliance with expec-
tations for all fitted pools, an increase in the average FWHM 
as a function of B1 was observed.
Final CEST contrasts of a heathy volunteer at 3 T were 
in line with previous results at 7 T,29 showing a hyperintense 
APT signal for the LD and MTRRex‐metric in gray matter 
(Figure 5D, E) and a hyperintense rNOE signal in white mat-
ter (Figure 5G, H). The AREX maps of the APT and rNOE 
signals were similar, but interestingly showed substantial dif-
ferences in the gray matter of the putamen (Figure 5F, I, pink 
arrows). In addition, all CEST contrasts were independent of 
B0 and B1 inhomogeneities (Figure 5B, C), demonstrating the 
functionality of the applied field‐correction methods.
To demonstrate the applicability of the acquisition pro-
tocol in a clinical setting, a patient with newly diagnosed 
glioblastoma was investigated (Figure 6). The relaxation‐
compensated MTRRex and AREX images of the APT and rNOE 
signals showed distinct changes in the tumor region, high-
lighting several different morphological features. For exam-
ple, in the AREX‐rNOE images, a consistent signal drop was 
observed within the tumor area, whereas the MTRRex‐APT 
contrast showed increased signal intensity within the dorso‐
lateral tumor area (Figure 6, pink arrows). Acquisition of 3D 
data enabled an investigation of specific contrast features over 
several slices in the tumor region, and therefore a more reli-
able assignment of these features to morphological changes. 
However, for a conclusive assessment of the observed con-
trast changes to clinical questions, a sufficiently large cohort 
has to be investigated.
4 |  DISCUSSION
In this study, the established acquisition protocol for relaxa-
tion‐compensated CEST‐MRI at 7 T has been translated 
to a clinically relevant magnetic field strength of 3 T. The 
implementation at 3 T is based on the central finding of a 
spectral range of CEST signals of approximately ±15 ppm 
(Figure 1A). In contrast, CEST signals at this magnetic field 
strength are generally assumed to be present only in the range 
of about ±6 ppm.18,38-40 The actual spectral range of CEST 
signals at 3 T is not readily assessable, as at low magnetic 
field strengths distinct peaks are no longer resolved in the 
F I G U R E  3  Z‐spectra for gray matter (GM) (A,C) and white matter (WM) (B,D) of a healthy volunteer for multiple B1 at 3 T. Besides the 
dominant signal of the DS and the ssMT (A,B), distinct peaks were not resolved and only slight dips of the amide proton transfer (APT) and relayed 
nuclear Overhauser effect (rNOE) signals could be observed at approximately +3.5 ppm and −3.5 ppm, respectively (C,D)
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Z‐spectrum. Nonetheless, investigation of gradual signal 
changes as a function of B0 in this study (Figure 1) provides 
a means to more reliably distinguish between actual CEST 
signals and competing background effects (i.e., DS). The 
observed broadening of CEST signals with decreasing B0 is 
in line with common observations in MR spectroscopy47 and 
is based on the illustration of MR spectra as a function of the 
chemical shift in units of ppm, whereas the spectral width of 
MR signals is constant for units of Hz. CEST signals with a 
spectral range larger than ±6 ppm were also recently observed 
by chemical exchange rotation transfer48 and dualCEST5 
experiments at 3 T, which also provide a means to effectively 
remove DS and ssMT effects. This prior knowledge about 
the spectral range of CEST signals enabled a reliable and 
stable Lorentzian fitting also at 3 T without the need for more 
advanced approaches, such as multistep fitting procedures or 
special lineshapes for the ssMT.38-40,49 With respect to previ-
ous approaches,38-40,49 adjustment of the measurement pro-
tocols according to the observed findings in this study (i.e., 
increasing the sampling range of frequency offsets as well as 
the fitting range for the widths of the CEST signals) will not 
change the fundamental CEST contrasts. The advantage in 
applying these new conditions is the stabilization of the fit 
and the improvement of the contrast to noise ratio, as more of 
the actual CEST signals would be employed.
Due to the extensive broadening of CEST signals at 3 T, 
the number of pools for the established Lorentzian‐fit model 
at 7 T was reduced from 5 to 4 pools. Consequently, the 
pool at +3.5 ppm represents the collective signal of all 
chemically exchanging protons resonating downfield from 
the water signal (i.e., amide, amine, guanidinium, and 
hydroxyl). However, due to the applied low‐power saturation 
(i.e., B1 < 1 µT) and the evaluation at +3.5 ppm, this pool 
can primarily be associated with the amide proton signal,37 
which is why it was termed APT. In addition, a compensa-
tion for underlying downfield‐rNOE signals is possible by 
the dnsAPT metric.30,31 Following previous findings,5,23,29 
the ssMT was set to be asymmetric around the DS and to 
resonate at approximately −2.5 ppm.
Application of relaxation‐compensated CEST‐MRI for 
quantitative analyses (i.e., using Equation 3 to measure the 
exchange‐dependent relaxation rate: AREX = Rex50) is, in 
principle, also possible at 3 T. However, this requires, in 
addition to the steady‐state criterion (tsat >> T1, Equation 2), 
compliance with the large‐shift limit (Δω >> γB1).26,27 For 
the applied saturation powers in this study, in which B1 is 
less than 1 µT, the large‐shift limit is fulfilled for frequency 




θ is the tilt angle of the effective field), and thus does not 
need to be considered for the evaluation of the APT and 
rNOE signal (Figure 4A, orange line). For evaluation of 
frequency offsets closer to the water signal or for application 
of higher B1 amplitudes, the relaxation‐compensated 










.26,27,51 This allows relaxation‐
compensated CEST‐MRI to also be applicable for high‐B1 
approaches or imaging of CEST agents resonating close to 
the water signal.
With regard to application in a clinical setting, the pre-
sented acquisition protocol for relaxation‐compensated 
CEST‐MRI at 3 T is ready for use. Final CEST contrasts at 3 
T were found to be in line with previous results at 7 T.29 The 
overall acquisition duration is 20 minutes, including the two 
required CEST scans at different B1, as well as B0, B1, and T1 
mapping for correction of field inhomogeneities and relax-
ation compensation. Thus, the required time is approximately 
the same as for conventional 1H‐MRSI, which has already 
F I G U R E  4  A, Z‐spectra and AREX spectra (B1 = 0.6 µT) of 
a representative voxel in white matter at 3 T. The spectral range of 
CEST signals (orange arrow) is the same as for protein model solutions 
(compare with Figure 1A). B, Histograms of the resulting parameters 
of a 4‐pool Lorentzian‐fit analysis in one slice of a healthy volunteer. 
The illustrated values at two different B1 belong to the CEST images of 
the same subject and slice as in Figure 5
Publication II
41
   | 629GOERKE Et al.
F I G U R E  5  CEST image data of a 
healthy volunteer at 3 T (B1 = 0.7 µT, slice 
6 of 16). A‐C, T1 maps and field maps 
required for correction of the CEST images. 
Final APT (D‐F) and rNOE (G‐I) contrasts 
for all three metrics of Lorentzian difference 
(D,G), inverse magnetization transfer ratio 
(MTRRex) (E,H), and AREX (F,I) are in line 
with previous results at 7 T. The pink arrows 
indicate the putamen brain region. The 
CEST images were calculated from the fit 
parameters illustrated in Figure 4
F I G U R E  6  Relaxation‐compensated CEST‐MRI (B1 = 0.7 µT, slices 10‐12 of 16) of a patient with newly diagnosed glioblastoma (WHO 
grade IV) examined at 3 T. The tumor volume can be seen in the co‐registered gadolinium contrast‐enhanced T1‐weighted (Gdce‐T1w) images. The 
pink arrows indicate a hyperintense region, which most likely corresponds to a blood clot within the tumor
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been demonstrated to be applicable in a clinical routine. 
To further improve the current acquisition protocol, a real‐
time frequency drift correction as recently proposed for the 
MTRasym analysis52-54 could be included, although it was not 
required in this work because the small changes in B0 at 3 
T of about 0.02 ppm55 during a 20‐minute examination are 
compensated for by the Lorentzian fitting. For the next step, 
this acquisition protocol will be used to comprehensively 
assess the actual clinical relevance of relaxation compen-
sation in CEST‐MRI for various neuro‐oncological clinical 
questions. In particular, the translation to 3 T enables investi-
gation of the controversially discussed overcompensation of 
T1 at this magnetic field strength using the AREX approach 
(Equation 3).56-58 The unravelling of the different CEST sig-
nals and compensation for competing relaxation effects by 
the presented acquisition protocol can also enable obtaining 
more detailed information on the origin of CEST contrast 
in vivo. For general recommendations regarding acquisition 
parameters for CEST‐MRI at 3 T, we refer to the APT‐
weighted approach of Zhou and van Zijl et al,59-61 as they 
have collected a sizeable amount of clinical evidence up until 
now. Note that the saturation power of 0.7 µT used in this 
study generates a different CEST contrast and cannot be di-
rectly compared with APT‐weighted MRI using 2 µT.
5 |  CONCLUSIONS
The established acquisition protocol for relaxation‐com-
pensated CEST‐MRI at ultrahigh magnetic field strengths 
was successfully translated to a clinically relevant mag-
netic field strength of 3 T. Reliable and stable Lorentzian 
fitting of the APT and rNOE signals at 3 T, where dis-
tinct peaks are not resolved in the Z‐spectrum, was ena-
bled by obtaining prior knowledge about the spectral range 
of CEST signals at multiple magnetic field strengths. 
In addition, the image readout was extended to three 
dimensions, allowing adequate coverage of the tumor 
volume. The overall acquisition duration, including all 
required data for relaxation compensation, was 20 minutes, 
making the acquisition protocol applicable in a clinical set-
ting. Examination of a patient with glioblastoma revealed 
similar CEST contrasts at 3 T as was obtained at ultrahigh 
magnetic field strengths. With this acquisition protocol at 
hand, the clinical relevance of relaxation compensation in 
CEST‐MRI can now be assessed in larger patient cohorts.
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High image signal–to–noise ratio (SNR) is required to reliably detect the inherently
small chemical exchange saturation transfer (CEST) effects in vivo. In this study, it
was demonstrated that identifying spectral redundancies of CEST data by principal
component analysis (PCA) in combination with an appropriate data–driven extraction
of relevant information can be used for an effective and robust denoising of CEST
spectra. The relationship between the number of relevant principal components and
SNR was studied on fitted in vivo Z–spectra with artificially introduced noise. Three
different data–driven criteria to automatically determine the optimal number of nec-
essary components were investigated. In addition, these criteria facilitate straightfor-
ward assessment of data quality that could provide guidance for CEST MR protocols
in terms of SNR. Insights were applied to achieve a robust denoising of highly sam-
pled low power Z–spectra of the human brain at 3 and 7 T. The median criterion pro-
vided the best estimation for the optimal number of components consistently for all
three investigated artificial noise levels. Application of the denoising technique to
in vivo data revealed a considerable increase in image quality for the amide and rNOE
contrast with a considerable SNR gain. At 7 T the denoising capability was quantified
to be comparable or even superior to an averaging of six measurements. The pro-
posed denoising algorithm enables an efficient and robust denoising of CEST data
by combining PCA with appropriate data–driven truncation criteria. With this gener-
ally applicable technique at hand, small CEST effects can be reliably detected without
the need for repeated measurements.
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Chemical exchange saturation transfer (CEST) allows for the indirect detection of diluted molecules through transfer of their saturation to the
abundant water pool.1-3 Many different diluted solutes have been reported to be detectable with CEST, including peptides and proteins,3-6 with
dependency on protein conformation,7-9 creatine10,11 and glutamate,12,13 as well as injected solutes such as iopamidol,14-16 glucose17-20 and glu-
cose derivatives.21,22
Several CEST applications involve the fitting of spectrally selective CEST effects related to proteins, including isolation of amide, amine and
relayed nuclear Overhauser effects (rNOE), as well as smaller peaks potentially related to creatine and choline–containing phospholipids.10,11,23,24
Due to recent reports of spatial correlations between isolated amide CEST and gadolinium ring enhancement,5,6 changes in rNOE with correlation
to histology,25-28 and the ability of these contrasts to measure and predict brain tumor therapy response,29-32 spatial correlations of spectrally
selective protein CEST effects are also garnering increased clinical interest. Furthermore, novel experiments that target CEST signals specifically
originating from bulk mobile proteins33 are being investigated to identify altered states of proteins under conditions of disease.
As CEST effects are inherently small in magnitude, much effort is typically made to optimize saturation parameters for spectral selectivity and
CEST effect size, in addition to optimizing imaging readouts. Experiments are often performed at ultra–high field strengths to take advantage of
the inherent high signal–to–noise ratio (SNR). Still, both at clinical field strengths34 and at ultra–high field,4,23 these spectrally selective CEST
effects are small and difficult to detect reliably. This is true not only for multi–Lorentzian fitting approaches,5,35 which can have dozens of free
parameters and depend on initial and boundary conditions, but also for simpler approaches like the three–point method,36 where noise in the
baseline points can lead to noise in the contrast. When saturation and imaging parameters are already optimized, further gains in SNR are usually
achieved by averaging. However, this approach increases scan time and frequently comes at the cost of reduced resolution or volume coverage,
neither of which is ideal for clinical applications. An alternative approach is iterative downsampling in the image domain to gradually improve esti-
mates of fitting parameters,37 but this method increases postprocessing times and can introduce aliasing artifacts into reconstructed images.
In addition to being more SNR–efficient than conventional 2D imaging, volumetric acquisitions such as the snapshot CEST approach38 also
generate tens of thousands of Z–spectra in a single experiment, opening up the possibility of statistical denoising. A common method to exploit
data redundancy for denoising is to use a low–rank approximation of structured signals, of which the main features can be identified using singular
value decomposition39 or principal component analysis (PCA).40 Low–rank approximations of Z–spectra have been used to improve SNR in hyper–
CEST images,41 as well as for iterative motion correction of creatine CEST spectra in skeletal muscle.42 However, in both applications, few spectral
peaks are present compared with the feature–rich in vivo Z–spectra acquired in CEST experiments with low saturation powers.
The aim of the present work is to improve the effective SNR of spectrally selective Z–spectra acquired in low–power CEST experiments. In this
study, the use of PCA and low–rank approximations are investigated for denoising of fitted in vivo Z–spectra with artificially introduced noise
(termed synthesized data from here on), and in vivo experiments at 3 and 7 T. In particular, we examine the relationship between the number
of relevant principal components (PCs) and SNR, and investigate three possible criteria for determining the number of PCs to retain in vivo.
2 | METHODS
2.1 | PCA
PCA is a technique to reduce the dimensionality of data, while retaining the essence of its contained information. By identifying and exploiting the
linear correlations in the observations of a dataset, it extracts a new set of uncorrelated variables called PCs and ranks them according to the pro-
portion of data variability for which they account for.40 The variance (ie information content of a signal) will concentrate in the first few PCs,
whereas the noise is spread evenly over the dataset.43 Therefore, preserving only the first few PCs can remove noise from the dataset.
The PCA denoising approach proposed for CEST imaging data is summarized in Figure 1. For a CEST experiment, each saturation frequency
offset functions as a variable with the corresponding Z–value of each voxel being a different observation. The single CEST image Z(Δωi) of spatial
dimensions u × v × y, can be rearranged into a vector z(Δωi) of length m ≤ u · v · y. Here, m is the number of actually considered voxels, which can
be smaller than the total number of voxels due to the exclusion of regions outside the brain or dominated by fat. The full dataset consisting of n
images for the saturation frequency offsets {Δω1,…,Δωn} is then reshaped into a Casorati matrix C of size m × n (Figure 1, step 1).
C ¼ z Δω1ð Þ z Δω2ð Þ…z Δωnð Þð Þ ¼
z1 Δω1ð Þ z1 Δω2ð Þ





⋮ ⋮ ⋱ ⋮
zm Δω1ð Þ zm Δω2ð Þ … zm Δωnð Þ
0BBBB@
1CCCCA (1)
where each column represents a complete segmented image for one saturation frequency offset and each row represents the Z–spectrum of one
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voxel. PCA is performed by eigendecomposition of the covariance matrix (Figure 1, step 2).
cov Cð Þ ¼ 1
n − 1
eCTeC ¼ ΦTΛΦ (2)
FIGURE 1 Illustration of the proposed denoising algorithm (the Z–spectrum of an exemplary voxel is shown in red). Step 1: The normalized and
for B0–inhomogeneities corrected CEST data is reformatted into a Casorati matrix with voxels outside the segmentation being omitted. Step 2:
PCA using the covariance matrix yields the mean Z–spectrum, the eigenvectors as well as the associated eigenvalues (blue). Step 3: Data–driven
approaches based on the magnitude and slope changes of the eigenvalues approximate the optimal number of components to preserve. Step 4:
Projection onto these first eigenvectors results in the denoised Z–spectra (step 5), which are reformatted back to an image series in the end
BREITLING ET AL. 3 of 14
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with Φ = (φ1φ2…φn) being the n × n orthonormal eigenvector matrix and Λ = diag (λ1, λ2,…, λn) being the associated diagonal eigenvalue matrix
with λ1 ≥ λ2 ≥ … ≥ λn. For calculation of the covariance matrix, the column–wise mean–centered Casorati matrix eC ¼ ez Δω1ð Þ ez Δω2ð Þ…ez Δωnð Þð Þ
is used, where the corresponding rows are obtained by subtraction of the mean Z–spectrum z Δωið Þ ¼ 1m∑
m
j¼1zj Δωið Þ.
To remove the contributions which are associated only with noise, eC is projected onto a reduced set of the k highest ranked PCs
Φ(k) = (φ1φ2…φk) with 1 ≤ k ≤ n (Figure 1, step 4):
eC kð Þ ¼ eCΦ kð ÞΦTkð Þ (3)
The denoised Casorati matrix is obtained by addition of the mean Z–spectrum: zj; kð Þ Δωið Þ ¼ ezj; kð Þ Δωið Þ þ z Δωið Þ. Finally, the denoised Casorati
matrix is reformatted into a denoised image series of dimensions u × v × y × n (Figure 1, step 5).
The outcome of the algorithm mainly depends on one parameter: the number of preserved components k (Figure 1, step 3). If too few
components are preserved, actual information will be lost, leading to missing or deformed resonances, whereas too many components would
diminish the denoising effect. A close to optimal value of k is therefore essential for the performance of the denoising. The number of com-
ponents can be based upon prior knowledge about the composition of the examined object if available, as was demonstrated in the case of a
hyper–CEST agent.41 For in vivo applications focusing on endogenous contrast and multiple spectral features, the choice of k must be carefully
tuned.
Therefore, in this study, we apply PCA in conjunction with data–driven approaches to objectively determine the optimal k for any noise level
and without prior knowledge about the spectral composition. The associated eigenvalues of the PCA can be interpreted for each component as
the variability of the signal as well as of the noise, with the first components being mainly related to the signal and the later components only to
noise. Data–driven approaches based on the associated eigenvalues can be used to approximate the optimal k of respective datasets. In the fol-
lowing, three suitable methods are presented and thereafter investigated for their applicability to denoising of in vivo CEST MRI data. The three
examined criteria were chosen based on their simplicity, straightforward applicability and robustness. However, they only represent a selective
choice and there are numerous other approaches.44-46
2.1.1 | Malinowskis empirical indicator function
The first approach is based on a theory of error concerning abstract factor analysis.47 Assuming knowledge of the correct number of components,







From RE an empirical indicator function can be derived, which was shown to reach a minimum when the — actually unknown— correct number
of components is employed:48





2.1.2 | Nelson criterion
The second approach is based on the shape of the course of the eigenvalues plotted as a diminishing series (Figure 1, step 3). A sharp change in the
slope marks the transition from signal–related components to noise–related components.49 The latter noise–related eigenvalues exhibit a charac-
teristic linear fall–off, which enables identifying them with an iterative linear regression. To this end, the coefficient of determination r2 can be
expressed as:
r2 kð Þ ¼ n−kð Þ∑
n
l¼kþ1 lλl−∑l∑λl
n−kð Þ∑l2− ∑lð Þ2
 1=2






The largest subset of eigenvalues (ie smallest number of excluded leading eigenvalues) achieving r2 ≥ 0.8 was shown to indicate separation of
signal– and noise–related components, and thereby the optimal number of components:50
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kreg ¼ min kjr2 kð Þ ≥ 0:8
 
(7)
2.1.3 | Median criterion
The third approach uses the median of the eigenvalues to estimate the noise level of the data and thereby determines a threshold for the signal–
related eigenvalues.51 To increase robustness and minimize the impact of the signal itself, only a subset λt is used in the median estimation, with


















The noise estimate is obtained after taking into account the previously stated empirical correction factor (β = 1.29)51 and is used as a threshold
to determine the number of components:
kmed ¼ max kjλk ≥ β2·median λtð Þ
n o
(9)
2.2 | CEST MR imaging
2.2.1 | CEST MR imaging at 3 T
CEST MRI was performed on three different 3 T whole–body MR–scanners (MAGNETOM Prisma, Siemens Healthineers, Erlangen, Germany) with
the vendor's head/neck coil (64 channels) on six healthy subjects (V1/V2, V3/V4 and V5/V6 on scanners 1, 2 and 3, respectively), with informed
consent provided prior to the experiment and with the approval of the local ethics committee in accordance with the relevant guidelines and
regulations.
The employed 3D snapshot CEST acquisition38 consisted of a presaturation module followed by a single–shot radiofrequency (RF) and gradient
spoiled gradient echo readout with centric spiral reordering. The image–readout parameters optimized for 3 T34 were: GRAPPA acceleration factor
2, TE = 2 ms, TR = 4 ms, bandwidth = 700 Hz/pixel, elongation factor = 0.5 with a flip angle (FA) = 5°, field of view = 220 × 180 × 54 mm3, and
matrix size of 128 × 104 × 18 yielding a 1.7 × 1.7 × 3 mm3 resolution for the measurement of V1; and a FA = 6°, field of view = 220 × 180 × 60 mm3,
and matrix size of 128 × 104 × 12 yielding a 1.7 × 1.7 × 5 mm3 resolution for the measurements of V2 through to V6. The resulting readout times
for one 3D–image were 2.9 and 2.0 seconds, respectively.
Presaturation was achieved by a train of 80 Gaussian–shaped RF pulses of mean amplitude B1 = FA/(γ·tp) = 0.6 μT, pulse duration tp = 20 ms
and duty cycle (DC) = 50%, resulting in a total saturation time of tsat = 3.2 seconds. Z–spectrum data were acquired after saturation at 55 offsets in
the range between ±100 ppm and normalized by M0 scans with 12 seconds of relaxation and saturation at −300 ppm. CEST measurements were
acquired six times to enable generation of high SNR data by averaging. B0– and B1–mapping were obtained using the WASABI approach
52 with
the same image–readout parameters as for the CEST measurements. All image data were motion–corrected using the AFNI's 3Dvolreg function.53
2.2.2 | CEST MR imaging at 7 T
CEST MRI was performed on a 7 T whole–body MR–scanner (MAGNETOM, Siemens Healthineers) with a 24 channel head coil on one healthy
subject (ie V7), with informed consent provided prior to the experiment and with the approval of the local ethics committee of the Medical Faculty
of the University of Heidelberg, and in accordance with the relevant guidelines and regulations.
The snapshot CEST acquisition used at 7 T differed from the 3 T settings of V1 in the following parameters: GRAPPA acceleration factor 3,
bandwidth = 560 Hz/pixel, FA = 6° and elongation factor = 0.6. The resulting readout time for one 3D image was 2.0 seconds.
Optimized presaturation for 7 T consisted of a train of 140 Gaussian–shaped RF pulses with mean amplitude B1 = 0.6 μT or 0.9 μT, pulse dura-
tion tp = 15 ms and DC = 60%, resulting in a tsat = 3.5 seconds. Z–spectrum data were acquired after saturation at 54 offsets in the range between
±100 ppm and normalized by M0 scans with 12 seconds of relaxation and saturation at −300 ppm. Similar to the 3 T measurements, at 7 T, B0–
and B1–mapping were obtained using the WASABI approach
52 and CEST measurements were repeated six times to enable generation of high SNR
data by averaging. All image data was coregistered using an intensity–based rigid registration algorithm in MITK.54
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2.3 | Data evaluation
For both 3 and 7 T data, M0 images were manually masked to isolate brain tissues and CSF with the outermost slices excluded due to slice profile
artifacts in the slab–selective readout. CEST images were generated from the Z–value Z (Δω), given by the ratio of the saturated image Msat (Δω)
and the unsaturated image M0: Z(Δω) = Msat(Δω)/M0. The resulting Z–spectra were shifted along the frequency offset dimension according to the
acquired B0–map to correct for field shifts. After B0–correction, Z–spectra were either averaged or denoised using PCA with one of the three
criteria listed above to determine the number of relevant PCs to retain. For the denoising the entire masked volume was used, comprising brain
tissue and CSF with a total of between 40 000 and 70 000 voxels.
Z–spectra at 7 Twere fitted voxel–wise by a five–pool Lorentzian fit model comprising contributions of direct water saturation (0 ppm), semisolid
magnetization transfer (−2.0 ppm), aswell as rNOE (−3.5 ppm), amide (3.5 ppm) and amine (2.0 ppm) resonances. Amore detailed description of the fit
model (ie start values and boundaries) can be found in the supporting information. By omitting the pool of interest a reference Z–spectrum Zref is
obtained.5 For Z–spectra at 3 T, Zref is generated by a two–pool background fit model consisting of direct water saturation and semisolid magnetiza-
tion transfer.34 Peak specific CEST contrasts were calculated by the Lorentzian difference method4 according to MTRLD = Zref − Z, where Z are the
actual data points. Amide and rNOE contrast imageswere generated by evaluating the correspondingMTRLDmaps at 3.5 and− 3.5 ppm, respectively.
The 7 T CEST contrasts were corrected for B1–inhomogeneities by a two–point contrast correction
55 (reconstructed to B1 = 0.7 μT).
2.4 | Simulations
2.4.1 | Generation of synthesized data
To demonstrate the performance of the denoising approach, artificial noise was introduced to fitted in vivo Z–spectra. This allowed investigation
of the dependence on the number of components with a defined reference (ie ground truth).
The fitted Z–spectra of the averaged high SNR 7 T CEST data acquired with B1 = 0.6 μT without application of the denoising algorithm were
used as a starting point for generating realistic simulation data. Image data were obtained by multiplication of the input Z–spectra with the M0
used for normalization. To obtain a realistic noise distribution, a GRAPPA reconstruction was simulated with a similar set–up as for the in vivo
imaging at 7 T (24 coils, acceleration factor 3, 32 ACS lines), with the image for each coil being corrupted in k–space with additive circular complex
Gaussian noise with amplitude σ, normalized variance of 1 at each coil, and a correlation coefficient between coils of ρ = 0.1.56 The final noisy Z–
spectra were obtained after normalization with the noise–afflicted M0 image. The ground truth for comparison was generated by performing the
procedure without addition of noise. This process is illustrated in Figure S1.
2.4.2 | Quantification of the truncation
Different data–driven approaches were investigated to determine the required number of PCs to best describe the data. To determine the optimal
number of components, the peak signal–to–noise ratio (PSNR) over all voxels j and offsets i was determined as an evaluation measure:









The PSNR is equivalent to the mean square error and was chosen due to its simplicity and its straightforward applicability to spectral data. To
reliably assess the denoising performance for different SNR levels, 100 different realizations were generated at each noise level and evaluated.
3 | RESULTS
3.1 | Synthesized data
The effect of noise on the ability to detect Z–spectrum features, and the corresponding improvement with low–rank approximations, is illustrated
using synthesized spectra in Figure 2. Upon introduction of artificial noise, the quality of exemplary single voxel grey matter (GM) and white mat-
ter (WM) Z–spectra of the synthesized data degrade significantly, preventing a clear identification of CEST peaks in the spectrum, especially for
the low SNR case (Figure 2, bottom row). PCA of the noisy data and subsequent low–rank approximation by retaining a small number of compo-
nents leads to smoother Z–spectra in all cases, allowing reliable identification of CEST resonances. Observing the residuals (dotted lines, enlarged
by a factor of 10) and the mean absolute error (MAE) of WM and GM combined, shows that fluctuations decrease when using fewer and fewer
components, but if too few components are used (Figure 2, sigma = 0.001, k = 7) then the Z–spectra cannot be fully described by the reduced
basis and errors increase again. This shows that it is important to use enough components to not introduce new errors. Interestingly, the MAE
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does not increase much with more truncation in the case of higher noise levels (Figure 2, sigma = 0.01, k = 7). This observation illustrates that the
best truncation depends on the noise level. This effect can be studied by the PSNR value (Equation 10), which uses the simulated ground truth for
comparison.
The PSNR value as a function of retained components k is shown in Figure 3, along with the mean truncation point suggested by the pro-
posed application of the Malinowski criterion, Nelson criterion and median criterion. For all SNR levels there is one defined (global) optimum
PSNR value and corresponding PC truncation point. The three data–driven approaches based on the associated eigenvalues yield a good
approximation of the optimal number of components, as determined by the PSNR (Table 1). The Malinowski criterion tends to underestimate
the necessary number of components (Table 2), especially for the medium SNR data (Figure 3, middle), but yields good results for lower SNR
data. The median criterion consistently provided the number of components that resulted in the highest PSNR for all SNR levels. As SNR
decreases, the optimum PC truncation point shifts as expected to fewer components; additional components are corrupted by noise and
thereby would deteriorate the spectral approximation (Figure 3, top). Furthermore, for noisier data a larger gain in the PSNR between the opti-
mal denoising and the initial data (data with all components) was observed (3.38 compared with 2.07 dB for the high SNR data; Table 1, first
and last rows). This observation is in line with the associated smaller number of necessary components to describe the noisier spectra, which
implies more PCs can be omitted with a consequential larger achievable denoising effect. Or, in other words, a higher initial noise level will
enable the removal of more noise from the dataset.
Observing the square root of the eigenvalues λi (Figure 3, bottom), which are a measure of the influence of the individual PCs, enables




can be shown to be equal to the maximum possible change at a
single frequency offset in the Z–spectrum upon the addition or omission of this ith PC. For higher noise levels, the influence of the trailing,
noise–corrupted PCs increases. Because we can determine the optimal truncation point with the criteria, this leads to an important finding:
we can now evaluate if the noise level of our data is sufficiently small to describe an effect we are interested in. Because the optimal trun-




(square root of the first eigenvalue after the truncation
point) can be used as an estimate of the maximum possible noise–induced error at a single frequency offset, and thereby of the smallest
detectable effect size. If the effect size of interest in the Z–spectrum SE is larger than this value, we can in principle resolve it; if it is smaller,
then the data is too noisy and potentially we cannot retrieve the information we are interested in. This value is, however, to be understood as
an upper limit. For example, sampling the Z–spectrum very densely and taking nearby offsets into account in the analysis potentially enables
detecting even smaller effects.
FIGURE 2 Effect of denoising in synthesized gray matter (GM, red) and white matter (WM, blue) Z–spectra of exemplary single voxels. As the
noise level increases (from top to bottom rows), more PCs are corrupted by noise and fewer components give the best spectral approximation.
However, using too few PCs can introduce small residual errors, which can be seen in the high SNR data (top right) as an increase of the combined
mean absolute error (MAE) of WM and GM. Please note that the absolute error (dotted) between ground truth (dashed) and data (solid) is scaled
by a factor of 10 for visualization purposes
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3.2 | In vivo data
To enable the assessment of the performance of the denoising in vivo, high SNR data were obtained at 3 and 7 T by averaging six measurements.
As these still do not constitute a real ground truth, only a qualitative assessment based on visual inspection is performed, as opposed to
FIGURE 3 Determining the optimum PC truncation in synthesized Z–spectra (exemplary gray and white matter voxels shown in Figure 2). Top:
Peak signal–to–noise ratio (PSNR) over all voxels and offsets compared with the ground truth. Results are shown as the mean for 100 different
noise realizations with the error bars showing the corresponding standard deviation. An increase in noise (from left to right) results for the PSNR
maximum in a shift to a smaller optimal number of components as well as a larger gain compared with the noisy input data (Table 2, first and
bottom rows). Bottom: The transition point of the eigenvalues corresponds to the PSNR optimum (gray), and can be automatically determined by
the three different data–driven criteria. The median stopping criterion (orange) suggests a close to optimal number of PCs resulting in the lowest
residual error. The necessary number of components is underestimated by the Malinowski criterion (green) and overestimated by the Nelson
criterion (blue)
TABLE 1 Peak signal–to–noise ratio corresponding to each proposed criterion for different noise levels. Results are obtained as the mean of 100
repetitions of the denoising algorithm each run with a different noise realization. The values in the brackets are the corresponding standard




σ = 0.001 σ = 0.01 σ = 0.1
All components 58.70 (5) 48.69 (5) 38.68 (7)
Malinowski 60.49 (7) 50.21 (7) 41.89 (13)
Nelson 60.60 (7) 51.03 (11) 41.83 (16)
Median 60.74 (7) 51.17 (9) 42.01 (15)
Optimum 60.77 (7) 51.18 (9) 42.06 (14)
TABLE 2 Mean difference between the suggested number of retained components of each proposed criterion and the actual optimum. A
negative value implies too few retained components, a positive one too many. Results are obtained as the mean of 100 repetitions of the




Mean difference between component number and optimal truncation
σ = 0.001 σ = 0.01 σ = 0.1
Malinowski −2.0 (0) −7.7 (5) −2.0 (1)
Nelson 4.0 (4) 3.6 (7) 3.0 (4)
Median 1.2 (4) 1.4 (5) 0.8 (5)
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quantitative measures. Figure 4 illustrates the effect of PCA denoising on MTRLD images acquired at 7 T with an estimated
57 SNR≈ 185 for the
M0 image. In this dataset, the median criterion suggested 16 components should be retained (Table 3). As observed in the synthesized data,
retaining fewer components (in this case, six) yielded even smoother images than the averaged ones, but with reduced GM/WM contrast. This
effect also becomes evident in the corresponding Bland–Altman plot (Figure S2). Both results illustrate one possible pitfall of uncontrolled and
thereby potentially excessive PCA denoising, namely the distortion of contrast.
Similar results are obtained in MTRLD images acquired from 3 T spectra, as illustrated in Figure 5. At clinical field strengths, CEST effects are
spectrally broad and coalesced, making isolated spectrally selective effects particularly sensitive to noise. Denoising of the Z–spectra by retaining
14 components as determined by the median criterion results in an image quality comparable or even superior to those achieved by averaging the
six measurements. As observed in the 7 T data, retaining only the small amount of PCs as suggested by the Malinowski criterion resulted in excep-
tionally smooth images, with a slightly reduced GM/WM contrast (Figure 5, right). It should be noted that in this case, distortions in the contrasts
due to retaining too few components cannot be excluded with complete certainty. Application of the denoising algorithm using the median crite-
rion to the data of five additional subjects measured at three different MR scanners at 3 T yielded a considerable image quality gain for the MTRLD
contrasts compared with the unprocessed data (Figure 6). The corresponding suggested number of components to retain is consistent across all
subjects for all three criteria with an expectable small variability (Table 3).
4 | DISCUSSION
In this study, we propose a denoising algorithm for Z–spectral image data acquired from CEST experiments. PCA was applied to 3D datasets to
identify spectral redundancies, and thereby separate noise–like characteristics from meaningful spectral features. In conjunction with an appropri-
ate data–driven approach to determine the required number of components, we demonstrated that a PCA–based denoising algorithm can reduce
noise and provide a better approximation of the actual Z–spectrum signal. Importantly, PCA and subsequent low–rank approximations of the Z–
spectrum are fast computational operations that are simple to implement. The resulting SNR gain allows us to avoid the scan time trade–off of
reducing the volume coverage for more signal averages.
PCA has already been shown to be a powerful denoising technique in HyperCEST by Döpfert et al.41 Note that in that work, as opposed to the
approach presented here, each voxel was interpreted as a variable, with the saturation frequency offsets being the different observations. This
entails a row–wise mean–centering of the Casorati matrix and transposed dimensions for calculating the covariance matrix and the resulting
eigenvectors. It should be noted that this is not just a difference in formulation but in conception and yields slightly different results in the
denoising. In the HyperCEST study, the optimal number of components was deduced from the two–phase composition of the investigated phan-
tom. For conventional CEST experiments with multiple spectral resonances, the number of relevant components is not straightforward to deter-
mine, as the number of contributions, their dependencies on physiological parameters and pathological alterations thereof, are unknown. We
showed that for in vivo 1H CEST imaging, retaining too many components will diminish the denoising effect, while retaining too few components
FIGURE 4 MTRLD contrasts for amide (top) and rNOE (bottom) of a healthy volunteer (V7) acquired at 7 T. Application of the denoising algorithm to
the single measurement (left) results in smoother images for a decreasing number of retained components (middle to right). Preservation of 16 PCs as
determined by the median criterion yields an image quality (second from the right) comparable to averaging six measurements (second from the left).
A stronger truncation results in even smoother contrast (right), which, however, indicates the introduction of artifacts.
BREITLING ET AL. 9 of 14
Publication III
57
will result in missing or deformed resonances. We want to emphasize caution, as these artifacts can be difficult to recognize: although excessive
denoising leads to startlingly smooth images, these may no longer represent true spectral features.
Here, we investigated the optimal choice of retained components by means of synthesized data to allow for comparison with a ground truth.
The synthesized data were modeled from high SNR in vivo CEST spectra acquired by low–power saturation. By using the fitted data of an actual
in vivo CEST measurement, which was only corrected for motion and B0–inhomogeneities, the simulated signal still contained residual B1 inhomo-
geneities as well as the spatially variant coil sensitivity profile. The noise distribution was realistically simulated by adding the noise in k–space and
thereby takes into account the effects of the GRAPPA reconstruction, as is performed for the in vivo data. Consequences of this can also be seen
in the resulting differing noise levels in the exemplary voxels of GM and WM (Figure 2, sigma = 0.1, unprocessed), which can be attributed to the
spatially varying noise distribution as well as a scaling effect due to the normalization with the M0 image, which exhibits different signal amplitudes
for GM and WM. The synthesized signal assumes a five–pool Lorentzian model with no B0 shifts. The resulting numerous combinations of width,
amplitude and position of the Lorentzians should reflect the observable variety of Z–spectra in vivo. It has yet to be determined if the prior appli-
cation of a correction for B0 inhomogeneities affects the functioning of the PCA.
The data–driven truncation criteria examined in this study estimate the number of principle components which remain uncontaminated by noise.
Simulations indicated that all three criteria give reliable denoising results for each investigated SNR level. Here, the Median criterion yields the best
results for the synthesized data with a close to optimal truncation point, as reflected by PSNR, determined for all three noise levels. The Nelson cri-
terion tends to overestimate the necessary number of components in the synthesized data, diminishing the desired denoising effect. By contrast, the






Number of retained components k
Malinowski Nelson Median
V1 3 0.6 6 12 14
V2 3 0.6 9 15 19
V3 3 0.6 9 15 15
V4 3 0.6 10 14 17
V5 3 0.6 5 12 13
V6 3 0.6 9 16 17
V7 7 0.6 9 12 16
V7 7 0.9 9 13 16
FIGURE 5 MTRLD contrasts for amide (top) and rNOE (bottom) of a healthy volunteer (V1) acquired at 3 T. as for the 7 T data (Figure 4),
application of the denoising algorithm to the single measurement (left) results in smoother images with the decreasing number of retained
components (middle to right). Retaining 14 PCs as suggested by the median criterion yields an image quality (second from the right) superior to
averaging six measurements (second from the left). A stronger truncation as suggested by the Malinowski criterion results in even smoother
contrast (right); however, as a result the introduction of potential contrasts distortions by retaining too few PCs cannot be completely excluded
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Malinowski criterion is prone to underestimating the number of components to be retained; however, for low SNR data the criterion works well as a
lower limit. In vivo, MTRLD contrast images obtained from 7 T experiments exhibit only small differences after denoising with the number of compo-
nents according to each of the three criteria (Figure S3). It should, however, be noted that the suggested number of components by the median cri-
terion appears to be high and residual noisewas observed. As a result, the suggested number of components in vivo is even higher than the one for the
Nelson criterion, which is in strong contrast to the observed tendencies in the simulations. This might possibly be attributed to influences such as
motion and B0–inhomogeneities and their respective correction, which so far were not considered in the simulations. These effects should be
investigated further. As additional information, for each in vivo measurement and criterion, the lower limit for reliably detectable effect sizes in
the Z–spectrum can be estimated with the associated eigenvalues (Figure S4; compare with Figure 3, bottom row). For the 7 T data, the SNR gain
provided by PCA–based Z–spectral denoising according to the median criterion was quantified as comparable or even superior to averaging across
sixmeasurements (Figure S5). All in all, wewant to emphasize thatwe suggest using themedian criterion,which performedbest in the simulations and
suggests the highest number of components in vivo, to rule out any potential risk of distorted Z–spectra and contrasts at the expense of a potential
suboptimal denoising performance. In any case, the Malinowski criterion represents a lower limit, which should not be fallen short of.
In general, application of the proposed denoising algorithm is not restricted to low–power Z–spectra but can be applied to any CEST–related
approach providing a spectral dimension to exploit redundancies. A different choice of saturation parameters will thereby potentially affect the
required number of PCs to describe the spectra because the number of resolvable spectral components will change. However, the validity of
the criteria holds, which was confirmed in preliminary dualCEST33 measurements. The achievable denoising effect will generally depend on the
proportion of preserved components to acquired offsets. Thereby, the minimal number of necessary components is predetermined by the spectral
FIGURE 6 MTRLD contrasts for amide (top half) and rNOE (bottom half) of five subjects (V2 to V6) acquired at 3 T. Application of the denoising
algorithm using the median criterion (respective bottom rows) results in a considerable image quality gain compared with the unprocessed data
(respective top rows) for all five subjects. The corresponding number of components to retain as suggested by the median criterion (also for the
other two criteria) is very consistent across the subjects with an expectable small variability (Table 3)
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composition of the investigated object, as well as the distribution of the acquired offsets. The maximal number of components is equal to the num-
ber of acquired offsets. Therefore, the denoising effect will be diminished for approaches with only a few frequency offsets and benefits from
densely sampled Z–spectra. PCA also requires a sound statistical basis to be applicable. In particular, a sufficient number of observations (ie voxels)
are required. While 3D imaging easily meets this requirement, 2D imaging may not provide a sufficient number of observations for effective
denoising.
To ensure correct functioning of the PCA, appropriate preprocessing of the image data is crucial. A correction for B0–inhomogeneities as well
as for possible movements and deformations during the measurement is necessary to restore the required spectral redundancy across all voxels.
Otherwise, unaddressed frequency shifts and displacements will result in distorted PCs and a higher number of necessary components to describe
the data. Furthermore, prior segmentation of meaningful tissue regions in the images enables excluding the distorting influence of voxels that are
dominated by fat or depict only noise.
In this study, the entire masked volume was denoised together, yielding a joint set of PCs as well as a general truncation point for WM, GM and
CSF. In principal, one could also denoise the different parts of the brain separately, which should yield a reduced number of suggested PCs for
each compartment and thus a better denoising performance. However, this would require additional anatomical imaging to allow segmentation,
and would raise the question of how to deal with voxels which cannot be classified with absolute certainty. Furthermore, unique signatures of
local CEST signals (eg in tumor) should be better described by the joint set of PCs, which covers a broader range of different CEST effects.
Application of the denoising technique to synthetic and real data demonstrated the effective and robust denoising capabilities of CEST images
with a straightforward and computationally fast implementation. However, the proposed algorithm represents only a first introduction to
denoising techniques to in vivo CEST data, with potential remaining for advancements. For instance, the necessary rearrangement of the image
series into a 2D Casorati matrix reduces the available information to correlations between the frequency offsets and voxels. Any additional cor-
relations concerning spatial as well as tissue interdependencies are thereby lost. More advanced denoising techniques taking this additional infor-
mation into account by exploiting further redundancies in the image dimensions could potentially achieve an enhanced denoising performance for
CEST imaging.
5 | CONCLUSION
The proposed denoising algorithm combines the identification of spectral redundancies by means of a PCA with an appropriate data–driven trunca-
tion criterion to separate the meaningful spectral features from noise–like characteristics. The latter is essential for the application to feature rich
in vivo data, where the number of necessary components cannot be determined a priori. The given criteria additionally facilitate a straightforward
assessment of data quality, providing guidance for CESTMRprotocols in terms of SNR. In a benchmark test consisting of fitted in vivo Z–spectrawith
artificially introduced noise, the median criterion demonstrated the best performance in estimating the optimal number of necessary components.
Application of the denoising algorithm to 3 and 7 T in vivo data revealed a considerable increase in image quality of the amide and rNOE contrasts,
with an SNR gain comparable or even superior to that achieved by an averaging of six measurements. Applicability of the algorithm is not restricted to
the investigated low–power Z–spectra but includes any CEST–related approach, providing an additional dimension to exploit redundancies. The
resulting robust and effective denoising allows for a reliable detection of small CEST effects for many different applications.
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Dual-frequency irradiation chemical exchange saturation transfer (dualCEST) allows
imaging of endogenous bulk mobile proteins by selectively measuring the intramolec-
ular spin diffusion. The resulting specificity to changes in the concentration, molecu-
lar size, and folding state of mobile proteins is of particular interest as a marker for
neurodegenerative diseases and cancer. Until now, application of dualCEST in clinical
trials was prevented by the inherently small signal-to-noise ratio and the resulting
comparatively long examination time. In this study, we present an optimized acquisi-
tion protocol allowing 3D dualCEST-MRI examinations in a clinically relevant time
frame. The optimization comprised the extension of the image readout to 3D, all-
owing a retrospective co-registration and application of denoising strategies. In addi-
tion, cosine-modulated dual-frequency presaturation pulses were implemented with
a weighted acquisition scheme of the necessary frequency offsets. The optimization
resulted in a signal-to-noise ratio gain by a factor of approximately 8. In particular,
the application of denoising and the motion correction were the most crucial
improvement steps. In vitro experiments verified the preservation of specificity of
the dualCEST signal to proteins. Good-to-excellent intra-session and good inter-
session repeatability was achieved, allowing reliable detection of relative signal dif-
ferences of about 16% or higher. Applicability in a clinical setting was demonstrated
by examining a patient with glioblastoma. The optimized acquisition protocol for
dualCEST-MRI at 3 T enables selective imaging of endogenous bulk mobile proteins
under clinically relevant conditions.
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Chemical exchange saturation transfer (CEST) MRI1-3 has emerged as an important imaging modality for the detection of low concentration
organic compounds in living tissue such as peptides and proteins4-7 and various other metabolites.8-10 In particular, CEST signals attributed to pro-
teins have been shown to provide information of clinical interest, such as the amide proton transfer (APT)4 signal and the relayed nuclear Over-
hauser effect (rNOE)6 of aliphatic protons. Applications range from tumor detection,11,12 grading,13,14 and therapy response assessment15-17 to
the diagnosis of neurological diseases such as Alzheimer's,18,19 Parkinson's,20 and multiple sclerosis.21 However, the superposition of signals from
various cellular compounds in living tissues as well as their dependence on physiological conditions (i.e. pH and/or temperature)4,22,23 prevents
exclusive assignment of the observed effects to proteins. Although the value of conventional protein-weighted CEST-MRI has been demonstrated
in diverse studies, increased specificity to proteins would allow better assessment of the actual protein contribution to CEST signal changes in dis-
ease states, which may reveal so far undetected effects and correlations.
Recently, dual-frequency irradiation CEST (dualCEST)24 has been introduced as a novel technique overcoming these limitations. This method
allows the selective detection of endogenous bulk mobile proteins in vivo without contributions from saturation transfer effects of metabolites,
lipids, or semi-solids. The specificity of this approach is achieved by using the coupling of different CEST signals as a distinguishing feature.24,25
Detection of this coupling is accomplished by extending the RF presaturation scheme to a simultaneous irradiation at two frequency offsets. The
dualCEST signal depends on changes in bulk mobile protein concentration, average molecular size, and global folding state.24,26-28 Due to its spec-
ificity and sensitivity, dualCEST could serve as a reference for assessing the assignment of conventional CEST approaches to proteins and may
lead to novel insights into the origin of protein-related CEST contrasts in vivo. Furthermore, dualCEST is of interest as a non-invasive imaging
technique for diseases associated with structural and conformational changes of proteins such as cancer and neurodegenerative diseases. How-
ever, until now, application in a clinical setting was prevented by the inherently small signal-to-noise ratio (SNR) in comparison with conventional
CEST approaches.
The aim of this work was to realize a clinically applicable dualCEST-MRI protocol at 3 T, with comparable image quality, examination duration,
and reproducibility to conventional protein CEST modalities. To achieve this goal we applied several methodological developments:
(i) implementation of cosine-modulated pulses29,30 allowed for a simultaneous presaturation at two frequency offsets; and was additionally com-
bined with (ii) a weighted acquisition scheme for optimal averaging. Furthermore, (iii) utilization of a 3D snapshot-CEST31 image readout allowed
for retrospective motion correction and (iv) facilitated the application of advanced denoising strategies.32 Preservation of specificity of the opti-
mized dualCEST protocol was demonstrated in vitro. Reproducibility was quantified by repeated in vivo measurements. Finally, clinical relevance
was demonstrated by examining a patient with glioblastoma.
2 | METHODS
2.1 | DualCEST approach
2.1.1 | Theory
DualCEST allows the coupling between CEST signals resonating at two different frequency offsets to be measured. In proteins, the observed
magnetization transfer—saturation crosstalk,24 T—is attributed to the intramolecular spin diffusion between dipolar-coupled protons.
DualCEST is based on acquiring the water MR signal after a dual frequency irradiation at a frequency offset pair, Δω and Δωc. The
corresponding Z-value is calculated by normalizing the presaturated signal, Msat(Δω, Δωc), by the equilibrium magnetization, M0: Z
(Δω, Δωc) = Msat(Δω, Δωc)/M0. The saturation crosstalk, T, which quantifies the coupling between the two frequency offsets, can be calcu-
lated according to24:
T Δω,Δωcð Þ= R1DC
1
Z Δω,Δωoffð Þ +
1







where the far off-resonant frequency offset, Δωoff = 295 ppm, is synonymous with disabling the saturation.
A comparatively broad saturation crosstalk of semi-solid macromolecular structures (ssMT, semi-solid magnetization transfer) is detected
in vivo, in addition to signals of mobile proteins. To isolate the superimposed signal of mobile proteins, the contribution of the ssMT has to be sub-
tracted. The actual amplitude thereof is determined by measuring combinations of the crosstalk between frequency offset pairs specific to the
ssMT24:
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Tprotein Δω,Δωcð Þ= T Δω,Δωcð Þ− T Δω,−ΔωssMTð Þ T ΔωssMT,Δωcð ÞT ΔωssMT,−ΔωssMTð Þ ð2Þ
where ΔωssMT = 30 ppm is a frequency offset off-resonant for proteins but on-resonant for ssMT. Note that this correction approach is indepen-
dent of the ssMT line shape and enables removal of both symmetric and asymmetric contributions.
2.1.2 | Cosine-modulated pulses
Dual-frequency irradiation at a frequency offset pair, Δω and Δωc, can be achieved by either (i) using an alternating RF irradiation scheme
(Figure 1A) or (ii) modulating the employed Gaussian-shaped RF pulses with a cosine (Figure 1B). With this irradiation, a more efficient simulta-
neous presaturation at both frequency offsets is achieved, with pulses centered at Δωcenter = (Δω+Δωc)/2 and modulation frequency
Δωmodulation = (Δω − Δωc)/2.29,30 Both presaturation types are characterized by their respective mean amplitude, B1 = flip angle/(γtp), pulse length,
tp, and duty cycle, DC = tp/(tp+td). Note that for dualCEST the DC is defined per frequency offset, implying a maximum of 50% for alternating
pulses. For the cosine-modulated pulses the mean amplitude of the enveloping Gaussian is set to 2B1, such that each frequency component
effectively receives the desired mean amplitude B1.
Imperfections of the cosine modulation, e.g. due to the limited number of 8000 digitized steps per pulse of our Siemens scanner (IDEA
VE11C), result in small deviations from the anticipated saturation as well as residual carrier leakage at Δωcenter = 0 ppm (Figure 1C inset). To com-
pensate for these deviations, slightly asymmetric frequency offsets were chosen to prevent unintentional direct water saturation. Furthermore,
frequency offset pairs, including a far-off resonant irradiation, are acquired using Gaussian RF pulses without cosine modulation to avoid the
corresponding very high modulation frequency and the consequent poor modulation with only a few digitized steps per cycle. With this approach,
the maximum spacing needed for acquisition of Msat(ΔωssMT, −ΔωssMT) is limited to 60 ppm, resulting in a sufficiently high number of at least
108 digitized steps per period of the cosine modulation (using tp = 20 ms at B0 = 3 T).
F IGURE 1 Implementation of cosine-
modulated saturation. Dual-frequency saturation
schemes can be achieved by using either
alternating RF irradiation (A) or the more efficient
cosine-modulated pulses (B). Z-spectra
(C) acquired using single-frequency irradiation (red
and blue, respectively) and cosine-modulated
pulses (black, fixed spacing of Δωmodulation =
30 ppm) exhibit only small differences (D, E),
verifying the functionality of the modulation. A
small residual carrier leakage can be seen as
attenuation around Δωcenter = 0 ppm (inset in C)
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2.1.3 | Weighted acquisition scheme
In principle, acquisition of nine Z-values is sufficient for the calculation of the final dualCEST contrast, Tprotein (Equation (2)). Certain frequency off-
set pairs have a larger impact on the final contrast quality than others, due to different amplitudes and resulting relative errors of the Z-values, as
well as their multiple usage in the calculation. As dualCEST-MRI requires multiple repetitions to be averaged in order to accumulate enough SNR,
averaging the higher impact Z-values more often will ultimately reduce the error of the final contrast while maintaining the same number of total
repetitions. The impact of each Z-value can be calculated by Gaussian error propagation using the covariance matrix, Σ, of the nine Z-values and
the respective Jacobian matrices, J1 and J2, of Equations (1) and (2) (Supplementary Information). By assuming an uncorrelated error with the same
variance, σ2, for each measurement, the entries of Σ will only depend on the number of repetitions, N = (n1, …, n9), acquired and thus can be writ-
ten without loss of generality as
Σ ij =




The optimal distribution of averages, Nopt, for a fixed number of repetitions, n =
P
ni, can be determined by minimizing the error, i.e. vari-
ance, of the final contrast:
Nopt = argmin
N
J2 J1 Σ  J1T  J2T: ð4Þ
This result is independent of σ2 and is therefore valid for all noise levels. However, determination of the Jacobian matrices requires the actual
Z-values and will result in a different Nopt depending on the tissue and saturation parameters. The optimal distribution for the intended in vivo
protocol was therefore determined as the median of the optimal samplings calculated for all voxels of a measurement.
2.2 | Materials
2.2.1 | Subjects
In vivo examinations were approved by the local ethics committee of the Medical Faculty of the University of Heidelberg and are in accordance with
relevant guidelines and regulations. Written informed consent was obtained prior to the experiment. Two healthy male volunteers (aged 26 and
28 years) were recruited. One was scanned as part of the optimization of the sequence and post-processing; the other was scanned for the
repeatability analysis twice on two different days (four times total) without repositioning in between the scans of each session. One patient with newly
diagnosed glioblastoma (WHO grade IV) was examined before therapy using an imaging protocol consisting of (i) conventional T1w, (ii) relaxation-
compensated APT and rNOE CEST, (iii) dualCEST, and (iv) APT-weighted (APTw) CEST. The image data obtained with the first two (i.e. contrast-
enhanced T1w and MTRRex amide and rNOE) have been published previously
33 and were re-used as reference in this study (see Figure 5 later).
2.2.2 | Model solutions
Three model solutions were prepared consisting of the main contributions in the Z-spectrum: proteins, metabolites, and ssMT. Bovine serum albu-
min (BSA, 5% (w/v)) and hair conditioner (HC, 50% (w/v)) (Schwarzkopf Gliss Kur Spuelung, Henkel, Dusseldorf, Germany) were selected to model
mobile proteins and ssMT respectively. HC has already been utilized in previous studies concerning CEST and ssMT due to its lamellar structure
resulting in molecular and structural properties of neural tissue in white matter (WM).19,34 Metabolite contributions were represented by a solu-
tion containing creatine (15 mM), carnosine (50 mM), and glutamate (25 mM). All model solutions were buffered at pH 7.3 using phosphate-
buffered saline and titrated using NaOH or HCl. The phantom was measured at room temperature.
2.3 | MRI protocol
2.3.1 | Imaging readout
The following imaging readout was utilized for all CEST-related measurements in this study. All measurements were made on a 3 T whole-body
MR-scanner (MAGNETOM Prisma; Siemens Healthineers, Erlangen, Germany) using the vendor's 64-channel head/neck coil. The image-readout
parameters of the employed 3D spiral-centric-reordered gradient-echo acquisition (snapshot CEST31) were taken from a previously established
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protocol33: GRAPPA acceleration factor = 2, TE = 2.75 ms, TR = 5.5 ms, bandwidth = 340 Hz/pixel, flip angle = 7, elongation factor = 0.5, with
FOV = 140 × 140 × 48 mm3 and matrix size 128 × 128 × 16 yielding a 1.1 × 1.1 × 3 mm3 resolution for the in vitro measurement, and
FOV = 220 × 180 × 48 mm3 and matrix size 128 × 104 × 16 yielding a 1.7 × 1.7 × 3 mm3 resolution for the in vivo measurement. The resulting
readout time for one 3D image was 3.6 s. The outer two slices on both sides were discarded due to aliasing artifacts in the slice direction, resulting
in effectively 12 slices. All in vivo image data were motion corrected using an automatic multimodal rigid registration algorithm in MITK,35,36 with
the exception of the two dualCEST acquisitions used for the respective comparison (see Figure 2A and 2B later).
In addition, B0 and B1 mapping were acquired by the WASABI
37 (simultaneous mapping of water shift and B1) approach and a T1 map using a
saturation recovery sequence. The acquisition time for WASABI and T1 mapping was 3 min 41 s and 1 min 58 s, respectively.
2.3.2 | DualCEST
Presaturation for the in vivo dualCEST measurement was achieved by either 255 cosine-modulated Gaussian-shaped RF pulses with DC = 85% or, for
the comparison study, with 129 pairs of Gaussian-shaped RF pulses with DC = 43% (Figure 2A), both with an effective mean amplitude B1 = 2 μT,
pulse duration tp = 20 ms, effective interpulse delay td = 3.5 ms, and a resulting total saturation time of tsat = 6 s. For the phantom measurement, the
saturation was extended to 500 cosine-modulated Gaussian-shaped RF pulses to ensure steady-state saturation considering the anticipated longer T1.
The nine frequency offset pairs required for calculation of Tprotein are given for the cosine-modulated pulses by the combination of
Δω = {295,29,3.5} ppm with Δωc = {295, −31, −5.5} ppm. To avoid unintentional direct water saturation at the carrier frequency, these pairs are
slightly shifted compared with the pairs used for the alternating dualCEST irradiation, Δω = {295,30,5} ppm and Δωc = {295, −30, −5} ppm. For
averaging, 90 saturated images were acquired in total, with the repetitions distributed either in an optimized weighted scheme (Supplementary
Information) or uniformly (10 repetitions each). For normalization, M0 was acquired with 12 s of relaxation and saturation at −300 ppm at the
beginning and end of the dualCEST experiment and interpolated to obtain an individual M0 for each saturated image. The acquisition duration for
the dualCEST data was 15 min 5 s in total.
The resulting Z-data were first denoised using an algorithm based on principal component analysis32 with the number of components deter-
mined according to the Malinowski criterion, and subsequently averaged to obtain the required nine Z-images. The final Tprotein contrast—as calcu-
lated from Equations (1) and (2)—was corrected for B1 inhomogeneities by the “one-point-contrast correction” method.
24,38 However, a
correction for B0 inhomogeneities is not necessary due to the comparatively broad dualCEST resonances at 3 T.
2.3.3 | Z-spectroscopy
For the characterization of the cosine modulation, presaturation was achieved by 500 either cosine-modulated or conventional Gaussian-shaped
RF pulses with a mean amplitude B1 = 0.6, 0.9, or 2 μT, tp = 20 ms, td = 3.5 ms, and DC = 85%, resulting in tsat = 12 s. The longer saturation dura-
tion is necessary to ensure steady-state saturation despite the anticipated longer T1. Z-spectra were sampled at 97 frequency offsets in unequal
steps between ±52 ppm. The obtained Z-spectra were corrected for B0 inhomogeneities.
For the in vitro specificity investigation, presaturation was achieved by 480 Gaussian-shaped RF pulses with a mean amplitude B1 = 0.7 or
2 μT, tp = 20 ms, td = 5 ms, DC = 80%, resulting in tsat = 12 s. Z-spectra were sampled at 57 frequency offsets in unequal steps between ±250
ppm. The obtained Z-spectra were corrected for B0 inhomogeneities.
2.3.4 | APTw CEST
In vitro APTw CEST contrast images were generated from the Z-spectra acquired with B1 = 2 μT by calculating the asymmetric magnetization
transfer ratio (MTRasym = Z(−Δω) − Z(Δω)) at Δω = 3.5 ppm.
Presaturation for the in vivo APTw measurement was achieved using four block RF pulses (B1 = 2 μT, tp = 20 ms, td = 1 ms, DC = 95%)39 with
Z-spectra sampled at −300 (1), ±4 (1), ±3.75 (2), ±3.5 (2), ±3.25 (2), and ±3 (1) ppm, where the number in the parenthesis is the number of repeti-
tions acquired for averaging. APTw CEST contrast images were generated from B0-corrected Z-spectra by calculating MTRasym at Δω = 3.5 ppm.
2.4 | Test-retest reliability in a healthy volunteer
Comparability of the different acquisitions was ensured by aligning the dualCEST images. To do so, the first image of every scan (the M0 image of
WASABI) was co-registered to the first scan of the first session. The corresponding transformation matrices were subsequently applied to the
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dualCEST contrasts to obtain comparable images. Bland-Altman plots40 and intraclass correlation coefficients (ICCs)41 were used to evaluate the
intra-session, i.e. two consecutive scans without repositioning in between, and inter-session repeatability of the technique. To obtain a more
meaningful assertion with regard to a possible diagnostic application, the mean of 3 × 3 × 1 regions was used as input for the evaluations instead
of single-voxel values. For intra-session repeatability, the first scan of each session was compared with the corresponding second scan, with the
scans separated by 20 min 44 s. For inter-session repeatability, the respective first and second scans of both sessions were compared with each
other, with the two sessions separated by 4 d. For each Bland-Altman analysis the bias was calculated as the median of the relative differences
between the two measurements and the limits of agreement (LOA) as the corresponding 2.5th and 97.5th percentiles such that 95% of the devia-
tions lay within them. ICC estimates and their 95% confidence intervals were calculated using IBM SPSS Statistics Subscription (Build 1.0.0.1246;
IBM, Armonk, NY) based on a single-measurement, absolute-agreement, two-way mixed-effects model. The ICC is a statistical quantity (i.e. an
estimate of the true value); therefore, the corresponding 95% confidence interval was taken into account for the assessment and interpretation of
the reliability.41 The respective combined data set of either both sessions or both scans was used as input for the intra- and inter-session repeat-
ability. To obtain an estimate for the overall repeatability, all four measurements were compared with one another. In the ideal case of perfect
repeatability and no noise, the bias and LOA would be zero and the ICC would be one.
3 | RESULTS
3.1 | Optimization and validation
Correct implementation and functionality of the cosine-modulated pulses was verified in a BSA phantom using a constant modulation frequency of
Δωmodulation = 30 ppm. The resulting Z-spectrum (Figure 1C, black line) exhibits the expected features of the dual-frequency irradiation: a superposition
of two conventional Z-spectra centered at Δωcenter ± 30 ppm. Measurements using only the corresponding single-frequency irradiation
(Δω = Δωcenter+30 ppm and Δωc = Δωcenter − 30 ppm) show nearly identical Z-spectra (Figure 1C, red and blue, respectively) with only small deviations
(|ΔZ| ≤ 0.005) compared with the cosine-modulated irradiation (Figure 1D and 1E). The very close agreement of the Z-spectra generated by single-
and dual-frequency irradiation confirms the correct implementation and functionality. However, a small residual carrier frequency leakage around
Δωcenter = 0 ppm is observable (Figure 1C inset). As the resulting interfering direct water saturation would ultimately distort the dualCEST signal, a
slightly asymmetric center frequency (|Δωcenter| ≥ 1 ppm) was used. This asymmetry was large enough to consider possible B0 field inhomogeneities.
Application of the cosine-modulated pulses in vivo (Figure 2B) resulted, compared with the reference image acquired using the alternating
dual-frequency irradiation (Figure 2A), in a small but insignificant SNR gain (34 ± 47%) across various tissue regions (Supporting Information
F IGURE 2 Improvements achieved by optimization of the dualCEST acquisition and post-processing (Slice 1 of 12): reference (A), cosine-
modulated pulses (B), and additional motion correction (C), which is essential for the application of the denoising (D), and an optimized weighted
acquisition scheme (E). The improvement achieved by each step was quantified by determining the mean relative SNR gain for regions of interest
in WM (blue), GM (orange), and combining the two (grey) (F). The error bars represent the corresponding standard deviations of the obtained
means. The SNR estimate was calculated by dividing the mean by the standard deviation for each region of interest (as defined in Supporting
Information Figure S1)
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Figure S1, including the absolute SNR values). However, both images are noisy, allowing only the cerebrospinal fluid (CSF) to be distinguished, but
no grey matter (GM) or WM structures. Additional co-registration of the image data to correct for potential motion artefacts yielded a smoother
dualCEST contrast (SNR gain of 91 ± 46%), but with a patchy and asymmetric appearance (Figure 2C). Initially, motion correction seems therefore
to be unnecessary or even adverse. However, motion correction is a prerequisite for effective utilization of denoising strategies and should not be
omitted. Application of a denoising approach based on a principal component analysis resulted in a tremendous improvement in image quality
(SNR gain of 131 ± 70%) (Figure 2D). The CSF is clearly delineable and exhibits signal values close to zero, which is in agreement with the
expected negligible amounts of proteins therein. Furthermore, a slight contrast between GM and WM structures is apparent, with higher signal
values in WM. Interestingly, the GM of the putamen was detected consistently as a hyperintense region across all relevant slices. Additional
implementation of the weighted acquisition resulted in further improvement of the image quality (SNR gain of 33 ± 10%) with an overall smoother
dualCEST contrast and a clearly defined putamen (Figure 2E). The optimization resulted in an overall SNR gain of approximately a factor of
8 (Figure 2F).
Specificity to proteins of the optimized protocol was investigated in model solutions containing three different compounds associated with
the main contributors to the in vivo Z-spectrum: proteins (represented by BSA), metabolites (represented by carnosine, creatine, and glutamate),
and ssMT (represented by HC). The low power Z-spectra with B1 = 0.7 μT (Figure 3A and 3B) exhibit CEST signals in the spectral range of
±15 ppm for BSA and −1 ppm to +8 ppm for the metabolites. In addition, the metabolite sample has a distinct resonance around Δω = 3.5 ppm,
which can be assigned to the APT signal of carnosine. The Z-spectrum of HC (Figure 3B, blue line) exhibits a very broad ssMT extending up to
±200 ppm. The asymmetry reported at higher field strengths19 was not observable, potentially due to the significantly lower spectral resolution at
3 T, as well as different saturation parameters. In the conventional APTw images (Figure 3C), this negligible asymmetry of the ssMT resulted in
values close to zero, whereas the protein compartment is clearly visible. As expected, the metabolite solution exhibits a signal of comparable
amplitude, preventing an unambiguous assignment of the APTw contrast to proteins. In contrast, dualCEST-MRI (Figure 3D) shows only a signal in
the BSA compartment with values close to zero everywhere else, confirming the specificity of the optimized acquisition protocol to proteins.
3.2 | Test-retest reliability in healthy volunteers
The intra- and inter-session repeatability of dualCEST was investigated by examining one subject twice on two different days. The acquired con-
trasts (Figure 4A-4D) were in very good agreement, with consistent contrast of GM and WM structures, as well as a clearly delineable CSF. How-
ever, in comparison with the first in vivo measurement (Figure 2), a slightly different contrast behavior can be observed, mainly visible as a
hyperintensity in the frontal WM. In contrast, the amplitude of the dualCEST signal in deep GM (i.e. putamen) is consistent and the occipital GM-
WM contrast is quite similar. Possible explanations could be an actual physiological variation between the two different subjects or an overcom-
pensation of B1 inhomogenities in the frontal WM. Furthermore, small differences in image quality (particularly Figure 4A) and contrast amplitude
are visible between the four scans for the repeatability assessment. The corresponding Bland-Altman analyses of mean values obtained in a
F IGURE 3 Protein specificity
of dualCEST at B0 3 T. Model
solutions (inset in A) containing
BSA (orange), HC (blue), and a
metabolite mixture (green) show
characteristic signal contributions
in the respective mean Zspectra
(B1 0.7 T) (A, B). The
conventional APTw image exhibits
a positive signal for both proteins
and metabolites (C), whereas the
dualCEST contrast is specific to
proteins (D)
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3 × 3 × 1 region (Figure 4E-4H) give similar results for intra- and inter-session comparisons. The corresponding bias and LOA are plotted as rela-
tive values as there was a clearly visible correlation between their absolute differences and their mean. In addition, plots involving the noisier first
scan of the first session (Figure 1A) exhibit a notably stronger scattering. Overall, the relative differences are small, with a bias close to zero (±2%)
and a maximal LOA of approximately ±16%. The LOA is an estimate of the threshold for the reliable detectability of signal differences across mul-
tiple scans and sessions. In other words, signal changes larger than 16% in a region of 3 × 3 × 1 voxels can be detected reliably. This result is fur-
ther supported by the corresponding ICCs (Table 1), which indicate a good inter-session and good-to-excellent intra-session and overall reliability
of the optimized dualCEST-MRI protocol.
3.3 | Patient measurement
Applicability of the proposed dualCEST acquisition protocol in a clinical setting was demonstrated by examining a patient with newly diagnosed
and histopathologically proven glioblastoma (WHO grade IV) (Figure 5). The optimized dualCEST-MRI allows clear delineation of the tumor region
F IGURE 4 The repeatability of the technique
is visualized by co-registered dualCEST images
(Slice 6 of 12) of a healthy volunteer acquired in
two different sessions with two different scans
each (A-D). The corresponding Bland-Altman plots
show the intra- (E, F) and inter-session (G, H)
repeatabilities. For the plots, the mean values of
3 × 3 ×1 regions are used to compute the relative
differences between the two measurements as
well as the associated bias (solid line) and LOA
(broken lines)
TABLE 1 ICCs and corresponding reliability for dualCEST examinations using the mean of 3×3×1 regions as input
Intraclass correlation
95% confidence interval
Indicated reliability41Lower bound Upper bound
Intra-session 0.918 0.875 0.943 Good to excellent
Inter-session 0.895 0.890 0.899 Good
Overall 0.902 0.888 0.913 Good to excellent
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by the significantly reduced Tprotein signal compared with the contralateral side. The healthy tissue exhibits a similar contrast between WM and
GM structures as observed in the two volunteers (cf. Figures 3, 4 and 5). A strong hyperintense region was observed in the dualCEST images
(Figure 5, pink arrows), which most likely coincides with a blood clot within the tumor. However, these strongly elevated signals are an artefact,
which can be traced back to a malfunctioning of the ssMT correction (Equation (2)). This error is caused by the lack of ssMT and resulting T
(ΔωssMT, −ΔωssMT) values close to or even below zero. However, identification and subsequent exclusion of the affected voxels is straightforward.
Interestingly, this region is also discernible in the other CEST modalities, particularly in APTw images. In general, the dualCEST contrast bears a
close resemblance to the rNOE contrast based on the MTRRex evaluation. The slight differences in the tumor region or the generally less pro-
nounced WM and GM contrast might be of particular interest, as they potentially indicate additional information. A conclusive interpretation of
the contrast changes with respect to the clinical relevance and diagnostic value of dualCEST will have to be made in further studies involving a
sufficiently large patient cohort.
4 | DISCUSSION
In this study, we optimized the acquisition protocol for dualCEST-MRI at 3 T to enable clinically relevant examinations of the human brain, includ-
ing changes in the presaturation, image readout, and post-processing of the technique. A first dualCEST proof-of-concept in vivo examination has
already been conducted at 3 T.24 However, the inherently low SNR of the dualCEST approach has led to a comparatively long measurement time
for the acquisition of sufficiently good images, preventing its application in clinical trials. The optimization presented in this study allowed the
reduction of number of averages from 18 to 10, which resulted in an approximately two times shorter imaging protocol, with an increased resolu-
tion by a factor of two (now 1.7 × 1.7 × 3 mm3 compared with 1.9 × 1.9 × 5 mm3). Additionally, this increased image quality no longer necessi-
tates Gaussian smoothing. The overall acquisition duration of the proposed protocol—consisting of the dualCEST scan, as well as B1 and T1
mapping to correct for field inhomogeneities and water relaxation properties—is 20 min, which is comparable to the acquisition of relaxation-
compensated CEST contrasts.7,33
The optimization comprised implementation of (i) a simultaneous dual-frequency presaturation, (ii) a weighted acquisition scheme, (iii) a 3D
image acquisition enabling retrospective motion correction, and (iv) application of advanced denoising strategies. An SNR analysis across multiple
tissue regions revealed that the latter two steps contributed most to the achieved improvement. In contrast to most of the conventional CEST
modalities, for the registration of dualCEST image data no specialized motion correction is required as no fully saturated images are acquired at the
direct water saturation (Δω = 0 ppm), which otherwise potentially yield artifacts.42 In addition to the resulting SNR gain, motion correction is an
essential prerequisite for the subsequent denoising.32 Application of the denoising algorithm resulted in a tremendous improvement in image quality.
F IGURE 5 DualCEST-MRI
examination (Slices 6-8 of 12) of a
patient with newly diagnosed and
histopathologically proven
glioblastoma (WHO grade IV)
examined at B0 = 3 T. For
comparison, conventional APTw
and relaxation-compensated
CEST (amide and rNOE) contrasts
are illustrated. The tumor volume
can be identified in the
gadolinium contrast-enhanced T1-
weighted MR image (Gd-ce T1w).
The dualCEST contrast exhibits
an artefact (pink arrow), which
most likely coincides with a blood
clot within the tumor and is also
visible as a hyperintense region in
the other CEST modalities
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The utilized algorithm combines principal component analysis with an appropriate data-driven criterion to differentiate meaningful spectral
features from noise-like characteristics to avoid the potential risk of excessive denoising.32 For the in vivo data the criterion consistently determined
six components to be optimal, which seems adequate compared with the maximally possible nine degrees of freedom (i.e. frequency offset pairs).
In comparison to the post-processing steps, the implementation of the cosine-modulated pulses and the weighted acquisition scheme
resulted in only a minor improvement. Based on the previous investigations, the effectively doubled DC of a simultaneous presaturation was
expected to result in a substantially more efficient saturation and thereby improved image quality. However, usage of the cosine-modulated
pulses resulted in only an insignificant SNR gain. This can be explained by the Z-values for an increased DC being smaller and closer to the noise
level, counteracting the potential gain by the increased DC. Furthermore, this approach required shifting the frequency offsets to exclude the pos-
sibility of unintentional direct water saturation by the residual carrier leakage (Figure 1C). Due to the comparatively broad dualCEST resonances
at 3 T, this frequency shift does not impair the specificity of the approach. However, in the presence of large B0 inhomogeneities (i.e. |Δ
B0| ≥ 0.5 ppm) the shifted frequency offsets might result in an off-resonant saturation. To avoid the susceptibility to large B0 inhomogeneities
resulting from the frequency shift, parallel transmission systems43 could be used to achieve a simultaneous dual-frequency irradiation without
residual carrier frequency leakage (Figure 1C). Alternatively, a more robust acquisition protocol could be realized by using the conventional
alternating presaturation without a significant loss in SNR. In contrast to the cosine-modulated pulses, application of the weighted acquisition
scheme for averaging the frequency offset pairs resulted in a small but significant SNR increase. This was achieved by adjusting the averaging
according to the anticipated effect of the Z-values on the final contrast (see Section 2.1.3). In the future, the model could be extended by using
the actual Rician44 error distribution instead of a Gaussian distribution, which would avoid the assumption of the error being independent of
the signal value. Nonetheless, the distribution obtained in this study is a good first approximation, yielding improved image quality compared with
previous uniform averaging.
Reproducibility was investigated by repeating in vivo measurements with the optimized dualCEST-MRI protocol. Respective mean values in
regions of 3 × 3 × 1 voxels were compared during data assessment (Bland-Altman analyses and ICC). More meaningful results are obtained using
3 × 3 × 1 voxels than single voxels, as the spatial information of the image is taken into account (i.e. surrounding voxels). In contrast to using only
a single region of interest (e.g. a whole organ or tissue),45,46 this “fixed window” approach allowed for a larger sample size for the statistical ana-
lyses. It should be kept in mind that in doing so the following assessment results are only valid for evaluating regions of 3 × 3 × 1 voxels. Even
better repeatability and sensitivity can be expected for a potential diagnostic application assessing larger regions of interest. As expected, repeat-
ability (ICC and LOA) is lower for inter- compared with intra-session measurements. However, these marginal differences indicate that deviations
due to repositioning and resulting partial volume effects are quite small. The repeatability of CEST-MRI has so far only been evaluated in a few
studies with widely varying evaluation standards and in different entities.45-48 In the brain, repeatability was only evaluated using the less informa-
tive coefficient of variation, which could not be assessed in this study as there were only two repetitions for the intra- and inter-session evalua-
tion. Therefore, we resorted to comparing our results in the brain with breast and prostate imaging, which are however intrinsically more difficult
to reproduce due to e.g. increased B0 inhomogeneities and additional non-rigid motion. ICC values were reported as 0.963 (95% confidence inter-
val 0.852, 0.991)45 for conventional APT-CEST in the breast and as 33-38% LOA for conventional APT- and rNOE-CEST in the prostate.46 In
comparison with the values in this study (ICC = 0.902 with a 95% confidence interval of 0.888, 0.913; LOA = 16%), the reliability of dualCEST is
equal or even better. Furthermore, the obtained LOA of 16% is a threshold estimate for identifying signal differences caused by genuine biophysi-
cal effects. However, the diagnostic value will ultimately depend on the actual magnitude of change in pathologies which must be assessed in
future clinical studies. For example, a recent study on mice with Alzheimer's disease revealed conventional CEST signal changes attributed to pro-
teins to be of the order of 20%.19 The exceptional specificity of dualCEST to proteins might allow the isolation of signal changes from other con-
founding influences and thus result in an even larger observable effect.
This acquisition protocol enables the application of dualCEST-MRI in a clinical setting. The significant signal decrease in the tumor region
(approximately 35% compared with contralateral normal appearing WM) of a patient with glioblastoma (Figure 5) is in line with results of the pre-
vious proof-of-concept examination.24 In comparison to this previous examination,24 a superior image quality and resolution was achieved. In
addition, the specificity of the dualCEST approach was preserved in the optimized protocol (Figure 3), meaning that the signal decrease in the
tumor region can be attributed to a pathological modification of mobile proteins (i.e changes in the concentration, folding state, or molecular
size).24 With regard to protein content assessment, the dualCEST signal is a measure of the relative protein content and therefore depends on the
apparent water content.49 This is an unsolved issue in the research field of CEST-MRI in general and holds true for all exchange mediated
methods measuring solutes indirectly via the water signal. Therefore, part of the observable contrast between GM, WM, and tumor could be
attributed to differences in the water content. Assessment of absolute protein content is in principle possible by a correction of the water con-
tent, which can be quantified by established techniques based on for example T2* and T1 measurements.
50 The achieved specificity of the
dualCEST approach could be utilized as a reference to assess the assignment of conventional amide and rNOE CEST signals to proteins. Discrep-
ancies revealed by comparing different approaches would indicate confounding contributions (i.e. metabolites or lipids) or physiological depen-
dences (i.e. pH). In doing so, dualCEST may lead to novel insights into the origin of protein CEST contrasts in vivo. In the future, clinical studies
with larger patient cohorts need to be examined to assess the diagnostic value of dualCEST-MRI, particularly the potential of the dualCEST con-
trast as a biomarker for neurodegenerative diseases or cancer.




In this study, we developed an acquisition protocol for dualCEST-MRI at 3 T to enable selective imaging of endogenous bulk mobile proteins
under clinically relevant conditions. This goal was achieved by extending the image readout to 3D, allowing for retrospective motion correction
and application of denoising strategies. Furthermore, a simultaneous dual-frequency presaturation was implemented and combined with a
weighted acquisition scheme. Preservation of specificity was demonstrated in vitro. Repeated in vivo examinations indicated good-to-excellent
reliability and allowed estimation of a threshold to distinguish genuine biophysical effects from measurement noise. Applicability in a clinical set-
ting was demonstrated by examining a patient with glioblastoma, revealing significant alterations of the dualCEST contrast in the tumor region.
This optimized protocol enables examination of larger patient cohorts, and thus assessment of the diagnostic value of dualCEST-MRI.
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The non-invasive imaging of protein-attributed CEST signals has been shown to provide
biochemical insights in vivo, which have been shown to be correlated to clinically relevant
information for a variety of diseases. While conventional CEST imaging modalities suf-
fer from confounding signals of metabolites and macromolecules, the novel approach of
dualCEST enables increased protein specificity by selectively detecting the intramolecular
spin diffusion. However, its application has so far been restricted to spectrometer measure-
ments of model solutions at ultra-high magnetic field strengths. The aim of this thesis was
therefore the translation of the dualCEST technique from a spectrometer application to a
clinical whole-body MR scanner to enable, for the first time, examinations of the human
brain.
3.1 Translation fromNMR spectrometer to clinical scanner
This translation required, among other things, extending the technique from a spectroscopic
approach to an imaging modality and addressing the considerably smaller SNR of the lower
magnetic field strength, while at the same time meeting clinical needs in terms of practicabil-
ity, reproducibility, and imaging speed. In order to achieve these objectives, several method-
ological developments were utilized, covering all parts of the technique: signal preparation,
imaging readout, and post-processing.
Impact of clinical magnetic field strength
In general, the transfer of CEST approaches to lower magnetic field strengths is complicated
by the entailing decrease in the spectral resolution and resulting incapability to resolve indi-
vidual and distinct peaks. In contrast, for dualCEST this limitation can be bypassed by its
novel dimension of selectivity. Using the coupling of different CEST signals as a distinguish-
ing feature, rather than the resolution and isolation of the individual resonances, enables a
straightforward application at clinical magnetic field strengths. Moreover, the dualCEST
technique actually benefits from the decrease in spectral resolution. In proteins, the chemi-
cal shift of identical protons is dispersed depending on their location in the molecule and the
surrounding chemical environment.80 A decrease in the magnetic field strength results in a
spectral broadening of the presaturation pulses. As a result, more protons from neighbor-
ing chemical shifts are incorporated into the measurement procedure, yielding a larger sig-
nal. With regard to the occurrence of B0-inhomogeneities, the comparatively broad plateau
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3 Discussion
of the dualCEST resonance at 3 T allows the omission of a correction procedure. Other-
wise, a time-consuming acquisition of additional frequency offset combinations would be
required. In view of those factors, the dualCEST technique seems suited for application at
clinical magnetic field strengths. However, the concomitant and considerable SNR decrease
(SNR∝ B01.65)81 becomes problematic in combination with the already inherently low SNR
of dualCEST. The latter can be attributed to the complex calculation of the final contrast
(Chapter 1, equations 7 and 8) and consequent error propagation for nine error-containing
signal values. The improvement of SNR was therefore paramount for all subsequent deci-
sions and further developments.
Presaturation
For optimizing the presaturation parameters, the aforementioned novel dimension of se-
lectivity and the beneficial spectral broadening of the presaturation pulses can be further
exploited. Firstly, the signal strength can be increased by applying presaturation pulses with
a shorter duration tp (Publication I, figure 3E and F). In a similar manner to the decrease
in the magnetic field strength, the resulting increase of the spectral bandwidth results in a
larger number of saturated protons. Secondly, as dualCEST is only relying on the coupling
of CEST signals, this allows the application of high B1 amplitudes to increase the signal
strength without any loss in the specificity. This is in strong contrast to conventional CEST
approaches, where the extensive peak broadening for high B1 amplitudes results in an unde-
sirable deterioration of the spectral selectivity.82 However, it should be noted that even for
dualCEST, an excessive broadening of signals is possible, resulting in an erroneous signal
quantification. This erroneous signal quantification is the case if the resulting linewidths are
larger than the distance between the two frequency offsets ∆ω and ∆ωc. In other words,
a direct saturation of CEST signals at one frequency offset induces pulses applied to the
other. Nevertheless, the utilized spacing of |∆ω−∆ωc| ≥ 10 ppm should be sufficient to
avoid such influences, while at the same time allowing for a broad range of possible B1 am-
plitudes and pulse lengths. With these specifications, the presaturation parameters in this
study were optimized to maximize the dualCEST signal while avoiding an excessive broad-
ening of the resonances. For the determined optimal parameters (tp = 20ms, B1 = 2 μT)
the dualCEST signal is in addition approximately linear as a function of B1, which enables
a straightforward correction of the B1-inhomogeneities encountered in vivo.83
In a next step, as part of Publication IV, the presaturation was further developed by intro-
ducing dual-frequency pulses. The previous implementations of the dualCEST technique
utilized a train of Gaussian-shaped pulses to alternately saturate the two different frequency
offsets (Figure 2A). However, as only every second pulse is effectively saturating the same
frequency offset, such an alternating pulse scheme is inefficient. Modulating the employed
Gaussian-shaped RF pulses with a cosine function allows for the simultaneous saturation
of both frequency offsets,77, 78 thereby effectively increasing the duty cycle by a factor of
two. Based on the previous investigations of the duty cycle dependence,32, 33 a considerably
more efficient saturation, and thus increase in SNR, was expected. However, usage of the
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cosine-modulated pulses resulted in only an insignificant gain. This lack of improvement
could potentially be explained by the acquired Z-values of this more efficient saturation be-
ing smaller while the signal noise of the image itself remains constant. Hence, the Z-values’
relative error actually increases. As a result, a higher dualCEST contrast value might be
observed in the end, however, the corresponding error would increase even more and nullify
any SNR gain. For future applications, it should therefore be investigated whether a less
efficient saturation is actually beneficial for the SNR. In this context, a simultaneous satu-
ration using a decreased B1 amplitude – as opposed to the previous alternating scheme with
high B1 – is preferable as it allows the same saturation efficiency to be achieved but without
any unnecessary signal broadening.
It should be noted that the implementation of the simultaneous saturation using the cosine-
modulated pulses comes at the disadvantage of requiring the intended frequency offsets to
be shifted to exclude a potential direct water saturation. Imperfections of the cosine modu-
lation, e.g. due to the finite number of digitized steps per pulse, result in addition to small
deviations in a residual carrier leakage. For a pair of frequency offsets positioned symmet-
rically around the water resonance ∆ω = 0 ppm, this residual carrier leakage will result in
an unintentional direct water saturation. To avoid this effect, slightly asymmetric frequency
offsets had to be utilized. Due to the comparatively broad plateau of the dualCEST res-
onance, this adaption does not impair the specificity of the dualCEST signal. However,
in combination with the occurrence of severe B0-inhomogeneities (i.e. |∆B0| ≥ 0.5 ppm)
the shifted frequency offsets could potentially result in the saturation being off-resonant.
To avoid the necessity of shifting frequency offsets and the entailing susceptibility to large
B0-inhomogeneities altogether, parallel transmission systems84–86 could be used to achieve
simultaneous saturation without residual carrier frequency leakage. For this purpose, the
alternating dual-frequency irradiation would be applied to the different coil elements with
adjacent channels having the opposite order of frequency offset.
Imaging readout and acquisition scheme
In general, the right choice of signal acquisition is – besides the details of the presaturation –
of the uttermost importance for CEST imaging. The immediately commencing decay of the
prepared signal towards the equilibrium magnetization necessitates a fast signal acquisition
to minimize any contrast loss. For dualCEST, the extension from a spectroscopic approach
to an imaging modality was first achieved by combining the presaturation module with an es-
tablished 2D gradient echo pulse sequence with a centric reordered k-space acquisition.13, 87
In this context, gradient echo-based approaches offer a particularly high robustness in addi-
tion to a sufficiently fast imaging speed. Moreover, the centric reordering of k-space, which
samples the crucial central data points first, allows for an efficient acquisition of the contrast
generated by the presaturation phase.
As a next step, the subsequent extension of the image readout to 3D facilitated both coverage
of a larger volume and the possibility to apply retrospective motion correction algorithms.
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However, the straightforward solution of a sequential multi-slice approach was not feasi-
ble. This would otherwise have resulted in a significantly deteriorated contrast due to the
longer acquisition time and simultaneous decay of the prepared signal. Consequently, the
dualCEST preparation was combined with the sophisticated imaging readout of the recently
published snapshot-CEST approach.71 The centric-spiral sampling of the k-space of this
approach allows a 3D volume to be acquired in a single-shot with tolerable contrast loss.
The snapshot-CEST sequence has many parameters that affect the image quality and acqui-
sition duration. The influence of the main parameters (GRAPPA acceleration factor and
bandwidth) were investigated and optimized in Publication II. As a result, it was possible
to maximize the acquired 3D volume and the SNR, while at the same time minimizing the
acquisition time and thus preserving the contrast.
An additional small but significant SNR increase was achieved by developing and implement-
ing a weighted acquisition scheme. As dualCEST-MRI still requires multiple averages to
accumulate enough SNR, the distribution of the number of averages spent per frequency
offset pair is as well an optimizable parameter. The idea behind this method is that certain
frequency offset pairs will have a larger impact on the final contrast quality than others. Es-
sentially, the acquired Z-values have different amplitudes, thus different relative errors, and
are used in different places in the equations. The aim is therefore to average the high-impact
Z-values more often to ultimately reduce the error of the final contrast for a fixed number of
repetitions. In this way, adjustment of the averaging scheme to the anticipated effect of the
Z-values allowed an SNR gain of 33%. Application of this approach is straightforward and
does not necessitate any complicated changes to the sequence. Nevertheless, this implemen-
tation is only a first step and there is still room for improvement. The proposed determination
of the optimal distribution assumes uncorrelated and normally distributed errors with a uni-
form variance, which in most cases does not hold true. As a next step, the model should
be extended to incorporate a Rician,88 instead of Gaussian, noise distribution, which avoids
the assumption of the noise being independent of the actual signal value. To be even more
realistic, the noise correlations induced by the utilized parallel imaging should be incorpo-
rated as well.89 However the latter is not straightforward, as it would rule out an analytical
solution and would necessitate a numerical optimization using simulations. Nonetheless,
the approach presented here and the obtained distribution are a good first approximation
and have already resulted in a significant improvement compared to the previous uniform
averaging scheme.
Post-processing
As previously mentioned, the main challenge of this work was the considerable SNR de-
crease due to the lower field strength in combination with the intrinsically low SNR of the
dualCEST technique. In addressing this issue, the development and application of a novel
denoising algorithm resulted in the largest improvement compared with all other advance-
ments. The basis for this approach is the application of a PCA, which allows the dimension-
ality of the data to be reduced while preserving the essence of information. In combination
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with an appropriate data-driven approach to determine the crucial number of remaining
components, this technique enables an efficient and robust separation of noise-like charac-
teristics from meaningful spectral features.
PCA has previously been reported to be a powerful denoising technique for HyperCEST
by Döpfert et al.90 However, for these previous attempts the optimal number of necessary
components was determined based on prior knowledge about the composition of the imaged
phantom. For in vivo data, comprising multiple spectral resonances, the number of necessary
components is not a straightforward deduction as the number of contributions as well as their
dependence on physiological influences and pathological alterations are unknown. The fact
that the number of components is unknown is problematic, as the right number is crucial for
the performance of the approach: preservation of too many components will diminish the
denoising effect, while too few components will result in unacceptable contrast distortions.
Therefore, in Publication III, the combination of the PCA with several data–driven criteria
were examined, which estimate the number of principle components remaining uncontam-
inated by noise. The performance and validity of the different criteria was investigated for
synthetic and in vivo data sets of conventional CEST experiments. Utilization of synthesized
data allowed for the comparison with a ground truth, which is necessary for determining the
actual optima. The synthesized data was generated from high SNR in vivo CEST spectra,
taking into account B1 inhomogeneities, the spatially variant coil sensitivity profile, and the
accurate noise distribution of the utilized GRAPPA reconstruction.89 The simulations and
in vivo data determined that all three investigated criteria yield robust and reliable results
with the denoising capability being comparable or even superior to an averaging of six mea-
surements (i.e. a factor of 2.5). The latest investigations of Appendix A even indicated a
remarkable SNR gain by a factor of 3.5 (Figure A.3) by additionally incorporating a correc-
tion for the Rician noise induced bias.91
This approach is in general not limited to the investigated conventional CEST experiment
but is applicable to all related approaches providing an additional dimension to exploit re-
dundancies. For dualCEST this is realized by stringing together the individual acquisitions,
i.e. the combined dimension of frequency offset pairs and repetitions. In Publication IV,
application of the denoising approach to in vivo dualCEST data yielded an SNR increase by
a factor of 2.3, which is consistent with the results for the conventional CEST. Moreover,
the consistently determined number of six components seems appropriate with regard to the
overall possible nine degrees of freedom (i.e. frequency offset pairs), again indicating the
general validity of the utilized criterion.
To ensure correct functioning of the denoising approach, adequate preprocessing of the data
is essential. Prior segmentation of meaningful tissue (i.e. brain matter and cerebral spinal
fluid (CSF)) is required to exclude the distorting influence of voxels dominated by fat, noise,
or large vessels. With regard to large vessels, special emphasis should be placed on the sagittal
sinus superior, since failing to properly exclude this region has resulted in serious defects on
numerous occasions. In addition to the segmentation, a correction for possible movements
and deformations during the measurement is crucial to restore the underlying correlations
across all voxels. Unaddressed or remaining displacements will result in corrupted spectral
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components and in a higher number of necessary components to describe the data. In this
context, the previous extension of the image readout to 3D is vital as it allows correcting
for a displacement or tilting of the investigated body region out of the imaging plane. In
addition to being an essential prerequisite for the denoising approach, application of the mo-
tion correction resulted directly in a significant SNR gain by a factor of 1.9. In comparison
to other conventional CEST approaches, registration of dualCEST image data does not re-
quire a specialized motion correction as there is no fully saturated image acquired (i.e. with
only little image intensity values at the direct water saturation ∆ω = 0 ppm), which typically
results in severe malfunctioning.92 Nevertheless, application of such specialized approaches
might still be beneficial as the complex calculation of the dualCEST contrast is susceptible
to even small remaining displacements, which are then potentially corrected. In the future,
the necessity for retrospective motion corrections could be avoided altogether by real-time
tracking of the head motion and corresponding adjustment of the position and orientation
of the field of view. The necessary sophisticated tracking could be realized by optical markers
rigidly attached to the head or additional navigator scans determining the current position
shortly before the actual acquisition.93, 94
As impressive as the results are, the algorithm presented in Publication III represents only
a first introduction of denoising techniques to the field of in vivo CEST, with potential
remaining for advancements. For instance, the utilized PCA reduces the data set to solely
the correlations between the frequency offsets across all voxels. Any additional information
about the spatial as well as tissue interdependencies is thereby lost. To exploit at least the lat-
ter to some extent, in Appendix A the PCA was combined with a prior formation of subsets
of similar spectra, which most likely originate from tissue with comparable properties. By
exploiting only the remaining subtle differences of these subsets – instead of the entire data
set – a better identification and isolation of the underlying spectral features is achieved.95, 96
Application of this extended approach to conventional in vivo CEST data resulted in an
additional SNR increase by .114%. Moreover, the selection and subsequent denoising of
subsets of similar spectra reduces the risk of spectral features being undesirably distorted
or removed altogether. This is particularly important for unique signatures, which are only
present in a small area of the acquisition volume, as is usually the case for tumors. In com-
parison to a simple prior segmentation of the image into different tissue classes (i.e. white
matter (WM), gray matter (GM), CSF, etc.) with a subsequent denoising of these compart-
ments, the data-driven grouping of similar spectra avoids a presumptuous classification of
aberrant voxels and results in a more diverse and better representation of the spectral features.
In the future, a further incorporation of the latent spatial information would be desirable;
however, this is not possible on the basis of a simple PCA. For that purpose, more sophisti-
cated approaches would have to be utilized, combining both spatial and spectral information
to improve the denoising performance even further.96, 97
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Further acceleration – an outlook
Altogether, the developments discussed above facilitated the establishment of a dualCEST
imaging protocol, which overcame the combined challenges and limitations of the technique
itself and the considerably lower magnetic field strength – in particular the inherently low
SNR. The resulting overall acquisition time for dualCEST-MRI, including B1 and T1 map-
ping for correcting field inhomogeneities and tissue water relaxation properties, is 20 min-
utes. This time is on par with conventional relaxation-compensated CEST approaches13, 98
and allowed this technique to be used in pilot studies investigating its diagnostic value. The
results of these pilot studies are discussed in the last section. The future long-term objec-
tive for dualCEST should not only be its applicability in studies, but also in clinical routine,
which means even stricter requirements for the acquisition time and a resulting necessity to
accelerate the approach even further.
An acceleration of dualCEST-MRI can in principle be realized in two ways: by increasing
the SNR of each repetition to reduce the necessary number of averages, or by shortening the
time for one repetition. Possible methods for the former have already been mentioned in the
respective parts of this chapter, i.e. advanced denoising strategies and utilization of parallel
transmission systems for the presaturation, and will therefore not be discussed in more detail
here. With regard to a reduction of the repetition time, shortening the presaturation phase
would be of particularly impactful, as it represents a long waiting period, which accounts
currently for 60% of the total examination duration. The necessity for this long saturation
time arises from the fact that dualCEST requires, as do most other quantitative techniques,
a saturation time in the order of 3-5 times T1 to reach the steady-state condition.45
In Appendix B, a method for (conventional) CEST approaches is presented, which allows
this time-consuming problem to be avoided by calculating the steady-state signal from an
experiment with a significantly reduced saturation period. In order to achieve this reduced
saturation period, the analytical description of the signal evolution (Equation 3) is solved for
the steady-state signal, which as a result can then be determined from data acquired with
an arbitrary saturation time. In other words, the method is a fairly accurate extrapolation of
the accelerated data based on the analytical model of the signal evolution. Two important
things can already be deduced from this fact: the extrapolation will only be as accurate as the
underlying model, and the further the extrapolation is (i.e. for very short saturation times),
the worse the results will be. The final calculation (Equation B.3) requires multiple quanti-
ties to be determined: the dualCEST measurement with a shortened presaturation period,
B0-, B1- and T1-maps (usually already acquired, as they are required for dualCEST) and
a calibration measurement with the dualCEST sequence parameters. The only additional
measurement is the calibration, which does not require too much extra time. An acceleration
of the imaging protocol is thus achieved as soon as the time, saved by the reduction of the
presaturation, outweighs the additional expenditure of the calibration measurement, which
is given for almost all experimental setups.
For conventional CEST experiments this method was shown to be able to provide a very
close approximation of the steady-state Z-spectra using a presaturation period in the order
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of one-time T1 (Figures B.2 and B.3). The discrepancies in the solid components of the
brain were limited to only small deviations for GM in the Z-spectrum region of the rNOE;
however, rather considerable differences were observable in the CSF. The first observation is
potentially explainable by the rather slow exchange rate of the rNOE (approximately 5 Hz)99
in combination with the longer T1 of GM. Within this limit, the underlying assumption
of a mono-exponential decay does not hold anymore and additional rotational effects and
exchange processes in the pauses would have to be considered.100 To avoid this problem as
much as possible, long pulses, if not even a continuous saturation, should be used with a
saturation time that is at least one-time T1 of the ‘slowest’ tissue of interest. The deviations
in CSF can be understood in terms of partial volume effects, which prevent assignment of
a single decay rate for each voxel and thereby prevent a correct determination of the steady-
state. However, for most applications the main emphasis is on the solid components of the
brain, for which the method yields reliable results. Overall, the method has shown very
promising results for accelerating CEST experiments relying on steady-state conditions.
For dualCEST, this technique bears the promise of enabling examination times which com-
ply with the requirements for the daily clinical routine. In principle, there should be direct
applicability, as the underlying analytical model also retains its validity for dualCEST. Pre-
vious experiments and simulations indicated the required exponential decay and build-up
of the dualCEST signal.32, 69 In a next step, further investigations will be needed to con-
firm these results, in particular the strictly mono-exponential behavior of the signal evolu-
tion. To this end, the utilization of the previously discussed simultaneous saturation might
be beneficial as this would avoid the potential complication of two interleaved saturation
phases with an individual exponential decay each. Another potential issue might be the pre-
viously observed small deviations for the rNOE in conventional CEST experiments. As the
dualCEST signal is related closely to the same underlying physical phenomenon, i.e. the
intramolecular spin diffusion processes, these deviations are very likely to also come into
play here. Due to the complex calculation of the final dualCEST contrast, these small devi-
ations could result in large errors for the final contrast. A potentially excessive acceleration
should therefore be avoided at all cost. Having said that, even a moderate and cautious re-
duction of the presaturation should be sufficient to enable tremendous time savings while
avoiding many of the aforementioned issues. For example, halving the current presaturation
time from six to three seconds would guarantee a reasonable saturation of at least two times
T1 and lead to a 30% faster acquisition. In summary, this method presents a promising
technique to facilitate a prospective application of dualCEST-MRI in the clinic.
3.2 In vivo application
Using the combined further developments discussed in the previous section, in Publication
IV an imaging protocol was created which fulfills the requirements for clinical studies in
terms of image quality and acquisition speed. The achieved protein specificity, reproducibil-
ity, and sensitivity to pathological alterations are of particular interest to further verify the
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clinical applicability of this technique. Consequently, extensive investigations of biochemi-
cal model solutions and volunteers were performed, and first pilot studies with brain tumor
and Alzheimer’s patients were conducted.
Specificity and reproducibility
The preserved specificity of the dualCEST technique was investigated on the basis of bio-
chemical model solutions. In a similar manner, previous in vitro experiments on a 14.1 T
narrow-bore NMR spectrometer demonstrated the exceptional specificity of the approach to
proteins. In conjunction with further investigations, observed signal changes were assignable
to changes in the concentration, folding state, or molecular size of the bulk mobile proteins.32
To verify the preserved specificity and thus enable the assignment of observed changes in vivo
to proteome alteration, a phantom with three model solutions was examined in this study.
Each solution represented one of the major contributions to an in vivo Z-spectrum: proteins,
metabolites, and macromolecules. As anticipated, only the protein compartment exhibited
a non-zero signal in the acquired dualCEST images with negligible values everywhere else.
This result confirms the preserved specificity of the approach, and thus allows the assignment
of signal changes in vivo to genuine alterations of the proteome.
In addition to the specificity, a precise understanding of two other factors is required in or-
der to properly assign observed features in patients to possible pathological alterations: the
already preexisting contrast in healthy tissue and the comparability between different sub-
jects. With regard to the latter, dualCEST has the advantage, that the measured quantity,
i.e. Tprotein, is a quantitative value, which renders a direct comparison between different sub-
jects possible. It should be noted that a necessary prerequisite to ensure the comparability is
the use of an identical experimental setup, i.e. the same imaging sequence, presaturation pa-
rameters, and magnetic field strength. With regard to the already preexisting contrast, in all
subjects examined for this thesis, a small but consistent contrast between healthy tissue struc-
tures was observed with generally higher signal values in WM compared to GM. The only
exception to this observation was the deep GM of the putamen, which was detected as a hy-
perintense region in multiple subjects and across several imaging slices. From previous MR
spectroscopy studies analyzing macromolecular resonances attributed to mobile proteins, no
significant differences in protein concentration or composition are expected for WM and
GM.101 The observed differences are therefore most likely attributable to differences in the
apparent water content of the two tissues. The dualCEST signal has previously been shown
to be a measure of the relative protein concentration, and thus a dependence on the apparent
water proton concentration is consequential.32 Of note, this additional dependence on the
apparent water proton concentration is an unsolved issue for CEST-based approaches in
general and affects all exchange-mediated techniques quantifying solutes indirectly via the
water proton signal. As a consequence of this dependence, for an otherwise equal protein
concentration and composition, the differences in water content of GM and WM (litera-
ture values of 81.9% and 70.9% respectively)102 result in a 15% higher signal for WM. This
estimate is close to the actual observed contrast in this study, thus supporting the previous
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conclusions. To exclude this influence as well, in principle, an absolute protein content as-
sessment could be achieved by a simple multiplication with a correction factor. To this end,
the apparent water content would have to be quantified using established approaches based
on T1 and T2* measurements.102 Overall, the comparability of the dualCEST signal values
between multiple subjects and the nearly imperceptible contrast in healthy tissue facilitate
the identification of pathological alterations in forthcoming patient studies.
In a next step, as part of publication IV, the reproducibility of dualCEST-MRI was in-
vestigated by repeating measurements in vivo. To this purpose, mean values in regions of
3× 3× 1 voxels were determined in a ’moving window’ fashion and each time compared
between the different measurements using Bland-Altman analysis103 and the intraclass cor-
relation coefficient (ICC).79 By assessing the reproducibility based on regions of 3× 3× 1
voxels, more meaningful results are obtained compared to using single voxels, as the spatial
information is additionally incorporated (i.e. surrounding voxels). In contrast to taking only
the mean of a single region of interest (e.g. a whole organ, tissue compartment or tumor),
this approach avoids the reduction of a whole data set to a single value and thus preserves
the ’image’ nature of the data. Moreover, this approach results in a larger sample size for the
statistical analyses and therefore in a more reliable quantification. It should be kept in mind
that in doing so the obtained assessment results are only valid for investigations of 3×3×1
voxel regions and thus have limited informative value for the individual image voxels. With
regard to a potential diagnostic application assessing larger regions of interest, i.e. the entire
tumor or the hippocampus for Alzheimer’s, an even better reproducibility and sensitivity can
be expected.
Scanning one healthy volunteer twice on two different days each (four times in total) al-
lowed the determination of the intra-session, i.e. two consecutive measurements without
repositioning in between, and the inter-session reproducibility. As might be expected, the
determined intra-session reproducibility is better compared with inter-session repetitions.
However, the only marginal differences indicate that the additional deviations, due to the
repositioning and resulting partial volume effects, are rather small. Altogether, dualCEST-
MRI demonstrated a good inter-session and good-to-excellent intra-session and overall re-
liability.79
The reproducibility of conventional CEST-MRI has so far only been evaluated in a few stud-
ies, with various entities being investigated and widely varying evaluation standards.104–109
Most studies concerning an application in the brain utilized the coefficient of variation as
their method of choice. However, for this study, the approach was not feasible as the co-
efficient of variation depends on determining the respective mean and variance of the in-
vestigated quantity (i.e. signal value of a single voxel or region of interest) across the re-
peated measurements, which is problematic with only two available data points (i.e. repeti-
tions) for the intra- and inter-session evaluation. Moreover, in particular for APT-weighted
CEST, it is questionable whether the coefficient of variation is a valid measure, as the in-
vestigated quantity (MTRasym) does not have a ’natural’ zero point and therefore does not
qualify as a ratio variable, but only as an interval scale.110 A comparison of results would
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thus be rendered meaningless. Studies based on more appropriate and sophisticated evalua-
tion methods reported for APT-weighted CEST an ICC of 0.84 (95% confidence interval
CI95% = [0.72, 0.91]) in the healthy brain and up to 0.96 (CI95% = [0.91, 0.99]) for patients
with a glioma,108 and an ICC of 0.95 (no confidence interval given) for patients with general
brain tumors.109 In comparison with the results obtained in Publication IV (ICC of 0.902
withCI95% = [0.888, 0.913]), dualCEST-MRI demonstrates reproducibility comparable to
established conventional CEST-MRI protocols.
In addition to quantifying the reproducibility, repeated measurements allowed the small-
est contrast change resolvable with dualCEST-MRI to be estimated. The utilized Bland-
Altman analysis yields in addition to the bias, determined as the mean or median of the
relative differences between two measurements, the limits of agreement, which confine 95%
of these deviations. The determined relative limits of agreement of maximal 16% can there-
fore be interpreted as a threshold to distinguish genuine biophysical effects from measure-
ment noise: contrast changes above 16% are with almost complete certainty genuine effects,
whereas everything below could be a fluctuation. Whether this resolution capability is good
enough to be of any diagnostic value will depend on the actual magnitude of change in
pathologies, which must be assessed in future clinical studies. An estimate can be obtained
from the preliminary results of pilot studies concerning cancer and Alzheimer’s.
Pilot studies
In order to evaluate the diagnostic significance of dualCEST-MRI for examinations of hu-
mans, two pilot studies, examining brain tumor (Publications I and IV) and Alzheimer pa-
tients (Appendix C), are being conducted. The underlying hypothesis is that the increased
specificity of the approach is particularly beneficial in two areas: (i) Due to its specificity,
dualCEST could be used as a reference to evaluate the actual contribution of proteins to
conventional CEST signal changes in disease states, which would provide new insights into
the true clinical significance of protein CEST-MRI. And (ii), the better isolation of the pro-
tein signal changes from other interfering influences could lead to a larger observable effect
and thus to a better sensitivity to the pathology under investigation. In the following section,
the results of the pilot studies are discussed and analyzed in relation to both questions. It
should be noted that the small number of patients examined so far does not yet allow for a
final evaluation of either of the two questions. Nevertheless, the observations made so far
already provide initial indications of possible findings.
In the first study with brain tumor patients, the dualCEST technique was confirmed to be
able to identify the tumorous tissue. In both examined patients, a considerably lower signal
was observed in the area of necrotic tissue, facilitating a clear delineation of the tumor region.
In comparison, the surrounding healthy tissue exhibited contrast values in the order of the
values obtained in volunteers, attesting once more to the comparability between different
subjects. Due to the preserved specificity of dualCEST, the observed signal changes can
be attributed to genuine pathological modification of mobile proteins (i.e. changes in the
89
3 Discussion
relative concentration, folding state, or molecular size). This attribution is further supported
by the fact that necrotic tissue is known to consist of decomposing or dead cells.
The achieved specificity of the dualCEST approach is of particular interest for comparisons
with conventional protein-attributed CEST signals, as it could provide new insights into
the origin of protein CEST signals in vivo. In the first investigations, a great similarity be-
tween the dualCEST contrast and the conventional rNOE contrast was observed, which
is also illustrated by a similar appearance in tumor tissue. This result is in line with previ-
ous expectations, since both quantities are primarily attributed to the intramolecular spin
diffusion processes of mobile proteins.23, 32 The remaining slight differences in the tumor
region, as well as a generally less pronounced WM and GM contrast, could therefore be
of particular interest, as they might indicate the contribution of additional effects, such as
confounding contributions of metabolites or lipids, or additional physiological dependences.
This is as well very interesting with regard to the first part of the study hypothesis, as these
additional effects might have been misinterpreted as pathological protein changes. All in all,
the observed contrast similarities and even more so the discrepancies, once again prove the
necessity to investigate the origin and assignment of protein CEST signals.
A more precise assignment of the signals would not only be of interest for cancer, but also
for neurodegenerative diseases such as Alzheimer’s. For instance, a previously published pa-
tient study showed that there is a significant change in the CEST signal in the hippocampus
of patients with Alzheimer’s, but the tentative hypothesis that this is attributable to an in-
crease of cytosolic proteins and peptides cannot be answered unequivocally from the data
available.14 In this respect, the chosen asymmetry analysis (MRTasym) is especially prob-
lematic as it mixes different signal influences. In addition to the targeted amide signal, the
observed signal changes could also be caused by superimposing signals from rNOE, metabo-
lites, lipids, and macromolecules, as well as by changes in the relaxation times T1 and T2,
or of the pH.64 In this context, the results of a recent study in a mouse model indicate that
the larger part of the contrast is actually caused by signals in the upfield frequency range,
i.e. mainly attributed to the rNOE but potentially also to lipids and macromolecules.15 In
contrast to the first Alzheimer study, the authors attribute the observed signal changes to
protein aggregation processes. However, due to the ambiguity of the utilized method, no
final conclusion is possible. The improved specificity of dualCEST might allow to evaluate
the assignment of the signal changes to proteins, and more specifically to the aggregation
thereof.
The first results of the Alzheimer’s study, which was recently started as part of this work, indi-
cate that a pathological change in the proteome can be detected. For one of the two patients
examined, a significantly reduced dualCEST signal was observed across the whole image
compared to the healthy control group. For this comparison, the age-induced biases were
minimized by including only subjects from the same age group. Again, due to the specificity
of dualCEST the signal differences can be attributed to a reduced relative concentration, a
reduced average molecular size, or a denatured global folding state of bulk mobile proteins.
In particular, the last possibility also includes the pathological formation of amyloid fibrils,
90
3.2 In vivo application
i.e. the aggregation of amyloid-β proteins, as demonstrated previously using in vitro experi-
ments.69 With regard to the conclusions of the previous Alzheimer’s studies, the specificity
of dualCEST allows at least some of the signal changes to be attributed to proteins, and
additional indications are provided to support the assignment of the changes to aggregation
processes.
In addition to the more precise assignment of effects, the preliminary results also seem to sup-
port the second part of the hypothesis, namely that the improved specificity of the dualCEST
contrast also entails a better sensitivity. This can be understood in terms of the improved
specificity of the approach allowing a better isolation of the protein signal of interest from
other confounding signals, which would either dilute or even completely suppress the observ-
able effect. The now observed larger effect size (25% relative signal change for dualCEST
as compared to 20% for the conventional rNOE CEST) seems to corroborate this interpre-
tation as it demonstrates the aforementioned effect dilution. However, as with all results of
pilot studies, it is necessary to determine in a larger cohort whether this observation is valid
only for the few cases studied or whether it corresponds to a consistent trend.
In the preliminary results it is striking that only in one of the two patients a change in the
signal was observed, while the second showed no significant difference to the control group.
At first glance, this result naturally casts doubt on the sensitivity of the method and the sig-
nificance of the results obtained so far. However, the different response in both patients is
consistent with the conventional rNOE CEST signals, and moreover with observations for
an established anatomical marker, i.e. the enlargement of the ventricles. The latter has previ-
ously shown that it allows conclusions to be drawn about the current stage of the disease.111
The seeming failure could therefore be the ability of dualCEST to assess disease progression.
If this is true, dualCEST-MRI could be used to avoid other invasive modalities to monitor
disease progression. As a result, examinations could be performed on a more regular and fre-
quent basis, resulting in an improved level of patient care. However, due to the very small
group of patients to date, these conclusions are rather speculative and should be treated with
care. Nevertheless, the initial results seem promising and a subsequent inclusion of further
study participants will allow final conclusions to be drawn.
In summary, the preliminary results of the two pilot studies show that dualCEST enables the
identification of tumor tissue and first indications for a possible identification of Alzheimer’s
disease were obtained. For the Alzheimer’s study, the effect size seems to be higher than what
was observed for previous CEST approaches and, in addition, there might be evidence for
a correlation with the disease progression. Smaller differences between the dualCEST and
conventional protein contrast in tumor patients indicate that additional signaling influences
are present, proving the value of dualCEST as a reference for in vivo experiments. However,
for both studies the number of subjects is too small to draw any final conclusions. In the
future, the inclusion of more study participants into the ongoing studies, as well as the start
of new clinical studies with larger patient cohorts will be needed to conclusively assess the
diagnostic value of dualCEST-MRI, particularly the potential of the dualCEST contrast as




The aim of this study was the translation of the recently introduced dualCEST technique to
a clinical whole-body MR scanner to enable the non-invasive imaging of endogenous pro-
teins in vivo. To achieve this, several methodological developments were utilized, covering
all parts of the technique: signal preparation, imaging readout, and post-processing. The
developed imaging protocol was validated in extensive investigations of biochemical model
solutions and volunteers, and was applied in pilot studies with brain tumor and Alzheimer’s
patients.
First, the impact of lower magnetic field strengths on the dualCEST signal was investi-
gated, which revealed the signal broadening – which typically impairs conventional CEST
approaches – to be beneficial for the dualCEST technique. A subsequent optimization of
the RF saturation pulses in terms of amplitude, length, and timing allowed the maximiza-
tion of signal strength while avoiding excessive broadening of spectral resonances. To fur-
ther increase the saturation efficiency, novel cosine-modulated pulses were implemented
which enabled a simultaneous irradiation of both involved frequency offsets. Finally, the
dualCEST signal preparation module was combined with a fast and robust image readout
and optimized for maximum SNR and volume coverage while avoiding contrast deviations.
Moreover, a newly developed weighted acquisition scheme allowed for an optimal use of the
limited examination time by adjusting the number of averages per frequency offset pair to
the anticipated effect of the Z-value on the final contrast.
An important milestone for the application of dualCEST-MRI was the development and
implementation of an effective and robust denoising technique. This technique is based on a
dimensionality reduction using spectral redundancies, which are identified and exploited by
the linear correlations between the tens of thousands of spectra acquired for each measure-
ment. Combining the well-established dimensionality reduction technique PCA with an
appropriate data-driven identification of the relevant information allowed noise-like charac-
teristics to be separated from meaningful spectral features. Of note, the resulting improve-
ments are not limited to the topic of this study but are relevant for CEST research in general.
With regard to dualCEST-MRI, the denoising allowed the technique’s inherently low SNR
to be overcome, which facilitated examinations in a clinical setting.
The capability of the final dualCEST imaging protocol to meet the clinical needs in terms
of practicability, reproducibility and imaging speed was verified in extensive in vivo and in
vitro experiments. The preserved specificity of the dualCEST technique – following the ex-
tensive adaption to the clinical whole-body MR scanner – was confirmed in measurements
of biochemical model solutions comprising all major compounds present in living tissue.
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Furthermore, repeated volunteer measurements demonstrated the reproducibility and imag-
ing speed to be on par with established conventional CEST imaging protocols. The repro-
ducibility assessment moreover allowed quantification of the technique’s capability to resolve
genuine contrast changes from random fluctuations.
Finally, dualCEST-MRI was successfully applied in two pilot studies with brain tumor
and Alzheimer’s patients, demonstrating its applicability in a clinical setting. Due to the
confirmed specificity of the dualCEST approach, the observed significant signal decrease
in the glioblastoma region can be attributed to a pathological modification of mobile pro-
teins. Furthermore, recent preliminary results of dualCEST-MRI examinations of the two
Alzheimer’s patients and two healthy age-matched volunteers revealed a considerable sig-
nal alteration in the hippocampus of one subject, potentially indicating the capability of
dualCEST to assess disease progression. In the future, clinical studies with larger patient
cohorts will allow the diagnostic value of dualCEST-MRI to be investigated, particularly its
potential as a biomarker for neurodegenerative diseases or cancer. The exceptional protein
specificity of this approach will allow for novel insights into the origin of protein CEST
contrasts in vivo and, for the first time, for the determination of the actual contribution of
mobile proteins to conventional CEST signal changes in pathologic tissue.
Within this study, a clinical dualCEST imaging modality was established, which enables
the non-invasive investigation of endogenous proteins in living tissue. Due to its specificity,
the approach may become a valuable diagnostic tool, providing complementary information
on a molecular level for many diseases associated with pathological alterations of protein
expression, particularly for cancer and Alzheimer’s.
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A. Two-stage denoising of CEST-MRI data by principal
component analysis of spectral groups
Johannes Breitling1, Steffen Goerke1, Mark E. Ladd1, Peter Bachert1, Andreas Korzowski1
1 Division ofMedical Physics inRadiology, GermanCancerResearchCenter (DKFZ),Heidelberg,
Germany
Synopsis
In this study a novel method for the denoising of CESTMRI data is presented, combining the formation
of subsets of similar spectra and the subsequent application of a principal component analysis. Exploiting
only the subtle spectral differences of these reduced datasets – as opposed to using all spectra for the analysis
– allows for a better identification and isolation of the obscured underlying spectral features. The proposed
denoising resulted in an SNR gain by approximately a factor of four compared to the noisy initial data and
an additional 14% compared to the conventional principal component analysis denoising.
Introduction
Recently, we developed an adaptive denoising algo-
rithm for CEST spectra, combining the identifica-
tion of spectral redundancies by means of a princi-
pal component analysis (PCA) with an appropriate
data-driven truncation criterion to separate the rele-
vant spectral features from noise-like characteristics.A1
However, an even better denoising performance for
CEST data is desirable, for example, to generate high-
SNR ground truths for the reliable training of neural
networks. In this study a novel method is presented,
extending the previous approach by a second stage of
denoisingA2,A3 (Step 3 in methods section). To this
end, the result of the previously established denoising
approach is used to define for each spectrum the subset
of its most similar spectra. Subsequent application of a
PCA to these reduced datasets – exhibiting only subtle
spectral differences – allows for a better identification
and isolation of the obscured underlying spectral fea-
tures.
Methods
The proposed denoising algorithm comprises the fol-
lowing steps (Fig. A.1):
Step 1: The acquired CEST data of size u× v× y×n
(one 3D image for each of the n saturation frequency
offsets) is reformatted into a Casorati matrix of size
m×n (with m≤ u ·v ·y being the number of remaining
voxels after skull stripping). Subsequently, a variance-
stabilizing transformation (VST) is applied to the ma-
trix to correct for the Rician noise induced bias.A4
Step 2: In the first denoising stage, all noisy spectra
are denoised using the previously established adaptive
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Figure A.1: Illustration of the proposed denoising algorithm (representative spectrum in color). In the first stage,
transformed spectra (red) are denoised using an adaptive principal component analysis (PCA). In
the second stage, each resulting prefiltered spectrum (orange) is grouped with its closest K spectra.
The corresponding noisy groups are individually denoised using an adaptive PCA. The final de-
noised spectra (dark green) are obtained by averaging the corresponding spectra (light green) from
all denoised groups. Finally, back transformation yields the denoised dataset.
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PCA, whereby the optimal truncation is determined
by the Nelson criterion.A1,A5
Step 3: In the newly introduced second denoising
stage, each resulting prefiltered spectrum is used to de-
fine the group of its K (in this study set to 10 ·n) most
similar spectra (Step 3a),A3 whereby the similarity be-
tween two spectra and is determined by the cosine sim-
ilarity:
sim(si,s j) =
si · s j
‖si‖ · ‖s j‖
The corresponding groups of noisy spectra are each
denoised individually using again the adaptive PCA
(Step 3b and c). As a result, each group yields an esti-
mate for all included spectra.
Step 4: The final denoised spectra are calculated by av-
eraging the corresponding estimates from all groups.
Step 5: Application of the inverse VST and reformat-
ting to an image series yields the denoised dataset.
In vivo 3D CEST MRI was performed on a 7T whole-
body scanner (Siemens Healthineers, Germany) using
the snapshot-CEST approachA6 with a matrix size of
128×104×12 and a resolution of 1.7×1.7×3 mm3.
Presaturation was obtained by 140 Gaussian-shaped
pulses (tp = 15ms, duty cycle= 60%, tsat = 3.5 s,
meanB1 = 0.7 μT) applied at 56 unevenly distributed
offsets. Low-SNR data as input for the denoising were
acquired with bandwidth (BW ) = 1560Hz/pixel and
flip angle (FA)= 1◦ and high-SNR data with BW =
560Hz/pixel and FA = 4◦. All acquired image data
were motion corrected using an automatic multimodal
rigid registration algorithm in MITK,A7 corrected for
B0 inhomogeneities and manually skull stripped. A
ground truth was obtained by averaging five high-SNR
datasets and application of the first stage (i.e. single-
stage) denoising. To obtain a reference for the denois-
ing performance, the conventional single-stage denois-
ing was also applied to the low-SNR data. Image con-
trasts were calculated by the asymmetric magnetization
transfer ratio (MTRasym = (M(−∆ω)−M(∆ω))/M0)
at ∆ω = 3.5 ppm.
Results
Application of the proposed two-stage denoising algo-
rithm to the low-SNR data results in an image qual-
ity comparable with the ground truth (see last para-
graph in Methods for definition of the ground truth)
and slightly improved compared to using only the con-
ventional denoising approach (Fig. A.2). In the cor-
responding Bland-Altman plots (Fig. A.3), this trans-
lates into a reduced spread of the limits of agreement –
and thereby gain in SNR – by a factor of approximately
four compared to the noisy initial data and 14% com-
pared to the single-stage denoising. A small bias of the
proposed denoising is observable (i.e. difference of the
mean from zero in the Bland-Altman plot), which can
however in large parts be assigned to the different BW
and FA of the low-SNR data acquisition with respect
to the ground truth as it is already present in the noisy
data.
Discussion
The proposed method extends the previously presented
denoising algorithmA1 by a second denoising stage al-
lowing, improved image quality. Moreover, the se-
lection and subsequent denoising of similar subsets of
spectra reduces the risk of spectral features being unde-
sirably removed or significantly blurred. This is espe-
cially important for rare spectral features only present
in a small region of the acquisition volume (e.g. in the
tumor) containing the important clinical information.
However, introduction of the second stage comes at
the cost of increased computation time, as the spec-
tral matching and subsequent denoising are repeated
for each voxel. In a next step, a thorough investigation
on realistic simulations will be necessary to be able to
compare the denoising results with an unbiased ground
truth, thereby allowing quantification of the SNR gain
across multiple noise levels, as well as investigation of
the effect of the denoising on rare spectral features.
Conclusion
In this study, a novel denoising algorithm for CEST
MRI is presented that exploits in a second stage the de-
noising of spectrally matched groups. The resulting im-
proved image and spectral quality might in the future
allow for the development of faster CEST imaging se-
quences, application of metrics and methods especially
prone to noise, and generation of high-SNR ground
truths for the reliable training of neural networks.
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Figure A.2: MTRasym contrasts (Slice 8 of 12) of a healthy volunteer demonstrating the slight improvement in
image quality with the proposed two-stage denoising compared to only using the previously estab-
lished single-stage approach.
Figure A.3: Bland-Altman plots of the corresponding MTRasym contrasts, including the bias (solid line) and the
95% limits of agreement (dashed lines). Application of the proposed two-stage denoising results in
a reduced spread of the limits of agreement – and thereby SNR gain – by a factor of four compared
to the noisy initial data and 14% compared to the single-stage denoising.
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Synopsis
In this study, we propose a novel approach to determine the steady-state of CEST experiments without the
application of prolonged saturation periods. This is achieved by numerically calculating the steady-state
from a measurement with a reduced saturation period (in the order of the water proton T1). This may allow
quantitative CEST measurements, capable of providing information about pH and metabolite concentra-
tions, in a reasonable and clinical relevant time frame.
Introduction
Quantitative chemical exchange saturation transfer
(CEST) imaging has been shown to in principle allow
absolute pH imaging and determination of metabo-
lite concentrationsB1,B2. However, most of these tech-
niques rely on the steady-state CEST signal, which re-
quires a long saturation period in the order of 3-5 times
the longitudinal relaxation time of water (T1w)B3. For
clinical applications a compromise has therefore to be
made between a sufficiently long contrast preparation
and feasible examination timesB3. Here we present an
approach, which can bypass this obstacle by determin-
ing the steady-state of CEST experiments without the
application of saturation in compliance with the steady-
state criterion. Methods
Methods
During a pulsed CEST experiment (Fig. B.1a) the
initial Z-magnetization Zinit can be assumed to mono-
exponentially decay – via the so-called transient-state
Z – towards the steady-state Zsspulsed with the effective
decay rate R1ρ,pulsed (Fig. B.1b)B4,B5.
Z(∆ω) = Zsspulsed +(Zinit −Zsspulsed)e−tsat ·R1ρ,pulsed
(B.1)
Zsspulsed itself depends on R1ρ,pulsed according to
Zsspulsed =
R1w(1−DC+ cos2 θ ·DC)
R1ρ,pulsed
(B.2)
with the tilt angle of the effective field θ =
tan−1(ω1/∆ω). This mathematical relation can be ex-
ploited to reduce the number of unknown parameters
in Eq. B.1. For a known Zinit , this allows determining
Zsspulsed from Z for an arbitrary saturation time. Solv-
ing Eq. B.2 for the denominator and insertion in Eq.
B.1 yields Z as function of Zsspulsed .
Z(∆ω) =Zsspulsed +(Zinit −Zsspulsed)·
e−tsat ·R1w(1−DC+cos
2 θ ·DC)/Zsspulsed (B.3)
Eq. B.3 cannot be solved analytically for Zsspulsed .
However since Z is a strictly monotonously increasing
function of Zsspulsed , a numerical calculation can be ap-
plied. This calculus requires Z and Zinit for each fre-
quency offset ∆ω . In addition, B0, B1 and T1w have to
be determined once. Zinit can be estimated pixelwise
by the preceding measurement according to Zinit,i+1 =
P1 ·Zi+P0, where P1 and P0 are determined in a cali-
bration with the same sequence timings. All MR mea-
surements were performed on a 7T whole-body scan-
ner (Siemens Healthineers, Germany). Pre-saturation
was obtained by either 60 or 700 Gaussian-shaped
pulses (meanB1 = 0.5 μT, tsat = 15ms, duty cycle=
60%) leading to a saturation time of tsat = 1.5 s and
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Figure B.1: (a) Sequence diagram of a typical CEST experiment, consisting of a saturation and subsequent ac-
quisition phase. (b) During the saturation phase the initial Z-magnetization recovers towards the
steady-state and is eventually read-out resulting in the initial magnetization for the next frequency
offset.
17.5 s respectively. B0 and B1 were obtained using
the WASABI approachB6 and T1w with a saturation
recovery sequence. Quantitative relayed nuclear Over-
hauser effect (rNOE)-CEST images were calculated
using the apparent exchange-dependent relaxation rate
(AREX)B5 with a 5-pool Lorentzian fit analysis.
Results
In a region of interest (ROI) analysis (Fig. B.2a), the
conventional spectra exhibit strong differences in all
ROIs (blue lines in Fig.B.2 b-d). On the contrary,
the reconstructed Z-spectra (red lines) exhibit good
agreement with negligible deviations in white mat-
ter (WM) and only minor ones in grey matter (GM)
around ∆ω = −3.5 ppm. However, in cerebrospinal
fluid (CSF) large differences can be observed. The
calculated rNOE-CEST images display similar results
for the novel approach compared to the steady-state
with discrepancies only around the CSF, whereas the
rNOE-CEST images acquired by the conventional
method show significantly lower signal values across
the entire image (Fig. B.3).
Discussion
In contrast to the conventional approach, the presented
method was able to reproduce the steady-state in the
main regions of the brain. As expected, the highest
agreement can be observed in WM due to a short
T1w of 1.4 s (≈ tsat ). The small deviations around
∆ω = −3.5 ppm in GM can potentially be explained
by a comparably small exchange rate of the rNOE
(around 5Hz)B7 in combination with a longer T1w.
In this limit, the assumption of a mono-exponential
decay does not hold anymore and rotation effects as
well as exchange processes in the pauses would have
to be consideredB8. In the reconstructed Z-spectrum
of CSF considerable differences to the steady-state re-
main. This can be understood in terms of a partial vol-
ume effect, which does not allow assigning a single de-
cay rate to each voxel and thereby prevents a correct
reconstruction. However, in most CEST experiments
the main emphasis is on the solid components of the
brain (WM and GM) anyhow, for which the novel ap-
proach yields reliable results.
Conclusion
The proposed method was shown to enable steady-
state CEST measurements without application of pro-
longed saturation periods. The resulting reduction in
the required measurement time will eventually enable
performing quantitative CEST examinations, allow-




Figure B.2: (a) T1-map illustrating ROI evaluation for WM, GM and CSF of a healthy volunteer. (b-d) Strong
deviations, plotted as residuum (dotted lines), between steady-state (black) and conventional (blue)
Z-spectra in all ROIs are observable. By contrast, the novel approach (red) is able to reproduce the
steady-state almost without deviations apart from CSF.
Figure B.3: Quantitative rNOE-CEST images show good agreement between the novel method and steady-
state with larger deviations only observable around the CSF. In contrast, the images acquired by the
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C. Application to patients with Alzheimer’s disease
The specificity of dualCEST-MRI for the detection of changes in the concentration, molec-
ular size, and folding state of mobile proteins is of particular interest as a marker for degener-
ative diseases such as Alzheimer’s.32 In particular, it was possible to monitor the aggregation
of amyloid beta and the formation of amyloid fibrils in vitro as decrease of the dualCEST
signal.33 Preliminary studies using the rather rudimentary APT-weighted CEST signal
have revealed a signal increase in patients with however the origin not being unambiguously
assignable to changes in the APT, rNOE or ssMT.14 Moreover, recently, a comparable
decrease of conventional rNOE CEST signals was confirmed in an Alzheimer’s disease
transgenic mouse model.15 Examinations in human patients and volunteers are therefore
of special interest to evaluate the potential of CEST- and in particular dualCEST-MRI
for the diagnostic imaging of Alzheimer’s and further more to investigate the underlying
signal origin. In the following the first preliminary study results for dualCEST-MRI are
presented.
Two patients with diagnosed Alzheimer’s disease (56 and 68 years) and two healthy age-
matched volunteers (56 and 57 years) were examined. Examinations were approved by the
local ethics committee of the Medical Faculty of the University of Heidelberg and are in
accordance with the relevant guidelines and regulations. Written informed consent was
obtained prior to the examination.
All examinations were performed on a 3 T MR scanner (MAGNETOM Prisma; Siemens
Healthineers, Erlangen, Germany) using the vendor’s 64-channel head/neck coil. The imag-
ing protocol consisted of (i) conventional T2-weighted, (ii) relaxation-compensated APT
and rNOE CEST,98 (iii) APT-weighted CEST, and (iv) dualCEST. With regard to the
imaging protocol established in publication IV, only the denoising was altered and replaced
by the advanced approach described in appendix A. The image data of the first three modal-
ities have been submitted as a conference abstract to the 28th Annual Meeting of the Interna-
tional Society for Magnetic Resonance in Medicine, Paris, France 2020.112
The dualCEST-MRI of healthy volunteers exhibits the expected contrast with a clearly de-
lineated CSF and a slightly hyperintense WM compared to GM (cf. Figure C.1 and Figure
5 of publication IV). However, for the Alzheimer’s patients an incoherent contrast behavior
is observable. In patient one a global decrease of the dualCEST protein signal is appar-
ent, indicating, as expected, a considerable degeneration of the proteins and decline of the
brain structure. In contrast patient two exhibits no apparent abnormalities compared to the
healthy volunteers. This differing behavior is however actually in coherence with the no-
ticeable ventricle enlargement of patient one as compared to patient two and could therefore
indicate a difference in the disease progression. Statistical analysis of the dualCEST contrast
in the hippocampus (Figure C.1, magenta border) determined significantly different signal
values for patient one compared to the other three subjects, with the mean being well out-
side of the other standard deviation ranges (Figure C.2). A similar tendency is apparent for




Figure C.1: Representative slices of the dualCEST-MRI examinations of two Alzheimer’s
patients and two healthy volunteers. For statistical analysis, regions of inter-
est in the hippocampus (magenta border) were defined on the anatomical T2-
weighted images.
Figure C.2: Violin plots (i.e. extended box plots) depicting the data distribution of
dualCEST voxel values inside the regions of interest (Fig. C.1). Data is shown
for both, individual subjects (patients P1 and P2, volunteers V1 and V2) and for
the overall data sets of patients (P) and volunteers (V). The plots include markers
for median, interquartile ranges, mean and standard deviation (SD) ranges.
104
C Application to patients with Alzheimer’s disease
Figure C.3: Violin plots depicting the rNOE data distribution, equivalent to figure C.2.
The preliminary results support the potential of dualCEST-MRI for diagnostic imaging of
Alzheimer’s disease. The observed signal decrease in the first patient is in line with the results
of the in vitro study33 and moreover with the mouse model examined using conventional
rNOE CEST.15 The differing contrast behavior of the second patient, exhibiting signal
values very similar to the ones of volunteers, could potentially be explained by a difference
in the disease progression. DualCEST-MRI might therefore have the potential to be used
for assessing the severity of the disease. However, the study size (two patients and two
volunteers) is yet too small to determine any statistical significance. In the future, inclusion
of more participants with clearly defined disease progression states will be essential to assess
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